Cover
Cover - USD ($) | 12 Months Ended | ||
Dec. 31, 2022 | Jan. 31, 2023 | Jun. 30, 2022 | |
Document Information [Line Items] | |||
Document Type | 10-K | ||
Document Period End Date | Dec. 31, 2022 | ||
Current Fiscal Year End Date | --12-31 | ||
Entity File Number | 1-4018 | ||
Entity Registrant Name | Dover Corporation | ||
Entity Incorporation, State or Country Code | DE | ||
Entity Tax Identification Number | 53-0257888 | ||
Entity Address, Address Line One | 3005 Highland Parkway | ||
Entity Address, City or Town | Downers Grove, | ||
Entity Address, State or Province | IL | ||
Entity Address, Postal Zip Code | 60515 | ||
City Area Code | (630) | ||
Local Phone Number | 541-1540 | ||
Entity Well-known Seasoned Issuer | Yes | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Large Accelerated Filer | ||
Entity Small Business | false | ||
Entity Emerging Growth Company | false | ||
ICFR Auditor Attestation Flag | true | ||
Entity Shell Company | false | ||
Entity Public Float | $ 17,347,519,018 | ||
Entity Common Stock, Shares Outstanding | 139,713,200 | ||
Document Fiscal Year Focus | 2022 | ||
Document Fiscal Period Focus | FY | ||
Document Annual Report | true | ||
Document Transition Report | false | ||
Amendment Flag | false | ||
Entity Central Index Key | 0000029905 | ||
Documents Incorporated by Reference | Certain Portions of the Proxy Statement for Annual Meeting of Shareholders to be held on May 5, 2023 (the "2023 Proxy Statement"). | ||
Common Stock, par value $1 | |||
Document Information [Line Items] | |||
Title of 12(b) Security | Common Stock, par value $1 | ||
Trading Symbol | DOV | ||
Security Exchange Name | NYSE | ||
1.250% Notes due 2026 | |||
Document Information [Line Items] | |||
Title of 12(b) Security | 1.250% Notes due 2026 | ||
Trading Symbol | DOV 26 | ||
Security Exchange Name | NYSE | ||
0.750% Notes due 2027 | |||
Document Information [Line Items] | |||
Title of 12(b) Security | 0.750% Notes due 2027 | ||
Trading Symbol | DOV 27 | ||
Security Exchange Name | NYSE |
Audit Information
Audit Information | 12 Months Ended |
Dec. 31, 2022 | |
Audit Information [Abstract] | |
Auditor Name | PricewaterhouseCoopers LLP |
Auditor Firm ID | 238 |
Auditor Location | Chicago, Illinois |
CONSOLIDATED STATEMENTS OF EARN
CONSOLIDATED STATEMENTS OF EARNINGS - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Income Statement [Abstract] | |||
Revenue | $ 8,508,088 | $ 7,907,081 | $ 6,683,760 |
Cost of goods and services | 5,444,532 | 4,937,295 | 4,209,741 |
Gross profit | 3,063,556 | 2,969,786 | 2,474,019 |
Selling, general and administrative expenses | 1,684,226 | 1,688,278 | 1,541,032 |
Operating earnings | 1,379,330 | 1,281,508 | 932,987 |
Interest expense | 116,456 | 106,319 | 111,937 |
Interest income | (4,430) | (4,441) | (3,571) |
Gain on dispositions | 0 | (206,338) | (5,213) |
Other income, net | (20,201) | (14,858) | (11,900) |
Earnings before provision for income taxes | 1,287,505 | 1,400,826 | 841,734 |
Provision for income taxes | 222,129 | 277,008 | 158,283 |
Net earnings | $ 1,065,376 | $ 1,123,818 | $ 683,451 |
Net earnings per share: | |||
Net earnings per share, Basic (in dollars per share) | $ 7.47 | $ 7.81 | $ 4.74 |
Net earnings per share, Diluted (in dollars per share) | $ 7.42 | $ 7.74 | $ 4.70 |
Weighted average shares outstanding: | |||
Weighted average shares outstanding - basic | 142,681,000 | 143,923,000 | 144,050,000 |
Weighted average shares outstanding - diluted | 143,595,000 | 145,273,000 | 145,393,000 |
CONSOLIDATED STATEMENTS OF COMP
CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Statement of Comprehensive Income [Abstract] | |||
Net earnings | $ 1,065,376 | $ 1,123,818 | $ 683,451 |
Foreign currency translation adjustments: | |||
Foreign currency translation (losses) gains | (119,010) | (39,819) | 55,450 |
Reclassification of foreign currency translation losses to earnings | 5,915 | 0 | 0 |
Total foreign currency translation adjustments (net of $(17,824), $(20,976) and $26,957 tax (provision) benefit, respectively) | (113,095) | (39,819) | 55,450 |
Pension and other postretirement benefit plans: | |||
Actuarial (losses) gains | (2,658) | 26,960 | 705 |
Prior service credit (cost) | 1,370 | (1,433) | 828 |
Amortization of actuarial losses included in net periodic pension cost | 1,903 | 9,451 | 6,695 |
Amortization of prior service costs included in net periodic pension cost | 888 | 1,023 | 1,153 |
Settlement and curtailment impact | 3,688 | 1,167 | 18 |
Total pension and other postretirement benefit plans (net of $(2,230), $(9,868) and $(3,197) tax provision, respectively) | 5,191 | 37,168 | 9,399 |
Changes in fair value of cash flow hedges: | |||
Unrealized net (losses) gains | (535) | 6,724 | (1,445) |
Net gains reclassified into earnings | (3,732) | (4,871) | (632) |
Total cash flow hedges (net of $1,217, $(532) and $607 tax benefit (provision), respectively) | (4,267) | 1,853 | (2,077) |
Other comprehensive (loss) earnings, net of tax | (112,171) | (798) | 62,772 |
Comprehensive earnings | $ 953,205 | $ 1,123,020 | $ 746,223 |
CONSOLIDATED STATEMENT OF COMPR
CONSOLIDATED STATEMENT OF COMPREHENSIVE EARNINGS (Parenthetical) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Statement of Comprehensive Income [Abstract] | |||
Foreign currency translation adjustments, tax benefit (provision) | $ (17,824) | $ (20,976) | $ 26,957 |
Pension and other postretirement benefit plans tax provision | (2,230) | (9,868) | (3,197) |
Cash flow hedges tax benefit (provision) | $ 1,217 | $ (532) | $ 607 |
CONSOLIDATED BALANCE SHEETS
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Current assets: | ||
Cash and cash equivalents | $ 380,868 | $ 385,504 |
Receivables, net | 1,516,871 | 1,347,514 |
Inventories, net | 1,366,608 | 1,191,095 |
Prepaid and other current assets | 159,118 | 137,596 |
Total current assets | 3,423,465 | 3,061,709 |
Property, plant and equipment, net | 1,004,825 | 957,310 |
Goodwill | 4,669,494 | 4,558,822 |
Intangible assets, net | 1,333,735 | 1,359,522 |
Other assets and deferred charges | 465,000 | 466,264 |
Total assets | 10,896,519 | 10,403,627 |
Current liabilities: | ||
Short-term borrowings | 735,772 | 105,702 |
Accounts payable | 1,068,144 | 1,073,568 |
Accrued compensation and employee benefits | 269,785 | 302,978 |
Deferred revenue | 256,933 | 227,549 |
Accrued insurance | 92,876 | 101,448 |
Other accrued expenses | 318,337 | 347,097 |
Federal and other income taxes | 31,427 | 91,999 |
Total current liabilities | 2,773,274 | 2,250,341 |
Long-term debt | 2,942,513 | 3,018,714 |
Deferred income taxes | 375,150 | 364,117 |
Noncurrent income tax payable | 44,313 | 48,385 |
Other liabilities | 474,903 | 532,542 |
Stockholders' equity: | ||
Preferred stock - $100 par value; 100,000 shares authorized; none issued | 0 | 0 |
Common stock - $1 par value; 500,000,000 shares authorized; 259,643,756 and 259,457,233 shares issued at December 31, 2022 and 2021 | 259,644 | 259,457 |
Additional paid-in capital | 867,560 | 857,636 |
Retained earnings | 10,223,070 | 9,445,245 |
Accumulated other comprehensive loss | (266,223) | (154,052) |
Treasury stock, at cost: 119,945,271 and 115,411,548 shares at December 31, 2022 and 2021 | (6,797,685) | (6,218,758) |
Total stockholders' equity | 4,286,366 | 4,189,528 |
Total liabilities and stockholders' equity | $ 10,896,519 | $ 10,403,627 |
CONSOLIDATED BALANCE SHEETS (Pa
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares | Dec. 31, 2022 | Dec. 31, 2021 |
Statement of Financial Position [Abstract] | ||
Preferred stock, par value per share | $ 100 | $ 100 |
Preferred stock, shares authorized | 100,000 | 100,000 |
Preferred stock, shares issued | 0 | 0 |
Common stock, par value per share (in dollars per share) | $ 1 | $ 1 |
Common stock, shares authorized | 500,000,000 | 500,000,000 |
Common stock, shares issued | 259,643,756 | 259,457,233 |
Treasury stock, shares | 119,945,271 | 115,411,548 |
CONSOLIDATED STATEMENT OF STOCK
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Parentheticals) - $ / shares | 12 Months Ended | |||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Statement of Stockholders' Equity [Abstract] | ||||
Common stock, par value per share (in dollars per share) | $ 1 | $ 1 | $ 1 | $ 1 |
Accounting Standards Update [Extensible Enumeration] | Accounting Standards Update 2016-13 | |||
Dividends paid per common share (in dollars per share) | $ 2.01 | $ 1.99 | $ 1.97 |
CONSOLIDATED STATEMENTS OF CASH
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Operating Activities: | |||
Net earnings | $ 1,065,376 | $ 1,123,818 | $ 683,451 |
Adjustments to reconcile net earnings to cash provided by operating activities: | |||
Depreciation and amortization | 307,538 | 290,123 | 279,051 |
Stock-based compensation | 30,821 | 31,111 | 25,026 |
Gain on dispositions | 0 | (206,338) | (5,213) |
Provision for losses on accounts receivable (net of recoveries) | 5,552 | 5,053 | 11,171 |
Deferred income taxes | (28,138) | (48,322) | (25,643) |
Employee benefit plan expense | 3,096 | 11,897 | 7,205 |
Other, net | (18,218) | (7,368) | (6,593) |
Cash effect of changes in assets and liabilities (excluding effects of acquisitions, dispositions and foreign exchange): | |||
Accounts receivable | (209,021) | (201,540) | 122,407 |
Inventories | (199,033) | (297,623) | 10,519 |
Prepaid expenses and other assets | (3,494) | (14,303) | (17,915) |
Accounts payable | 15,422 | 229,334 | (95,636) |
Accrued compensation and employee benefits | (34,803) | 65,482 | 12,277 |
Accrued expenses and other liabilities | (54,067) | 60,734 | 129,916 |
Accrued taxes | (62,417) | 88,190 | (5,412) |
Contributions to employee benefit plans | (12,890) | (14,383) | (19,801) |
Net cash provided by operating activities | 805,724 | 1,115,865 | 1,104,810 |
Investing Activities: | |||
Additions to property, plant and equipment | (220,962) | (171,465) | (165,692) |
Acquisitions (net of cash and cash equivalents acquired) | (312,855) | (1,112,075) | (335,786) |
Proceeds from sale of property, plant and equipment | 6,061 | 7,070 | 7,207 |
Proceeds from dispositions | 0 | 274,982 | 15,400 |
Other | (13,168) | 8,735 | (2,508) |
Net cash used in investing activities | (540,924) | (992,753) | (481,379) |
Financing Activities: | |||
Change in commercial paper and other short-term borrowings, net | 629,891 | 105,000 | (84,700) |
Dividends to stockholders | (287,551) | (286,896) | (284,312) |
Repurchase of common stock, including accelerated share repurchase program | (585,000) | (21,637) | (106,279) |
Payments to settle employee tax obligations on exercise of share-based awards | (14,637) | (41,924) | (28,476) |
Other | (2,968) | (4,423) | (2,523) |
Net cash used in financing activities | (260,265) | (249,880) | (506,290) |
Effect of exchange rate changes on cash and cash equivalents | (9,171) | (803) | (1,319) |
Net (decrease) increase in cash and cash equivalents | (4,636) | (127,571) | 115,822 |
Cash and cash equivalents at beginning of year | 385,504 | 513,075 | 397,253 |
Cash and cash equivalents at end of year | 380,868 | 385,504 | 513,075 |
Supplemental information - cash paid during the year for: | |||
Income taxes | 354,468 | 233,631 | 199,657 |
Interest | $ 112,469 | $ 102,139 | $ 108,119 |
CONSOLIDATED STATEMENT OF STO_2
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands | Total | Cumulative Effect, Period of Adoption, Adjustment | Common Stock, par value $1 | Additional Paid-In Capital | Retained Earnings | Retained Earnings Cumulative Effect, Period of Adoption, Adjustment | Accumulated Other Comprehensive Earnings (Loss) | Treasury Stock |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||
Adoption of ASU No. 2016-13- CECL | $ (2,112) | $ (2,112) | ||||||
Balance at beginning of year at Dec. 31, 2019 | $ 3,032,660 | $ 258,552 | $ 869,719 | $ 8,211,257 | $ (216,026) | $ (6,090,842) | ||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||
Net earnings | 683,451 | 683,451 | ||||||
Dividends paid | (284,312) | (284,312) | ||||||
Common stock issued for the exercise of share-based awards | (28,476) | 430 | (28,906) | |||||
Stock-based compensation expense | 25,026 | 25,026 | ||||||
Common stock acquired | (106,279) | (106,279) | ||||||
Other comprehensive (loss) earnings, net of tax | 62,772 | 62,772 | ||||||
Other | 3,043 | 3,043 | 0 | |||||
Balance at end of year at Dec. 31, 2020 | 3,385,773 | 258,982 | 868,882 | 8,608,284 | (153,254) | (6,197,121) | ||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||
Net earnings | 1,123,818 | 1,123,818 | ||||||
Dividends paid | (286,896) | (286,896) | ||||||
Common stock issued for the exercise of share-based awards | (41,924) | 475 | (42,399) | |||||
Stock-based compensation expense | 31,111 | 31,111 | ||||||
Common stock acquired | (21,637) | (21,637) | ||||||
Other comprehensive (loss) earnings, net of tax | (798) | (798) | ||||||
Other | 81 | 42 | 39 | |||||
Balance at end of year at Dec. 31, 2021 | 4,189,528 | 259,457 | 857,636 | 9,445,245 | (154,052) | (6,218,758) | ||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||
Adoption of ASU No. 2016-13- CECL | 4,189,528 | (154,052) | ||||||
Net earnings | 1,065,376 | 1,065,376 | ||||||
Dividends paid | (287,551) | (287,551) | ||||||
Common stock issued for the exercise of share-based awards | (14,637) | 187 | (14,824) | |||||
Stock-based compensation expense | 30,821 | 30,821 | ||||||
Common stock acquired | (585,000) | (6,073) | (578,927) | |||||
Other comprehensive (loss) earnings, net of tax | (112,171) | (112,171) | ||||||
Balance at end of year at Dec. 31, 2022 | 4,286,366 | $ 259,644 | $ 867,560 | $ 10,223,070 | (266,223) | $ (6,797,685) | ||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||
Adoption of ASU No. 2016-13- CECL | $ 4,286,366 | $ (266,223) |
Description of Business and Sum
Description of Business and Summary of Significant Accounting Policies | 12 Months Ended |
Dec. 31, 2022 | |
Accounting Policies [Abstract] | |
Description of Business and Summary of Significant Accounting Policies | 1. Description of Business and Summary of Significant Accounting Policies Description of Business Dover Corporation ("Dover" or "Company") is a diversified global manufacturer and solutions provider delivering innovative equipment and components, consumable supplies, aftermarket parts, software and digital solutions and support services. The Company's businesses are based primarily in the United States and Europe with manufacturing and other operations throughout the world. The Company operates through five business segments that are structured around similar business models, go-to market strategies and manufacturing practices: Engineered Products, Clean Energy & Fueling, Imaging & Identification, Pumps & Process Solutions and Climate & Sustainability Technologies. For additional information on the Company's segments, see Note 19 — Segment Information. Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. Intercompany accounts and transactions have been eliminated in consolidation. The results of operations of acquired businesses are included from the dates of acquisitions. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the Consolidated Financial Statements and accompanying disclosures. These estimates may be adjusted due to changes in future economic, industry, or customer financial conditions, as well as changes in technology or demand. Estimates are used for, but not limited to, allowances for doubtful accounts receivable, net realizable value of inventories, restructuring reserves, warranty reserves, pension and post-retirement plans, stock-based compensation, useful lives for depreciation and amortization of long-lived assets including finite-lived intangibles, future cash flows associated with impairment testing for goodwill, indefinite-lived intangible assets and other long-lived assets, deferred tax assets, unrecognized tax benefits and contingencies. Actual results may ultimately differ from these estimates, although management does not believe such differences would materially affect the consolidated financial statements in any individual year. Estimates and assumptions are periodically reviewed and the effects of changes in these estimates and assumptions are reflected in the Consolidated Financial Statements in the period that they are determined. Cash and Cash Equivalents Cash and cash equivalents include cash on hand, demand deposits and short-term investments, which are highly liquid in nature and have original maturities at the time of purchase of three months or less. The carrying value of cash and cash equivalents approximates fair value. Accounts Receivable and Allowance for Credit Losses Accounts receivable are recorded at face amounts less an allowance for credit losses. The allowance is an estimate based on historical collection experience, current and future economic and market conditions and a review of the current status of each customer's trade accounts receivable. Management evaluates the aging of the accounts receivable balances and the financial condition of its customers and all other forward-looking information that is reasonably available to estimate the amount of accounts receivable that may not be collected in the future and records the appropriate provision. See Note 8 — Credit Losses for additional information. Inventories Inventories are stated at the lower of cost, determined on the first-in, first-out (FIFO) basis, or net realizable value. An immaterial portion of domestic inventories is stated at cost, determined on the last-in, first-out (LIFO) basis, which is less than net realizable value. Property, Plant and Equipment Property, plant and equipment includes the historical cost of land, buildings, machinery and equipment, purchased software, finance lease assets and significant improvements to existing plant and equipment or, in the case of acquisitions, the fair value of acquired assets. Expenditures for maintenance, repairs and minor renewals are expensed as incurred. When property or equipment is sold or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts and the gain or loss realized on disposition is reflected in earnings. The Company depreciates its assets on a straight-line basis over their estimated useful lives as follows: buildings and improvements 5 to 31.5 years; machinery and equipment 3 to 15 years; furniture and fixtures 3 to 7 years; vehicles 3 to 7 years; and software 3 to 10 years. Derivative Financial Instruments The Company uses derivative financial instruments to hedge its exposures to various risks, including foreign currency exchange rate risk. The Company does not enter into derivative financial instruments for speculative purposes and does not have a material portfolio of derivative financial instruments. Derivative financial instruments used for hedging purposes must be designated and effective as a hedge of the identified risk exposure at inception of the contract. The Company recognizes all derivatives as either assets or liabilities on the consolidated balance sheet and measures those instruments at fair value. For derivatives designated as hedges of the fair value of assets or liabilities, the changes in fair value of both the derivatives and of the hedged items are recorded in current earnings. For derivatives designated as cash flow hedges, the change in the fair value of the derivatives is recorded as a component of other comprehensive earnings and subsequently recognized in net earnings when the hedged items impact earnings. Goodwill and Other Intangible Assets Goodwill represents the excess of purchase price over the fair value of net assets acquired. Goodwill and certain other intangible assets deemed to have indefinite lives (primarily trademarks) are not amortized. For goodwill, impairment tests are required at least annually, or more frequently if events or circumstances indicate that it may be impaired, when some portion but not all of a reporting unit is disposed of or classified as assets held for sale, or when a change in the composition of reporting units occurs for other reasons, such as a change in segments. Based on its current organizational structure, the Company identified reporting units for which cash flows are determinable and to which goodwill was allocated. The Company performs its goodwill impairment test annually in the fourth quarter at the reporting unit level. A quantitative test is used to determine existence of goodwill impairment and the amount of the impairment loss at the reporting unit level. The quantitative test compares the fair value of a reporting unit with its carrying amount, including goodwill. The Company uses an income-based valuation method, determining the present value of estimated future cash flows, to estimate the fair value of a reporting unit. If the fair value of a reporting unit exceeds its carrying amount, goodwill of the reporting unit is not impaired. If the carrying amount of a reporting unit exceeds its fair value, an impairment loss shall be recognized in an amount equal to that excess, limited to the total amount of goodwill allocated to that reporting unit. Factors used in the impairment analysis require significant judgment, and actual results may differ from assumed and estimated amounts. The Company uses its own market assumptions including internal projections of future cash flows, discount rates and other assumptions considered reasonable in the analysis and reflective of market participant assumptions. These forecasts are based on historical performance and future estimated results. The discount rates utilized are based on a capital asset pricing model and published relevant industry rates, which take into consideration the risks and uncertainties inherent to the reporting units and in the internally developed forecasts. See Note 9 — Goodwill and Other Intangible Assets for further discussion of the Company's annual goodwill impairment test and results. No impairment of goodwill was required for the years ended December 31, 2022, 2021, or 2020. The Company uses an income-based valuation method to annually test its indefinite-lived intangible assets for impairment. The fair value of the intangible asset is compared to its carrying value. This method uses the Company's own market assumptions, which are considered reasonable. Any excess of carrying value over the estimated fair value is recognized as an impairment loss. No impairment of indefinite-lived intangible assets was required for the years ended December 31, 2022, 2021, or 2020. Other intangible assets with determinable lives primarily consist of customer intangibles, unpatented technologies, patents and trademarks. The other intangible assets are amortized over their estimated useful lives, ranging from 5 to 20 years. Long-lived assets (including definite-lived intangible assets) are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable, such as a significant sustained change in the business climate. If an indicator of impairment exists for any grouping of assets, an estimate of undiscounted future cash flows is prepared and compared to its carrying value. If an asset group is determined to be impaired, the loss is measured by the excess of the carrying amount of the asset group over its fair value, as determined by an estimate of discounted future cash flows. Leases The Company determines if an arrangement is a lease at inception of a contract. The Company has operating and finance leases for corporate offices, manufacturing plants, research and development facilities, shared services facilities, vehicle fleets and certain office and manufacturing equipment. Operating lease right-of-use ("ROU") assets are included in other assets and deferred charges and operating lease liabilities are included in other accrued expenses and other liabilities in the consolidated balance sheet. Finance lease ROU assets are included in property, plant and equipment, and the related lease liabilities are included in other accrued expenses and other liabilities in the consolidated balance sheet. Leases with an initial term of 12 months or less are not recorded in the balance sheet. The Company accounts for each separate lease component of a contract and its associated non-lease components as a single lease component, thus causing all fixed payments to be capitalized. Variable lease payment amounts that cannot be determined at the commencement of the lease, such as increases in lease payments based on changes in index rates or usage, are not included in the ROU assets or lease liabilities. These are expensed as incurred and recorded as variable lease expense. ROU assets represent the Company's right to use an underlying asset during the lease term and lease liabilities represent the Company's obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the commencement date based on the net present value of fixed lease payments over the lease term. The lease term includes options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. ROU assets also include any advance lease payments made and exclude lease incentives. As most of the Company's operating leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. Finance lease agreements include an interest rate that is used to determine the present value of future lease payments. Fixed operating lease expense and finance lease depreciation expense are recognized on a straight-line basis over the lease term. Restructuring Accruals The Company takes actions to reduce headcount, close facilities, or otherwise exit operations. Such restructuring activities at an operation are recorded when management has committed to an exit or reorganization plan and when termination benefits are probable and can be reasonably estimated based on circumstances at the time the restructuring plan is approved by management or when termination benefits are communicated. Exit costs may include contractual terminations and asset impairments as a result of an approved restructuring plan. The accrual of both severance and exit costs requires the use of estimates. Though the Company believes that its estimates accurately reflect the anticipated costs, actual results may be different from the original estimated amounts. Foreign Currency Assets and liabilities of non-U.S. subsidiaries, where the functional currency is not the U.S. dollar, have been translated at year-end exchange rates and profit and loss accounts have been translated using weighted-average monthly exchange rates. Foreign currency translation gains and losses are included in the consolidated statements of comprehensive earnings as a component of other comprehensive earnings (loss). Assets and liabilities of an entity that are denominated in currencies other than an entity's functional currency are re-measured into the functional currency using end of period exchange rates, where applicable to certain balances. Gains and losses related to these re-measurements are recorded within the consolidated statements of earnings as a component of other income, net. Gains and losses arising from intercompany foreign currency transactions that are of a long-term investment in nature are reported in the same manner as translation adjustments. Revenue Recognition The majority of the Company's revenue is generated through the manufacture and sale of a broad range of specialized products and components, with revenue recognized upon transfer of control, title and risk of loss, which is generally upon shipment. Service revenue represents less than 5% of total revenue and is recognized as the services are performed. In limited cases, revenue arrangements with customers require delivery, installation, testing, certification, or other acceptance provisions to be satisfied before revenue is recognized. The Company includes shipping costs billed to customers in revenue and the related shipping costs in cost of goods and services. Stock-Based Compensation The principal awards issued under the Company's stock-based compensation plans include non-qualified stock appreciation rights ("SARs"), restricted stock units ("RSUs") and performance share awards ("PSAs"). The cost for such awards is measured at the grant date based on the fair value of the award. At the time of grant, the Company estimates forfeitures, based on historical experience, in order to estimate the portion of the award that will ultimately vest. The value of the portion of the award that is expected to ultimately vest is recognized as expense on a straight-line basis, generally over the explicit service period of three years (except for retirement-eligible employees) and is included in selling, general and administrative expenses in the consolidated statements of earnings. Expense for awards granted to retirement-eligible employees is recorded over the period from the date of grant through the date the employee first becomes eligible to retire and is no longer required to provide service. See Note 15 — Equity and Cash Incentive Program for additional information related to the Company's stock-based compensation. Income Taxes The provision for income taxes includes federal, state, local and non-U.S. taxes. Tax credits, primarily for research and experimentation, are recognized as a reduction of the provision for income taxes in the year in which they are available for tax purposes. Deferred taxes are provided using enacted rates on the future tax consequences of temporary differences. Temporary differences include the differences between the financial statement carrying amounts of assets and liabilities and their respective tax basis and the tax benefit of carryforwards. A valuation allowance is established for deferred tax assets for which it is more likely than not that some portion or all of the deferred tax benefit will not be realized. In assessing the need for a valuation allowance, management considers all available evidence, including the future reversal of existing taxable temporary differences, taxable income in carryback periods, prudent and feasible tax planning strategies and estimated future taxable income. The valuation allowance can be affected by changes to tax regulations, interpretations and rulings, changes to enacted statutory tax rates and changes to future taxable income estimates. Tax benefits are recognized from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position in consideration of applicable tax statutes and related interpretations and precedents. Tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than 50% likelihood of being realized on ultimate settlement. Research and Development Costs Research and development costs, including qualifying engineering costs, are expensed when incurred and amounted to $163,300 in 2022, $157,826 in 2021 and $142,101 in 2020. These costs as a percent of revenue were 1.9% in 2022, 2.0% in 2021 and 2.1% in 2020. Research and development costs are reported within selling, general and administrative expenses in the consolidated statements of earnings. Advertising Costs Advertising costs are expensed when incurred and amounted to $25,905 in 2022, $23,685 in 2021 and $21,375 in 2020. Advertising costs are reported within selling, general and administrative expenses in the consolidated statements of earnings. Risk, Retention, Insurance The Company's insurance programs contain various deductibles that, based on the Company's experience, are typical and customary for a company of its size and risk profile. The Company does not consider any of the deductibles to represent a material risk to the Company. The Company generally maintains insurance policies with deductibles for claims and liabilities related primarily to workers' compensation, health and welfare claims, general liability, product and automobile liability, cybersecurity risks, property damage and business interruption resulting from certain events. The Company accrues for claim exposures that are probable of occurrence and can be reasonably estimated. Recent Accounting Pronouncements Recently Issued Accounting Standards The following accounting standards updates ("ASU"), issued by the Financial Accounting Standards Board ("FASB"), will, or are expected to, result in a change in practice and/or have a financial impact to the Company's Consolidated Financial Statements: In September 2022, the FASB issued ASU No. 2022-04 Liabilities-Supplier Finance Programs (Topic 405-50): Disclosure of Supplier Finance Program Obligations. The amendments in this update require a buyer in a supplier finance program to disclose information about the program's nature, activity during the period, changes from period to period, and potential magnitude. The guidance will become effective January 1, 2023 and early adoption is permitted. Management is currently evaluating the impact of adopting this ASU on the Company's Consolidated Financial Statements. Recently Adopted Accounting Standards In October 2021, the FASB issued ASU No. 2021-08 Business Combinations (Topic 805)-Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The amendments in this update require that an acquirer recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606, Revenue from Contracts with Customers, as if the acquirer had originated the contracts. Under current guidance, the acquirer generally recognizes such contract assets and contract liabilities at fair value on the acquisition date. The amendments in this update are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The amendments in this update should be applied prospectively to business combinations occurring on or after the effective date of the amendments. Early adoption of the amendments is permitted, including adoption in an interim period. The Company early adopted the guidance as of January 1, 2022, which did not have a material impact on the Company's Consolidated Financial Statements. In March 2020 and January 2021, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform on Financial Reporting and ASU No. 2021-01, Reference Rate Reform, Scope, respectively. In December 2022, the FASB issued ASU No. 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848 as an update to ASU No. 2020-04. These updates provide optional guidance for a limited time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform, including expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments in these updates are elective and are effective upon issuance for all entities. The Company adopted the guidance, which did not have a material impact on the Company's Consolidated Financial Statements. |
Revenue
Revenue | 12 Months Ended |
Dec. 31, 2022 | |
Revenue from Contract with Customer [Abstract] | |
Revenue | 2. Revenue Revenue from contracts with customers A majority of the Company's revenue is short cycle in nature with shipments within one year from order. A small portion of the Company's revenue derives from contracts extending over one year. The Company's payment terms generally range between 30 to 90 days and vary by the location of businesses, the type of products manufactured to be sold and the volume of products sold, among other factors. Disaggregation of Revenue Revenue from contracts with customers is disaggregated by segment and geographic location, as they best depict the nature and amount of the Company's revenue. See Note 19 — Segment Information for revenue by segment and geographic location. Performance Obligations A majority of the Company's contracts have a single performance obligation which represents, in most cases, the equipment or product being sold to the customer. Some contracts include multiple performance obligations such as a product and the related installation, extended warranty, software and digital solutions, and/or maintenance services. These contracts require judgment in determining the number of performance obligations. The Company has elected to use the practical expedient to not adjust the promised amount of consideration for the effects of a significant financing component if it is expected, at contract inception, that the period between when the Company transfers a promised good or service to a customer, and when the customer pays for that good or service, will be one year or less. Thus, the Company may not consider an advance payment to be a significant financing component, if it is received less than one year before product completion. The majority of the Company's contracts offer assurance-type warranties in connection with the sale of a product to a customer. Assurance-type warranties provide a customer with assurance that the related product will function as the parties intended because it complies with agreed-upon specifications. Such warranties do not represent a separate performance obligation. The Company may also offer service-type warranties that provide services to the customer, in addition to the assurance that the product complies with agreed-upon specifications. If a warranty is determined to be a service-type warranty, it represents a distinct service and is treated as a separate performance obligation. Estimates are used to determine the amount of variable consideration in contracts, the standalone selling price among separate performance obligations and the measure of progress for contracts where revenue is recognized over time. The Company reviews and updates these estimates regularly. Some contracts with customers include variable consideration primarily related to volume rebates. The Company estimates variable consideration at the most likely amount to determine the total consideration which the Company expects to be entitled. Estimated amounts are included in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. The Company's estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely on an assessment of anticipated performance and all information (historical, current and forecasted) that is reasonably available. For contracts with multiple performance obligations, the Company allocates the total transaction price to each performance obligation in an amount based on the estimated relative standalone selling prices of the promised goods or services underlying each performance obligation. The Company uses an observable price to determine the standalone selling price for separate performance obligations or a cost plus margin approach when one is not available. Over 95% of the Company's performance obligations are recognized at a point in time, rather than over time, as the Company completes its performance obligations. Specifically, revenue is recognized when control transfers to the customer, typically upon shipment or completion of installation, testing, certification, or other substantive acceptance provisions required under the contract. Less than 5% of the Company's revenue is recognized over time and relates to the sale of equipment or services in which the Company transfers control of a good or service over time and the customer simultaneously receives and consumes the benefits as the Company performs, or our performance creates or enhances an asset the customer controls as the asset is created or enhanced, or our performance does not create an asset with an alternative use to the Company and the Company has an enforceable right to payment for its performance to date plus a reasonable margin. For revenue recognized over time, there are two types of methods for measuring progress and both are relevant to the Company: (1) input methods and (2) output methods. Although this may vary by business, input methods generally are based on costs incurred relative to estimated total costs. Output methods generally are based on a measurement of progress, such as milestone achievement. The businesses use the method and measure of progress that best depicts the transfer of control to the customer of the goods or services to date relative to the remaining goods or services promised under the contract. Transaction Price Allocated to the Remaining Performance Obligations At December 31, 2022, we estimated that $296,698 in revenue is expected to be recognized in the future related to performance obligations that are unsatisfied (or partially unsatisfied) at the end of the reporting period. We expect to recognize approximately 63.1% of our unsatisfied (or partially unsatisfied) performance obligations as revenue in 2023, with the remaining balance to be recognized in 2024 and thereafter. Remaining consideration, including variable consideration, from contracts with customers is included in the amounts presented in the preceding paragraph and pertains to contracts with multiple performance obligations, extended warranties on products and multi-year agreements, which are typically recognized as the performance obligation is satisfied. The Company applied the standard's practical expedient that permits the omission of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which the Company recognizes revenue at the amount to which the Company has the right to invoice for services performed. Contract Balances The following table provides information about contract assets and contract liabilities from contracts with customers: December 31, 2022 December 31, 2021 December 31, 2020 Contract assets $ 11,074 $ 11,440 $ 15,020 Contract liabilities - current 256,933 227,549 184,845 Contract liabilities - non-current 19,879 21,513 13,921 Contract assets primarily relate to the Company's right to consideration for work completed but not billed at the reporting date and are recorded in prepaid and other current assets in the consolidated balance sheets. Contract assets are transferred to receivables when the right to consideration becomes unconditional. Contract liabilities relate to advance consideration received from customers or advance billings for which revenue has not been recognized. Current contract liabilities are recorded in deferred revenue and non-current contract liabilities are recorded in other liabilities in the consolidated balance sheets. Contract liabilities are reduced when the associated revenue from the contract is recognized. The increase in current contract liabilities presented above primarily relates to advance payments received from customers. The revenue recognized during 2022 and 2021 that was included in the contract liabilities at the beginning of the respective periods amounted to $196,891 and $163,546, respectively. Contract Costs Costs incurred to obtain a customer contract are not material to the Company. The Company elected to apply the practical expedient to not capitalize contract costs to obtain contracts with a duration of one year or less, which are expensed and included within cost of goods and services in the consolidated statements of earnings. |
Acquisitions
Acquisitions | 12 Months Ended |
Dec. 31, 2022 | |
Business Combination and Asset Acquisition [Abstract] | |
Acquisitions | 3. Acquisitions 2022 During the year ended December 31, 2022, the Company acquired three businesses in separate transactions for total consideration of $312,855, net of cash acquired and inclusive of measurement period adjustments. Of these transactions, one includes additional consideration contingent on achieving certain financial performance targets. These businesses were acquired to complement and expand upon existing operations within the Pumps & Process Solutions segment. The goodwill recorded as a result of these acquisitions represents the economic benefits expected to be derived from product line expansions and operational synergies. The goodwill is non-deductible for U.S. income tax purposes for these acquisitions. Malema On July 1, 2022, the Company acquired 99.7% of the equity interests in Malema Engineering Corporation and its related foreign entities ("Malema"), a designer and manufacturer of flow measurement and control instruments serving customers in the biopharmaceutical, semiconductor and industrial sectors, for $223,462, net of cash acquired and inclusive of the impact of measurement period adjustments discussed below, subject to contingent consideration. During the fourth quarter of 2022, the Company acquired the remaining 0.3% of equity interests in Malema. The Malema acquisition expands the Company's biopharma single-use production offering within the Pumps & Process Solutions segment. The contingent consideration is based upon meeting certain financial performance targets for each twelve-month period over the next two years from March 31, 2022, with a maximum potential payout of $50,000. No value is attributed to the current estimated fair value of contingent earn-out liability, which will be reassessed quarterly during the performance periods. In connection with this acquisition, the Company recorded goodwill of $153,082 and intangible assets of $64,000 for customer intangibles, $16,000 for patents, and $4,000 for trademarks. The fair value for customer intangibles at the acquisition date was determined using the multi-period excess earnings method under the income approach. The fair value measurements of intangible assets are based on significant unobservable inputs, and thus represent Level 3 inputs. Significant assumptions used in assessing the fair values of intangible assets include discounted future cash flows, customer attrition rates and discount rates. The fair values of the assets acquired and liabilities assumed, and the related tax balances, are based on preliminary estimates and assumptions. These preliminary estimates and assumptions could change significantly during the measurement period as the Company finalizes the valuations of the assets acquired and liabilities assumed, and the related tax balances. During the year ended December 31, 2022, the Company recorded measurement period adjustments primarily related to its preliminary treatment of certain liabilities. These adjustments are based on facts and circumstances that existed, but were not known, as of the acquisition date which resulted in an increase in goodwill of $1,381. The following presents the preliminary allocation of purchase price to the assets acquired and liabilities assumed under the Malema acquisition, based on their estimated fair values at acquisition date: Total Current assets, net of cash acquired $ 8,985 Property, plant and equipment 2,733 Goodwill 153,082 Intangible assets 84,000 Other assets and deferred charges 1,159 Current liabilities (4,487) Non-current liabilities (22,010) Net assets acquired $ 223,462 Other acquisitions On December 14, 2022, the Company acquired 100% of the equity interests in Witte Pumps & Technology GmbH ("Witte"), a manufacturer of precision gear pumps, for $81,293, net of cash acquired. The Witte acquisition expands the Company's reach into gear pump manufacturing and associated spare parts and services for the chemical, plastics and polymer processing, food and beverage, and pharmaceutical industries within the Pumps & Process Solutions segment. In connection with this acquisition, the Company recorded goodwill of $45,528 and intangible assets of $34,791, primarily related to customer intangibles. On May 2, 2022, the Company acquired 100% of the equity interests in AMN DPI ("AMN"), a designer and manufacturer of polymer pelletizing tools, for $8,100, net of cash acquired. The AMN acquisition extends the Company's reach into polymer processing equipment production within the Pumps & Process Solutions segment. In connection with this acquisition, the Company recorded goodwill of $1,903 and intangible assets of $5,625, primarily related to customer intangibles. The following presents, for the two acquisitions other than Malema, the preliminary allocation of purchase price to the assets acquired and liabilities assumed, based on their estimated fair values at acquisition date: Total Current assets, net of cash acquired $ 23,369 Property, plant and equipment 4,325 Goodwill 47,431 Intangible assets 40,416 Other assets and deferred charges 20 Current liabilities (13,614) Non-current liabilities (12,554) Net assets acquired $ 89,393 The amounts assigned to goodwill and major intangible asset classifications for all 2022 acquisitions were as follows: Amount allocated Useful life Goodwill - non-deductible $ 200,513 na Customer intangibles 90,657 10 - 15 Patents 16,000 10 Unpatented technology 10,355 8 Trademarks 7,404 15 $ 324,929 2021 During the year ended December 31, 2021, the Company acquired nine businesses in separate transactions for total consideration of $1,125,786, net of cash acquired of $18,475, including contingent consideration of $13,002 and measurement period adjustments discussed below. These businesses were acquired to complement and expand upon existing operations within the Clean Energy & Fueling, Engineered Products, Imaging & Identification, and Pumps & Process Solutions segments. The goodwill recorded as a result of these acquisitions represents the economic benefits expected to be derived from product line expansions and operational synergies. Goodwill of $200,117 is deductible for income tax purposes and $384,269 is non-deductible for income tax purposes for these acquisitions. RegO On December 28, 2021, the Company acquired 100% of the voting stock of ECI Holding Company, LLC ("RegO"), a provider of highly-engineered components and services that facilitate the production, storage, and distribution of cryogenic gases, for $626,618, net of cash acquired and inclusive of the impact of measurement period adjustments discussed below. The RegO acquisition strengthens the Company's offering for the hydrogen ("H2"), liquefied natural gas ("LNG"), and liquefied petroleum gas ("LPG") applications, as well as Dover's participation in the attractive cryogenic industrial gases end market within the Clean Energy & Fueling segment. In connection with this acquisition, the Company recorded goodwill of $170,800 deductible for income tax purposes and $110,363 non-deductible for income tax purposes and intangible assets of $173,000 for customer intangibles, $40,000 for patents and $21,000 for trademarks. The fair value for customer intangibles at the acquisition date was determined using the multi-period excess earnings method under the income approach. The fair value measurements of intangible assets are based on significant unobservable inputs, and thus represent Level 3 inputs. Significant assumptions used in assessing the fair values of intangible assets include discounted future cash flows, customer attrition rates and discount rates. The fair value of assets acquired also includes trade receivables of $33,900. The gross amount is $34,606, of which $706 is expected to be uncollectible. During the year ended December 31, 2022, the Company recorded measurement period adjustments primarily related to deferred taxes and changes in net working capital. These adjustments are based on facts and circumstances that existed, but were not known, as of the acquisition date which resulted in an increase in goodwill of $4,187. The following presents the allocation of purchase price, net of cash acquired of $10,382, to the assets acquired and liabilities assumed under the RegO acquisition, based on their estimated fair values at acquisition date: Total Accounts receivable $ 33,900 Inventories 71,529 Other current assets 2,958 Property, plant and equipment 50,027 Goodwill 281,163 Intangible assets 234,000 Other assets and deferred charges 884 Current liabilities (20,150) Non-current liabilities (27,693) Net assets acquired $ 626,618 Acme Cryogenics On December 16, 2021, the Company acquired 100% of the voting stock of Acme Cryo Intermediate Inc. ("Acme Cryogenics"), a provider of highly-engineered components and services that facilitate the production, storage, and distribution of cryogenic gases, for $292,306, net of cash acquired and inclusive of the impact of measurement period adjustments discussed below. The Acme Cryogenics acquisition strengthens the Company's offering for the H2, LNG, and LPG applications, as well as Dover's participation in the attractive cryogenic industrial gases end market within the Clean Energy & Fueling segment. In connection with this acquisition, the Company recorded goodwill of $167,291 non-deductible for income tax purposes and intangible assets of $99,000 for customer intangibles, $21,800 for unpatented technology and $6,500 for trademarks. The fair value for customer intangibles at the acquisition date was determined using the multi-period excess earnings method under the income approach. The fair value measurements of intangible assets are based on significant unobservable inputs and thus represent Level 3 inputs. Significant assumptions used in assessing the fair values of intangible assets include discounted future cash flows, customer attrition rates and discount rates. The fair value of assets acquired also includes trade receivables of $14,644. The gross amount is $14,912, of which $268 is expected to be uncollectible. During the year ended December 31, 2022, the Company recorded measurement period adjustments primarily related to deferred taxes and changes in net working capital. These adjustments are based on facts and circumstances that existed, but were not known, as of the acquisition date which resulted in a decrease in goodwill of $1,918. The following presents the allocation of purchase price to the assets acquired and liabilities assumed under the Acme Cryogenics acquisition, based on their estimated fair values at acquisition date: Total Current assets, net of cash acquired $ 25,932 Property, plant and equipment 8,640 Goodwill 167,291 Intangible assets 127,300 Other assets and deferred charges 5,057 Current liabilities (7,286) Non-current liabilities (34,628) Net assets acquired $ 292,306 Other acquisitions On October 15, 2021, the Company acquired 100% of the voting stock of LIQAL B.V. ("LIQAL"), a turnkey supplier of LNG, hydrogen refueling equipment and solutions, and micro liquefaction solutions, for $27,701, net of cash acquired and including contingent consideration. The LIQAL acquisition strengthens the Company's offering of LNG and hydrogen products and solutions, as well as significant innovation capabilities and proprietary technologies, within the Clean Energy & Fueling segment. In connection with this acquisition, the Company recorded goodwill of $23,473 and intangible assets of $8,235, primarily related to customer intangibles. On September 15, 2021, the Company acquired 100% of the voting stock of The Espy Corporation ("Espy"), a manufacturer of advanced electronic radio frequency sensor systems, for $60,457, net of cash acquired. The Espy acquisition strengthens the Company's offering of complete signal intelligence systems with integrated software within the Engineered Products segment. In connection with this acquisition, the Company recorded goodwill of $29,317 and intangible assets of $21,100, primarily related to customer intangibles. The Espy acquisition was treated as an asset acquisition for U.S. income tax purposes, resulting in the goodwill and intangibles being classified as tax deductible. On July 23, 2021, the Company acquired 100% of the voting stock of CDS Visual, Inc. ("CDS Visual"), a leading provider of 3D visualization solutions tailored for industrial applications, for $29,147, net of cash acquired. The CDS Visual acquisition extends the Company's reach of customer-facing digital capabilities within the Engineered Products segment. In connection with this acquisition, the Company recorded goodwill of $20,863 and intangible assets of $9,930, primarily related to technology. On June 24, 2021, the Company acquired 100% of the voting stock of Blue Bite LLC ("Blue Bite"), a leading provider of consumer engagement and brand protection software solutions, for $30,143, net of cash acquired and including contingent consideration. The Blue Bite acquisition strengthens the Company's offering of product traceability and authentication solutions within the Imaging & Identification segment. In connection with this acquisition, the Company recorded goodwill of $20,458 and intangible assets of $13,250, primarily related to technology. On June 23, 2021, the Company acquired 100% of the voting stock of Quantex Arc Limited ("Quantex"), a leading provider of single-use, recyclable pumps, for $23,747, net of cash acquired and including contingent consideration. The Quantex acquisition enhances the offering of single-use pumps for biopharma and other hygienic applications within the Pumps & Process Solutions segment. In connection with this acquisition, the Company recorded goodwill of $14,327 and intangible assets of $11,034, primarily related to patented technology. On April 19, 2021, the Company acquired 100% of the voting stock of AvaLAN Wireless Systems Incorporated ("AvaLAN"), a leading provider of secure wireless communications solutions for the convenience and fuel retail industry, for $34,144, net of cash acquired. The AvaLAN acquisition extends the Company's reach into the systems and software offering within the Clean Energy & Fueling segment. In connection with this acquisition, the Company recorded goodwill of $26,803 and intangible assets of $14,630, primarily related to customer intangibles. One other immaterial acquisition was completed during the year ended December 31, 2021, within the Pumps & Process Solutions segment. The following presents, for the seven acquisitions other than RegO and Acme Cryogenics, the allocation of purchase price to the assets acquired and liabilities assumed, based on their estimated fair values at acquisition date: Total Current assets, net of cash acquired $ 12,751 Property, plant and equipment 8,272 Goodwill 135,932 Intangible assets 78,179 Other assets and deferred charges 4,485 Current liabilities (15,368) Non-current liabilities (17,389) Net assets acquired $ 206,862 The amounts assigned to goodwill and major intangible asset classifications for all 2021 acquisitions were as follows: Amount allocated Useful life Goodwill - tax deductible $ 200,117 na Goodwill - non deductible 384,269 na Customer intangibles 310,819 12 - 15 Patents 49,056 7 - 12 Unpatented technology 44,180 7 - 12 Trademarks 35,424 15 - 16 $ 1,023,865 2020 During the year ended December 31, 2020, the Company acquired six businesses in separate transactions for total consideration of $335,786, net of cash acquired. On December 30, 2020, the Company acquired 100% of the voting stock of Innovative Control Systems, Inc. ("ICS"), within the Clean Energy & Fueling segment, for $77,030, net of cash acquired. On August 20, 2020, the Company acquired 100% of the voting stock of Solaris Laser S.A. ("Solaris"), within the Imaging & Identification segment, for $18,680, net of cash acquired. On April 30, 2020, the Company acquired 100% of the voting stock of Em-tec GmbH ("Em-tec"), within the Pumps & Process Solutions segment, for $30,396, net of cash acquired. On February 18, 2020, the Company acquired 100% of the voting stock of So. Cal. Soft-Pak, Incorporated ("Soft-Pak"), within the Engineered Products segment, for $45,500, net of cash acquired. On January 24, 2020, the Company acquired 100% of the voting stock of Sys-Tech Solutions, Inc. ("Systech"), within the Imaging & Identification segment, for $161,830, net of cash acquired. One other immaterial acquisition was completed during the year ended December 31, 2020, within the Pumps & Process Solutions segment. The following presents the allocation of purchase price to the assets acquired and liabilities assumed, based on their estimated fair values at acquisition date: Total Current assets, net of cash acquired $ 44,159 Property, plant and equipment 8,424 Goodwill 205,805 Intangible assets 134,049 Other assets and deferred charges 12,986 Current liabilities (34,803) Non-current liabilities (34,834) Net assets acquired $ 335,786 The amounts assigned to goodwill and major intangible asset classifications were as follows: Amount allocated Useful life Goodwill - tax deductible $ 33,183 na Goodwill - non deductible 172,622 na Customer intangibles 103,310 10 - 14 Unpatented technology 21,125 5 - 9 Trademarks 9,614 15 $ 339,854 Pro forma Information (Unaudited) The following unaudited pro forma results of operations reflect the 2021 acquisitions of RegO and Acme Cryogenics as if they had occurred on January 1, 2020. The pro forma information is not necessarily indicative of the results that actually would have occurred, nor does it indicate future operating results of the combined companies. The pro forma earnings are adjusted to reflect the comparable impact of additional depreciation and amortization expense, net of tax, resulting from the fair value measurement of tangible and intangible assets; nonrecurring acquisition-related costs, net of tax, of $5,855; and inventory step-up charges, net of tax, of $15,082. These unaudited pro forma adjustments are based upon purchase price allocations. The actual revenues and earnings for RegO and Acme Cryogenics from the date of acquisition on December 28, 2021 and December 16, 2021, respectively, to December 31, 2021 were not material. Years Ended December 31, 2021 2020 Revenue: As reported $ 7,907,081 $ 6,683,760 Pro forma (unaudited) 8,163,185 6,920,929 Earnings: As reported $ 1,123,818 $ 683,451 Pro forma (unaudited) 1,145,106 669,458 The pro forma results for the remaining seven acquisitions in 2021, as well as the acquisitions in 2022 and 2020 are not presented as they are not considered material. |
Dispositions
Dispositions | 12 Months Ended |
Dec. 31, 2022 | |
Discontinued Operations and Disposal Groups [Abstract] | |
Dispositions | 4. Dispositions Management evaluates Dover's businesses periodically for their strategic fit within its operations and may from time to time sell or discontinue certain operations for various reasons. 2022 There was one immaterial disposition in 2022. 2021 On December 1, 2021, the Company completed the sale of Unified Brands ("UB"), a wholly owned subsidiary of the Company within the Climate & Sustainability Technologies segment. The Company recognized total consideration of $229,024. This sale resulted in a pre-tax gain on disposition of $181,615 included within the consolidated statements of earnings for the year ended December 31, 2021. The sale did not represent a strategic shift that had a major effect on operations and financial results and, therefore, did not qualify for presentation as a discontinued operation. On November 16, 2021, the Company disposed of Race Winning Brands ("RWB"), an equity method investment within the Engineered Products segment for a total consideration of $45,958, resulting in a recognized gain of $24,723 included within the consolidated statements of earnings for the year ended December 31, 2021. 2020 On March 6, 2020, the Company completed the sale of the Chino, California branch of The AMS Group ("AMS Chino"), a wholly owned subsidiary of the Company. The Company recognized total consideration of $15,400, which included a working capital adjustment. This sale resulted in a pre-tax gain on disposition of $5,213 included within the consolidated statements of earnings for the year ended December 31, 2020. The sale did not represent a strategic shift that had a major effect on operations and financial results and, therefore, did not qualify for presentation as a discontinued operation. |
Inventories, net
Inventories, net | 12 Months Ended |
Dec. 31, 2022 | |
Inventory, Net [Abstract] | |
Inventories, net | 5. Inventories, net The components of inventories, net were as follows: December 31, 2022 December 31, 2021 Raw materials $ 812,066 $ 671,195 Work in progress 230,865 271,659 Finished goods 458,881 377,800 Subtotal 1,501,812 1,320,654 Less reserves (135,204) (129,559) Total $ 1,366,608 $ 1,191,095 |
Property, Plant and Equipment
Property, Plant and Equipment | 12 Months Ended |
Dec. 31, 2022 | |
Property, Plant and Equipment [Abstract] | |
Property, Plant and Equipment, net | 6. Property, Plant and Equipment, net The components of property, plant and equipment, net were as follows: December 31, 2022 December 31, 2021 Land $ 62,495 $ 63,656 Buildings and improvements 620,500 582,314 Machinery, equipment and other 1,895,502 1,816,473 Property, plant and equipment, gross 2,578,497 2,462,443 Total accumulated depreciation (1,573,672) (1,505,133) Property, plant and equipment, net $ 1,004,825 $ 957,310 Total depreciation expense was $148,910, $147,309 and $140,008 for the years ended December 31, 2022, 2021 and 2020, respectively. |
Leases
Leases | 12 Months Ended |
Dec. 31, 2022 | |
Leases [Abstract] | |
Leases | 7. Leases The Company's ROU assets and lease liabilities are discussed in detail in Note 1 — Description of Business and Summary of Significant Accounting Policies. The components of lease costs were as follows: Years Ended December 31, 2022 2021 2020 Operating Lease Costs: Fixed $ 53,428 $ 54,397 $ 52,875 Variable 7,512 6,281 5,973 Short-term 22,097 17,847 18,436 Total (1) $ 83,037 $ 78,525 $ 77,284 (1) Finance lease cost and sublease income were immaterial. Supplemental cash flow information related to leases was as follows: Years Ended December 31, 2022 2021 2020 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows for operating leases $ 54,268 $ 55,921 $ 53,903 Operating cash flows for finance leases 335 357 434 Financing cash flows for finance leases 2,917 3,073 2,523 Total $ 57,520 $ 59,351 $ 56,860 Right-of-use assets obtained in exchange for lease obligations: Operating leases $ 57,190 $ 47,666 $ 21,381 Financing leases 3,149 2,016 3,708 Total $ 60,339 $ 49,682 $ 25,089 Supplemental balance sheet information related to leases were as follows : December 31, 2022 December 31, 2021 Operating Leases Right-of-use assets: Other assets and deferred charges $ 197,058 $ 169,022 Lease liabilities: Other accrued expenses $ 42,649 $ 43,086 Other liabilities 165,741 134,448 Total operating lease liabilities $ 208,390 $ 177,534 Finance Leases Right-of-use assets: Property, plant and equipment, net (1) $ 7,846 $ 8,588 Lease liabilities: Other accrued expenses $ 2,554 $ 2,475 Other liabilities 6,189 6,767 Total finance lease liabilities $ 8,743 $ 9,242 (1) Finance lease right-of-use assets are recorded net of accumulated depreciation of $8,017 and $7,675 for the years ended December 31, 2022 and December 31, 2021, respectively. The aggregate future lease payments for operating and finance leases as of December 31, 2022 were as follows: Operating Finance 2023 $ 47,843 $ 2,860 2024 40,524 2,432 2025 32,759 1,963 2026 23,009 1,480 2027 19,447 816 Thereafter 81,937 1 Total lease payments 245,519 9,552 Less interest (37,129) (809) Present value of lease liabilities $ 208,390 $ 8,743 Average lease terms and discount rates were as follows: December 31, 2022 December 31, 2021 December 31, 2020 Weighted-average remaining lease term (years) Operating leases 7.8 5.8 5.9 Finance leases 3.6 4.2 4.8 Weighted-average discount rate Operating leases 3.5 % 2.7 % 2.9 % Finance leases 3.4 % 3.4 % 3.6 % |
Leases | 7. Leases The Company's ROU assets and lease liabilities are discussed in detail in Note 1 — Description of Business and Summary of Significant Accounting Policies. The components of lease costs were as follows: Years Ended December 31, 2022 2021 2020 Operating Lease Costs: Fixed $ 53,428 $ 54,397 $ 52,875 Variable 7,512 6,281 5,973 Short-term 22,097 17,847 18,436 Total (1) $ 83,037 $ 78,525 $ 77,284 (1) Finance lease cost and sublease income were immaterial. Supplemental cash flow information related to leases was as follows: Years Ended December 31, 2022 2021 2020 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows for operating leases $ 54,268 $ 55,921 $ 53,903 Operating cash flows for finance leases 335 357 434 Financing cash flows for finance leases 2,917 3,073 2,523 Total $ 57,520 $ 59,351 $ 56,860 Right-of-use assets obtained in exchange for lease obligations: Operating leases $ 57,190 $ 47,666 $ 21,381 Financing leases 3,149 2,016 3,708 Total $ 60,339 $ 49,682 $ 25,089 Supplemental balance sheet information related to leases were as follows : December 31, 2022 December 31, 2021 Operating Leases Right-of-use assets: Other assets and deferred charges $ 197,058 $ 169,022 Lease liabilities: Other accrued expenses $ 42,649 $ 43,086 Other liabilities 165,741 134,448 Total operating lease liabilities $ 208,390 $ 177,534 Finance Leases Right-of-use assets: Property, plant and equipment, net (1) $ 7,846 $ 8,588 Lease liabilities: Other accrued expenses $ 2,554 $ 2,475 Other liabilities 6,189 6,767 Total finance lease liabilities $ 8,743 $ 9,242 (1) Finance lease right-of-use assets are recorded net of accumulated depreciation of $8,017 and $7,675 for the years ended December 31, 2022 and December 31, 2021, respectively. The aggregate future lease payments for operating and finance leases as of December 31, 2022 were as follows: Operating Finance 2023 $ 47,843 $ 2,860 2024 40,524 2,432 2025 32,759 1,963 2026 23,009 1,480 2027 19,447 816 Thereafter 81,937 1 Total lease payments 245,519 9,552 Less interest (37,129) (809) Present value of lease liabilities $ 208,390 $ 8,743 Average lease terms and discount rates were as follows: December 31, 2022 December 31, 2021 December 31, 2020 Weighted-average remaining lease term (years) Operating leases 7.8 5.8 5.9 Finance leases 3.6 4.2 4.8 Weighted-average discount rate Operating leases 3.5 % 2.7 % 2.9 % Finance leases 3.4 % 3.4 % 3.6 % |
Credit Losses
Credit Losses | 12 Months Ended |
Dec. 31, 2022 | |
Credit Loss [Abstract] | |
Credit Losses | 8. Credit Losses Effective January 1, 2020, the Company adopted ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments prospectively. This ASU replaces the incurred loss impairment model with an expected credit loss impairment model for financial instruments, including trade receivables. The amendment requires entities to consider forward-looking information to estimate expected credit losses, resulting in earlier recognition of losses for receivables that are current or not yet due. Upon adoption, the Company recorded a noncash cumulative effect adjustment to retained earnings of $2.1 million, net of $0.6 million of income taxes, on the opening consolidated balance sheet as of January 1, 2020. The Company is exposed to credit losses primarily through sales of products and services. Due to the short-term nature of such receivables, the estimate of amount of accounts receivable that may not be collected is based on aging of the accounts receivable balances and other historical and forward-looking information on the financial condition of the customers. Balances are written off when determined to be uncollectible. Estimates are used to determine the allowance, based on assessment of anticipated payment and all other historical, current and forward-looking information that is reasonably available. The following table provides a roll-forward of the allowance for credit losses that is deducted from the amortized cost basis of accounts receivable to present the net amount expected to be collected. 2022 2021 2020 Beginning Balance, January 1, $ 40,126 $ 40,474 $ 29,381 Adoption of ASU No. 2016-13, cumulative-effect adjustment to retained earnings — — 2,706 Provision for expected credit losses, net of recoveries 5,552 5,053 11,171 Amounts written off charged against the allowance (4,462) (5,307) (3,863) Other, including dispositions and foreign currency translation (1,817) (94) 1,079 Ending balance, December 31 $ 39,399 $ 40,126 $ 40,474 |
Goodwill and Other Intangible A
Goodwill and Other Intangible Assets | 12 Months Ended |
Dec. 31, 2022 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Goodwill and Other Intangible Assets | 9. Goodwill and Other Intangible Assets Goodwill The changes in the carrying value of goodwill by reportable operating segments were as follows: Engineered Products Clean Energy & Fueling Imaging & Identification Pumps & Process Solutions Climate & Sustainability Technologies Total Goodwill $ 693,576 $ 940,973 $ 1,117,589 $ 846,250 $ 544,715 $ 4,143,103 Accumulated impairment loss (1) (10,591) — — (59,970) — (70,561) Balance at January 1, 2021 682,985 940,973 1,117,589 786,280 544,715 4,072,542 Acquisitions 50,180 496,461 20,458 15,018 — 582,117 Measurement period adjustments — 2,640 (1,926) — — 714 Disposition of business — — — — (34,662) (34,662) Foreign currency translation (9,882) (12,383) (29,919) (8,459) (1,246) (61,889) Balance at December 31, 2021 723,283 1,427,691 1,106,202 792,839 508,807 4,558,822 Acquisitions — — — 200,513 — 200,513 Measurement period adjustments (286) 2,432 (1,544) 968 — 1,570 Foreign currency translation (10,455) (38,705) (26,399) (14,785) (1,067) (91,411) Balance at December 31, 2022 $ 712,542 $ 1,391,418 $ 1,078,259 $ 979,535 $ 507,740 $ 4,669,494 (1) Accumulated impairment loss as of December 31, 2022 is not subject to foreign currency translation. During 2022 and 2021, the Company recognized additions of $200,513 and $582,117, respectively, to goodwill as a result of acquisitions as discussed in Note 3 — Acquisitions. There were no dispositions of goodwill during 2022. During 2021, the Company disposed of $34,662 of goodwill as a result of dispositions of businesses as discussed in Note 4 — Dispositions. The Company reallocated goodwill upon disposal based upon the fair value of the disposed business relative to the remaining entities in its reporting unit. Annual impairment testing The Company tests goodwill for impairment annually in the fourth quarter of each year, whenever events or circumstances indicate an impairment may have occurred, or when a change in the composition of reporting units occurs for other reasons, such as a change in segments. The Company performed its annual goodwill impairment test during the fourth quarter of 2022 using a discounted cash flow analysis as discussed in Note 1 — Description of Business and Summary of Significant Accounting Policies. The Company performed a quantitative goodwill impairment test for each of its reporting units, concluding that the fair values of all of its reporting units were in excess of their carrying values. No impairment of goodwill was required. The discounted cash flow analysis includes management's current assumptions as to future cash flows and long-term growth rates. The discount rates utilized are based on a capital asset pricing model and published relevant industry rates, which take into consideration the risks and uncertainties inherent to the reporting units and in the internally developed forecasts. The discount rate used in the 2022 reporting unit valuations was 9.5%. Further, the Company assessed the current market capitalization, forecasts and the amount of headroom in the 2022 impairment test. While the Company believes the assumptions used in the 2022 impairment analysis are reasonable and representative of expected results, actual results may differ from expectations. Intangible Assets The Company's definite-lived and indefinite-lived intangible assets by major asset class were as follows: December 31, 2022 December 31, 2021 Gross Amount Accumulated Amortization Net Carrying Amount Gross Amount Accumulated Amortization Net Carrying Amount Amortized intangible assets: Customer intangibles $ 1,881,402 $ 996,947 $ 884,455 $ 1,829,492 $ 909,776 $ 919,716 Trademarks 265,466 132,791 132,675 263,367 116,633 146,734 Patents 219,199 146,337 72,862 205,910 140,327 65,583 Unpatented technologies 257,428 137,750 119,678 221,239 123,464 97,775 Distributor relationships 79,622 57,299 22,323 84,204 55,260 28,944 Drawings and manuals 26,062 26,062 — 27,792 27,303 489 Other 20,818 15,620 5,198 22,347 18,775 3,572 Total 2,749,997 1,512,806 1,237,191 2,654,351 1,391,538 1,262,813 Unamortized intangible assets: Trademarks 96,544 — 96,544 96,709 — 96,709 Total intangible assets, net $ 2,846,541 $ 1,512,806 $ 1,333,735 $ 2,751,060 $ 1,391,538 $ 1,359,522 The Company recorded $124,416 of acquired intangible assets in 2022. See Note 3 — Acquisitions for further information. During the year ended December 31, 2022, the Company acquired certain intellectual property assets related to electric refuse collection vehicles for approximately $29,750, including contingent consideration of up to $20,000. These assets were classified as unpatented technologies and included in the Engineered Products segment. Amortization expense was $158,628, $142,814 and $139,043 for the years ended December 31, 2022, 2021 and 2020, respectively, primarily comprised of acquisition-related intangible amortization. Estimated future amortization expense related to intangible assets held at December 31, 2022 for the next five years is as follows: Estimated Amortization 2023 $ 154,124 2024 149,866 2025 145,857 2026 138,090 2027 135,785 |
Other Accrued Expenses and Othe
Other Accrued Expenses and Other Liabilities | 12 Months Ended |
Dec. 31, 2022 | |
Accrued Liabilities and Other Liabilities [Abstract] | |
Other Accrued Expenses and Other Liabilities | 10. Other Accrued Expenses and Other Liabilities The following table details the major components of other accrued expenses: December 31, 2022 December 31, 2021 Accrued rebates and volume discounts $ 47,660 $ 52,909 Warranty 43,351 43,449 Operating lease liabilities 42,649 43,086 Taxes other than income (1) 33,782 49,992 Accrued interest 20,591 20,426 Accrued commissions (non-employee) 15,808 16,273 Restructuring and exit costs 14,510 13,797 Other (none of which are individually significant) 99,986 107,165 Total other accrued expenses $ 318,337 $ 347,097 (1) Taxes other than income includes a $15.3 million deferral of employment taxes related to the U.S. CARES Act as of December 31, 2021. The following table details the major components of other liabilities (non-current): December 31, 2022 December 31, 2021 Operating lease liabilities $ 165,741 $ 134,448 Defined benefit and other post-retirement benefit plans 92,630 138,992 Deferred compensation 82,479 88,681 Unrecognized tax benefits 34,361 79,757 Legal and environmental 30,139 31,304 Deferred revenue 19,879 21,513 Warranty 5,098 5,119 Other 44,576 32,728 Total other liabilities $ 474,903 $ 532,542 Warranty Estimated warranty program claims are provided for at the time of sale. Amounts provided for are based on historical costs and adjusted for new claims. The changes in the carrying amount of product warranties were as follows: Years Ended December 31, 2022 2021 2020 Beginning Balance, December 31 of the Prior Year $ 48,568 $ 51,088 $ 49,116 Provision for warranties 60,758 67,212 60,902 Settlements made (59,612) (65,498) (60,853) Other adjustments, including acquisitions and currency translation (1,265) (4,234) 1,923 Ending Balance, December 31 $ 48,449 $ 48,568 $ 51,088 |
Restructuring Activities
Restructuring Activities | 12 Months Ended |
Dec. 31, 2022 | |
Restructuring and Related Activities [Abstract] | |
Restructuring Activities | 11. Restructuring Activities The Company initiated various restructuring programs and incurred severance and other restructuring costs by segment as follows: Years Ended December 31, 2022 2021 2020 Engineered Products $ 3,194 $ 9,507 $ 10,307 Clean Energy & Fueling 9,571 3,609 6,681 Imaging & Identification 4,702 4,589 5,946 Pumps & Process Solutions 4,685 1,911 13,374 Climate & Sustainability Technologies 6,007 5,068 4,015 Corporate 2,321 2,021 4,145 Total $ 30,480 $ 26,705 $ 44,468 These amounts are classified in the consolidated statements of earnings as follows: Cost of goods and services $ 6,855 $ 12,895 $ 18,895 Selling, general and administrative expenses 23,625 13,810 25,573 Total $ 30,480 $ 26,705 $ 44,468 Total restructuring charges of $30,480 incurred during the year ended December 31, 2022, were primarily a result of restructuring programs initiated in 2021 and 2022 in response to demand conditions and broad-based operational efficiency initiatives focusing on footprint consolidation . Additional programs, beyond the scope of the announced programs may be implemented during 2023 with related restructuring charges. The $30,480 of restructuring charges incurred during 2022 primarily included the following items: • The Engineered Products segment recorded $3,194 of restructuring charges related primarily to headcount reductions. • The Clean Energy & Fueling segment recorded $9,571 of restructuring charges primarily due to headcount reductions and exit costs undertaken in light of market conditions. The segment will continue to make proactive adjustments to its cost structure through restructuring and other programs to align with current demand trends. • The Imaging & Identification segment recorded $4,702 of restructuring charges related primarily to headcount reductions and exit costs. • The Pumps & Process Solutions segment recorded $4,685 of restructuring charges related primarily to headcount reductions. • The Climate & Sustainability Technologies segment recorded $6,007 of restructuring charges related primarily to the substantial liquidation of businesses in certain Latin America countries and includes non-cash foreign currency translation losses. • Corporate recorded $2,321 of restructuring charges primarily related to exit costs and simplification of organizational structure. Restructuring expenses incurred in 2021 and 2020 also included headcount reductions, targeted facility consolidations at certain businesses, asset charges related to a product line exit, and actions taken to optimize the Company's cost structure. The following table details the Company's severance and other restructuring accrual activities: Severance Exit Total Balance at January 1, 2020 $ 13,751 $ 2,639 $ 16,390 Restructuring charges 25,716 18,752 44,468 Payments (29,768) (6,035) (35,803) Other, including foreign currency translation 848 (10,990) (1) (10,142) Balance at December 31, 2020 10,547 4,366 14,913 Restructuring charges 11,561 15,144 26,705 Payments (10,951) (6,171) (17,122) Other, including foreign currency translation (427) (10,272) (1) (10,699) Balance at December 31, 2021 10,730 3,067 13,797 Restructuring charges 15,388 15,092 (2) 30,480 Payments (13,975) (8,159) (22,134) Other, including foreign currency translation (136) (7,497) (2) (7,633) Balance at December 31, 2022 $ 12,007 $ 2,503 $ 14,510 (1) Other activity in exit reserves primarily represents the non-cash write-off of certain long-lived assets and inventory in connection with certain facility closures and product exits. (2) Other activity in exit reserves includes non-cash foreign currency translation losses recorded as restructuring charges due to the substantial liquidation of businesses in certain Latin America countries. The restructuring accrual balances at December 31, 2022 primarily reflect restructuring plans initiated during the year. |
Borrowings
Borrowings | 12 Months Ended |
Dec. 31, 2022 | |
Debt Disclosure [Abstract] | |
Borrowings | 12. Borrowings Borrowings consist of the following: December 31, 2022 December 31, 2021 Short-term: Commercial paper $ 734,936 $ 105,000 Other 836 702 Short-term borrowings $ 735,772 $ 105,702 During the year ended December 31, 2022, commercial paper borrowings increased $629,936. The borrowings outstanding under the commercial paper program had a weighted average annual interest rate of 2.29% and 0.38% as of December 31, 2022 and December 31, 2021, respectively. Carrying amount (1) Principal December 31, 2022 December 31, 2021 Long-term: 3.15% 10-year notes due November 15, 2025 $ 400,000 $ 398,063 $ 397,389 1.25% 10-year notes due November 9, 2026 (euro-denominated) € 600,000 631,522 674,217 0.750% 8-year notes due November 4, 2027 (euro denominated) € 500,000 525,654 561,293 6.65% 30-year debentures due June 1, 2028 $ 200,000 199,456 199,356 2.950% 10-year notes due November 4, 2029 $ 300,000 297,408 297,029 5.375% 30-year debentures due October 15, 2035 $ 300,000 296,808 296,559 6.60% 30-year notes due March 15, 2038 $ 250,000 248,279 248,166 5.375% 30-year notes due March 1, 2041 $ 350,000 344,982 344,705 Other 341 — Total long-term debt $ 2,942,513 $ 3,018,714 (1) Carrying amount is net of unamortized debt discount and deferred debt issuance costs. Total unamortized debt discounts were $12.7 million and $15.1 million as of December 31, 2022 and 2021, respectively. Total deferred debt issuance costs were $10.7 million and $12.5 million as of December 31, 2022 and 2021, respectively. The discounts are being amortized to interest expense using the effective interest method over the life of the issuances. The deferred issuance costs are amortized on a straight-line basis over the life of the debt, as this approximates the effective interest method. As of December 31, 2022, the Company maintained a $1 billion five-year unsecured revolving credit facility (the "Credit Agreement") with a syndicate of banks, which expires on October 4, 2024. The Company uses the Credit Agreement principally as liquidity back-up for Dover's commercial paper program and for general corporate purposes. At the Company's election, loans under the Credit Agreement will bear interest at a base rate plus an applicable margin. The Credit Agreement requires the Company to pay a facility fee and imposes various restrictions on the Company such as, among other things, a requirement to maintain a minimum interest coverage ratio of consolidated EBITDA to consolidated net interest expense of not less than 3.0 to 1. As of December 31, 2022, there were no outstanding borrowings under the Credit Agreement. The Company was in compliance with all covenants in the Credit Agreement and other long-term debt covenants at December 31, 2022 and had an interest coverage ratio of consolidated EBITDA to consolidated net interest expense of 15.3 to 1. As of December 31, 2022, the future maturities of long-term debt were as follows: Future Maturities 2024 $ 118 2025 400,103 2026 635,915 2027 529,829 2028 and thereafter 1,400,000 Total $ 2,965,965 Letters of Credit and other Guarantees |
Financial Instruments
Financial Instruments | 12 Months Ended |
Dec. 31, 2022 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Financial Instruments | 13. Financial Instruments Derivatives The Company is exposed to market risk for changes in foreign currency exchange rates due to the global nature of its operations and certain commodity risks. In order to manage these risks, the Company has hedged portions of its forecasted sales and purchases, which occur within the next twelve months that are denominated in non-functional currencies, with currency forward contracts designated as cash flow hedges. At December 31, 2022 and 2021, the Company had contracts with U.S. dollar equivalent notional amounts of $184,565 and $180,929, respectively, to exchange foreign currencies, principally the euro, pound sterling, Swedish krona, Canadian dollar, Chinese yuan, and Swiss franc. The Company believes it is probable that all forecasted cash flow transactions will occur. In addition, the Company had outstanding contracts at December 31, 2022 and 2021 with a total notional amount of $102,509 and $108,736, respectively, that are not designated as hedging instruments. These instruments are used to reduce the Company's exposure to operating receivables and payables that are denominated in non-functional currencies. Gains and losses on these contracts are recorded in other income, net in the consolidated statements of earnings. The following table sets forth the fair values of derivative instruments held by the Company as of December 31, 2022 and 2021 and the balance sheet lines in which they are recorded: Fair Value Asset (Liability) December 31, 2022 December 31, 2021 Balance Sheet Caption Foreign currency forward $ 944 $ 2,825 Prepaid and other current assets Foreign currency forward (2,760) (433) Other accrued expenses For a cash flow hedge, the change in estimated fair value of a hedging instrument is recorded in accumulated other comprehensive earnings (loss), net of tax as a separate component of the consolidated statements of stockholders' equity and is reclassified into revenues and cost of goods and services in the consolidated statements of earnings during the period in which the hedged transaction is recognized. The amount of gains or losses from hedging activity recorded in earnings is not significant and the amount of unrealized gains and losses from cash flow hedges that are expected to be reclassified to earnings in the next twelve months, is not significant; therefore, additional tabular disclosures are not presented. There are no amounts excluded from the assessment of hedge effectiveness, and the Company's derivative instruments that are subject to credit risk contingent features were not significant. The Company is exposed to credit loss in the event of nonperformance by counterparties to the financial instrument contracts held by the Company; however, nonperformance by these counterparties is considered unlikely as the Company's policy is to contract with highly-rated, diversified counterparties. The Company has designated the €600,000 and €500,000 of euro-denominated notes issued November 9, 2016 and November 4, 2019, respectively, as hedges of its net investment in euro-denominated operations. Changes in the value of the euro-denominated debt are recognized in foreign currency translation adjustments within other comprehensive earnings (loss) of the consolidated statements of comprehensive earnings to offset changes in the value of the net investment in euro-denominated operations. Changes in the value of the euro-denominated debt resulting from exchange rate differences are offset by changes in the net investment due to the high degree of effectiveness between the hedging instruments and the exposure being hedged. Amounts recognized in other comprehensive earnings (loss) for the gains (losses) on net investment hedges were as follows: 2022 2021 2020 Gain (loss) on euro-denominated debt $ 80,301 $ 94,003 $ (119,298) Tax (expense) benefit (17,824) (20,976) 26,957 Net gain (loss) on net investment hedges, net of tax $ 62,477 $ 73,027 $ (92,341) Fair Value Measurements ASC 820, Fair Value Measurements and Disclosures, establishes a fair value hierarchy that requires the Company to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument's categorization within the hierarchy is based on the lowest level of input that is significant to the fair value measurement. ASC 820 establishes three levels of inputs that may be used to measure fair value as follows: Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs include inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices in active markets for similar assets and liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of assets or liabilities. Level 3 inputs are unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions. The Company's assets and liabilities measured at fair value on a recurring basis as of December 31, 2022 and 2021 were as follows: December 31, 2022 December 31, 2021 Level 2 Level 2 Assets: Foreign currency cash flow hedges $ 944 $ 2,825 Liabilities: Foreign currency cash flow hedges 2,760 433 The derivative contracts are measured at fair value using models based on observable market inputs such as foreign currency exchange rates and interest rates; therefore, they are classified within Level 2 of the fair value hierarchy. In addition to fair value disclosure requirements related to financial instruments carried at fair value, accounting standards require disclosures regarding the fair value of all of the Company's financial instruments. The estimated fair value of long-term debt at December 31, 2022 and 2021 was $2,786,862 and $3,440,501, respectively. The estimated fair value of long-term debt is based on quoted market prices for similar instruments and is, therefore, classified as Level 2 within the fair value hierarchy. The carrying values of cash equivalents, trade receivables, accounts payable and short-term borrowings are reasonable estimates of their fair values as of December 31, 2022 and 2021 due to the short-term nature of these instruments. |
Income Taxes
Income Taxes | 12 Months Ended |
Dec. 31, 2022 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | 14. Income Taxes Income taxes have been based on the following components of earnings before provision for income taxes in the consolidated statements of earnings: Years Ended December 31, 2022 2021 2020 Domestic $ 731,796 $ 835,773 $ 464,145 Foreign 555,709 565,053 377,589 Total $ 1,287,505 $ 1,400,826 $ 841,734 Income tax expense (benefit) for the years ended December 31, 2022, 2021 and 2020 is comprised of the following: Years Ended December 31, 2022 2021 2020 Current: U.S. federal $ 106,768 $ 150,990 $ 79,305 State and local 1,450 28,106 13,312 Foreign 140,696 154,147 97,106 Total current 248,914 333,243 189,723 Deferred: U.S. federal (4,760) (14,143) 2,777 State and local 303 3,165 (10,526) Foreign (22,328) (45,257) (23,691) Total deferred (26,785) (56,235) (31,440) Total expense $ 222,129 $ 277,008 $ 158,283 Differences between the effective income tax rate and the U.S. federal income statutory tax rate are as follows: Years Ended December 31, 2022 2021 2020 U.S. federal income tax rate 21.0 % 21.0 % 21.0 % State and local taxes, net of federal income tax benefit 1.6 1.8 1.7 Foreign operations tax effect 0.1 (0.2) (0.8) Foreign-derived intangible income (1.3) (0.8) (1.1) Share awards (0.2) (0.8) (1.2) Dispositions — 0.3 — Audit resolutions (3.2) (1.4) (0.9) Other (0.7) (0.1) 0.1 Effective tax rate 17.3 % 19.8 % 18.8 % The tax effects of temporary differences that give rise to deferred tax assets and liabilities are as follows: December 31, 2022 December 31, 2021 Deferred Tax Assets: Accrued compensation, postretirement and other employee benefits $ 46,008 $ 61,388 Accrued expenses 20,608 30,143 Net operating loss and other carryforwards 317,186 334,483 Inventories 30,569 28,698 Allowance for credit losses 9,224 9,988 Accrued insurance 3,978 4,708 Long-term liabilities, warranty and environmental costs 2,851 3,043 Lease obligations 47,887 41,653 Capitalized research and development 26,548 — Total gross deferred tax assets 504,859 514,104 Valuation allowance (271,203) (306,066) Total deferred tax assets, net of valuation allowances $ 233,656 $ 208,038 Deferred Tax Liabilities: Intangible assets $ (417,809) $ (392,208) Property, plant and equipment (82,658) (77,918) Lease right-of-use assets (45,202) (40,181) Other liabilities (27,447) (28,786) Total gross deferred tax liabilities (573,116) (539,093) Net deferred tax liability $ (339,460) $ (331,055) Classified as follows in the Consolidated Balance Sheets: Other assets and deferred charges $ 35,690 $ 33,062 Deferred income taxes (375,150) (364,117) $ (339,460) $ (331,055) As of December 31, 2022, the Company has $263,260 of deferred tax assets recorded related to non-U.S. tax loss carryforwards primarily resulting from non-operating activities. The non-U.S. losses as of December 31, 2022 are available to be carried forward, with $59,366 of these losses expiring during the years 2023 through 2042, and the remaining $203,894 carried forward indefinitely. As of December 31, 2022, the Company has $53,617 of deferred tax assets recorded related to U.S. federal and state tax loss and tax credit carryforwards. The U.S. federal and state tax losses and credits as of December 31, 2022 are available to be carried forward, with $46,186 expiring during the years 2023 through 2042, and the remaining $7,431 carried forward indefinitely. The Company maintains valuation allowances by jurisdiction against the deferred tax assets related to certain of these carryforwards for which it is more likely than not that some portion or all will not be realized. Unrecognized Tax Benefits The Company files U.S federal, state, local and non-U.S. tax returns. The Company is routinely audited by the tax authorities in these jurisdictions, and a number of audits are currently underway. It is reasonably possible during the next twelve months that uncertain tax positions may be settled, which could result in a decrease in the gross amount of unrecognized tax benefits. This decrease may result in an income tax benefit. Due to the potential for resolution of U.S federal, state and non-U.S. examinations, and the expiration of various statutes of limitation, the Company's gross unrecognized tax benefits balance may change within the next twelve months by a range of zero to $5,113. All significant U.S. federal, state, local and non-U.S. matters have been concluded through 2018. The Company believes adequate provision has been made for all income tax uncertainties. The following table is a reconciliation of the beginning and ending balances of the Company's unrecognized tax benefits: Total Unrecognized tax benefits at January 1, 2020 $ 83,214 Additions based on tax positions related to the current year 3,134 Additions for tax positions of prior years 5,490 Reductions for tax positions of prior years (3,599) Cash settlements (6,214) Lapse of statutes (9,687) Unrecognized tax benefits at December 31, 2020 (1) 72,338 Additions based on tax positions related to the current year 5,859 Additions for tax positions of prior years 3,784 Reductions for tax positions of prior years (13,008) Cash settlements (1,490) Lapse of statutes (2,831) Unrecognized tax benefits at December 31, 2021 (1) 64,652 Additions based on tax positions related to the current year 3,315 Additions for tax positions of prior years 3,421 Reductions for tax positions of prior years (39,439) Cash settlements (411) Lapse of statutes (3,352) Unrecognized tax benefits at December 31, 2022 (1) $ 28,186 (1) If recognized, the net amount of potential tax benefits as of December 31, 2022 that would impact the Company's effective tax rate is $23,496. During the years ended December 31, 2022, 2021 and 2020, the Company recorded income of $8,931, $2,654 and $78, respectively, as a component of provision for income taxes related to the accrued interest and penalties on net reductions to unrecognized tax benefits. The Company had accrued interest and penalties of $6,175 at December 31, 2022 and $15,107 at December 31, 2021, which are not included in the above table. |
Equity and Cash Incentive Progr
Equity and Cash Incentive Program | 12 Months Ended |
Dec. 31, 2022 | |
Share-Based Payment Arrangement [Abstract] | |
Equity and Cash Incentive Program | 15. Equity and Cash Incentive Program The Company's share-based awards are typically granted annually at its regularly scheduled first quarter Compensation Committee meeting. For the years presented herein, employee awards were made pursuant to the terms of the Company's 2021 Omnibus Incentive Plan (the "2021 Plan") and 2012 Equity and Cash Incentive Plan (the "2012 Plan"). On May 7, 2021, the shareholders approved the 2021 Plan, to replace the 2012 Plan, which otherwise would have terminated according to its terms on May 3, 2022. Upon approval of the 2021 Plan, no additional awards could be granted under the 2012 Plan, and the remaining 4,888,197 shares available for additional award grant purposes became available for issuance under the 2021 Plan. The 2021 Plan provides for stock options and SARs, RSUs, PSAs, cash performance awards, directors' shares and deferred stock units. Under the 2021 Plan, a total of 8,300,000 newly authorized shares of common stock are reserved for issuance, resulting in a total of 13,188,197 authorized shares available for issuance. These shares are subject to adjustments resulting from stock dividends, stock splits, recapitalizations, reorganizations and other similar changes. Officers and other key employees, as well as non-employee directors, are eligible to participate in the 2021 Plan, and were also eligible under the 2012 Plan which had a ten-year term between May 3, 2012 to May 3, 2022. Stock-based compensation costs are reported within selling, general and administrative expenses in the consolidated statements of earnings. The following table summarizes the Company's compensation expense relating to all stock-based incentive plans: Years Ended December 31, 2022 2021 2020 Pre-tax stock-based compensation expense $ 30,821 $ 31,111 $ 25,026 Tax benefit (2,993) (2,859) (2,731) Total stock-based compensation expense, net of tax $ 27,828 $ 28,252 $ 22,295 SARs The exercise price per share for SARs is equal to the closing price of the Company's stock on the New York Stock Exchange on the date of grant. New common shares are issued when SARs are exercised. The period during which SARs are exercisable is fixed by the Company's Compensation Committee at the time of grant. Generally, the SARs vest after three years of service and expire at the end of ten years. In 2022, 2021 and 2020, the Company issued SARs covering 335,285, 413,173 and 390,780 shares, respectively. The fair value of each SAR grant was estimated on the date of grant using a Black-Scholes option-pricing model with the following assumptions: 2022 2021 2020 Risk-free interest rate 1.86 % 0.59 % 1.44 % Dividend yield 1.25 % 1.62 % 1.65 % Expected life (years) 5.4 5.5 5.5 Volatility 29.46 % 30.49 % 22.76 % Grant price $160.21 $122.73 $119.86 Fair value per share at date of grant $42.07 $29.08 $22.54 Expected volatilities are based on Dover's stock price history, including implied volatilities from traded options on Dover stock. The Company uses historical data to estimate SAR exercises and employee termination patterns within the valuation model. The expected life of SARs granted is derived from the output of the option valuation model and represents the average period of time that SARs granted are expected to be outstanding. The interest rate for periods within the contractual life of the awards is based on the U.S. Treasury yield curve in effect at the time of grant. A summary of activity relating to SARs granted under the 2021 Plan and the 2012 Plan for the year ended December 31, 2022 is as follows: SARs Number of Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term (Years) Outstanding at January 1, 2022 2,377,384 $ 89.49 Granted 335,285 160.21 Forfeited / expired (76,856) 135.59 Exercised (191,271) 76.15 Outstanding at December 31, 2022 2,444,542 98.70 6.0 Exercisable at December 31, 2022 1,443,544 $ 74.87 4.5 The following table summarizes information about outstanding SARs at December 31, 2022: SARs Outstanding SARs Exercisable Range of Exercise Prices Number of Shares Weighted Average Exercise Price Weighted Average Remaining Life in Years Aggregate Intrinsic Value Number of Shares Weighted Average Exercise Price Weighted Average Remaining Life in Years Aggregate Intrinsic Value $48.28 - $82.09 1,009,878 $ 67.86 3.8 $ 68,217 1,009,878 $ 67.86 3.8 $ 68,217 $84.94 - $119.86 771,613 $ 103.70 6.6 24,469 433,666 $ 91.20 6.1 19,172 $122.73 - $160.21 663,051 $ 139.87 8.6 4,515 — $ — 0 — 2,444,542 $ 97,201 1,443,544 $ 87,389 Unrecognized compensation expense related to SARs not yet exercisable was $9,855 at December 31, 2022. This cost is expected to be recognized over a weighted average period of 1.8 years. Other information regarding the exercise of SARs is listed below: 2022 2021 2020 Fair value of SARs that became exercisable $ 8,939 $ 10,199 $ 8,585 Aggregate intrinsic value of SARs exercised $ 11,992 $ 62,895 $ 55,031 PSAs PSAs granted are expensed over the three-year requisite performance and service period. Awards become vested if (1) the Company achieves certain market conditions and (2) the employee remains continuously employed by the Company during the performance period. Partial vesting may occur after separation from service in the case of certain terminations not for cause and for retirements. In 2022, 2021 and 2020, the Company issued performance shares covering 40,087, 50,371 and 49,056 shares, respectively. The PSAs granted in 2022, 2021 and 2020 are market condition awards as attainment is based on Dover's performance relative to its peer group (companies listed under the S&P 500 Industrials sector) for the relevant performance period. The performance period and vesting period for these awards is approximately three years. These awards were valued on the date of grant using the Monte Carlo simulation model (a binomial lattice-based valuation model), and are generally recognized ratably over the vesting period. The fair value is not subject to change based on future market conditions. The assumptions used in determining the fair value of the performance shares granted in 2022, 2021 and 2020 were as follows: 2022 2021 2020 Risk-free interest rate 1.68 % 0.19 % 1.40 % Dividend yield 1.25 % 1.62 % 1.65 % Expected life (years) 2.9 2.9 2.9 Volatility 31.10 % 31.90 % 23.30 % Grant price $160.21 $122.73 $119.86 Fair value per share at date of grant $196.40 $148.29 $165.71 A summary of activity for PSAs for the year ended December 31, 2022 is as follows: Number of Shares Weighted Average Grant-Date Fair Value Unvested at January 1, 2022 96,129 $ 156.88 Granted 40,087 196.40 Forfeited (4,690) 167.93 Vested (45,719) 165.71 Unvested at December 31, 2022 85,807 $ 170.03 Unrecognized compensation expense related to unvested performance shares as of December 31, 2022 was $7,702, which will be recognized over a weighted average period of 1.7 years. RSUs The Company also has restricted stock authorized for grant. Common stock of the Company may be granted at no cost to certain officers and key employees. In general, restrictions limit the sale or transfer of these shares during a three-year period, and restrictions lapse proportionately over the three-year period. The Company granted 79,556, 87,177 and 83,512 of RSUs in 2022, 2021 and 2020, respectively. The fair value of these awards was determined using Dover's closing stock price on the date of grant, which was $160.21, $122.73, and $119.86 in 2022, 2021 and 2020, respectively. A summary of activity for RSUs for the year ended December 31, 2022 is as follows: Number of Shares Weighted Average Grant-Date Fair Value Unvested at January 1, 2022 202,682 $ 107.03 Granted 79,556 160.21 Forfeited (14,920) 136.85 Vested (119,642) 101.41 Unvested at December 31, 2022 147,676 $ 135.98 Unrecognized compensation expense relating to unvested RSUs as of December 31, 2022 was $9,762, which will be recognized over a weighted average period of 1.4 years. Directors' Shares The Company issued the following shares to its non-employee directors as partial compensation for serving as directors of the Company: Years ended December 31, 2022 2021 2020 Aggregate shares granted 10,730 7,917 9,854 Deferred stock units (7,247) (5,322) (6,278) Net shares issued 3,483 2,595 3,576 |
Commitments and Contingent Liab
Commitments and Contingent Liabilities | 12 Months Ended |
Dec. 31, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingent Liabilities | 16. Commitments and Contingent Liabilities Guarantees The Company has provided typical indemnities in connection with sales of certain businesses and assets, including representations and warranties and related indemnities for environmental, health and safety, tax and employment matters. The Company does not have any material liabilities recorded for these indemnifications and is not aware of any claims or other information that would give rise to material payments under such indemnities. Litigation A few of the Company's subsidiaries are involved in legal proceedings relating to the cleanup of waste disposal sites identified under federal and state statutes which provide for the allocation of such costs among "potentially responsible parties." In each instance, the extent of the Company's liability appears to be relatively insignificant in relation to the total projected expenditures and the number of other "potentially responsible parties" involved and is anticipated to be immaterial to the Company. In addition, a few of the Company's subsidiaries are involved in ongoing remedial activities at certain current and former plant sites, in cooperation with regulatory agencies, and appropriate estimated liabilities have been established. See Note 10 — Other Accrued Expenses and Other Liabilities for additional details. The Company and some of its subsidiaries are also parties to a number of other legal proceedings incidental to their businesses. These proceedings primarily involve claims by private parties alleging injury arising out of use of the Company's products, patent infringement, employment matters and commercial disputes. Management and legal counsel, at least quarterly, review the probable outcome of such proceedings, the costs and expenses reasonably expected to be incurred and currently accrued to-date and consider the availability and extent of insurance coverage. The Company has estimated liabilities for these other legal matters that are probable and estimable, and at December 31, 2022 and 2021, these liabilities were immaterial. While it is not possible at this time to predict the outcome of these legal actions, in the opinion of management, based on the aforementioned reviews, the Company is not currently involved in any legal proceedings which, individually or in the aggregate, could have a material effect on its financial position, results of operations, or cash flows. |
Employee Benefit Plans
Employee Benefit Plans | 12 Months Ended |
Dec. 31, 2022 | |
Retirement Benefits [Abstract] | |
Employee Benefit Plans | 17. Employee Benefit Plans The Company offers defined contribution retirement plans which cover the majority of its U.S. employees, as well as employees in certain other countries. The Company’s expense relating to defined contribution plans was $57,543, $59,719 and $52,629 for the years ended December 31, 2022, 2021 and 2020, respectively. The Company sponsors qualified defined benefit pension plans covering certain employees of the Company and its subsidiaries. The plans' benefits are generally based on years of service and employee compensation. The Company also provides to certain management employees, through non-qualified plans, supplemental retirement benefits in excess of qualified plan limits imposed by federal tax law. In July 2013, the Company announced that, after December 31, 2013, the U.S. qualified and non-qualified defined benefit plans would be closed to new employees. All pension-eligible employees as of December 31, 2013 will continue to earn a pension benefit through December 31, 2023 as long as they remain employed by the Company participating in the impacted plans. The Company also announced that effective January 1, 2024, the plans would be frozen to any future benefit accruals. The Company also maintains other post-retirement benefit plans. These plans are closed to new entrants and are not considered to be significant. The supplemental and other post-retirement benefit plans are supported by the general assets of the Company. Obligations and Funded Status The following tables summarize the change in benefit obligations, change in plan assets, and funded status associated with the Company's significant defined benefit plans and the amounts recognized in the consolidated balance sheets at December 31, 2022 and 2021: Qualified Defined Benefits Non-Qualified Supplemental Benefits U.S. Plan Non-U.S. Plans 2022 2021 2022 2021 2022 2021 Change in benefit obligation: Benefit obligation at beginning of year $ 478,346 $ 524,181 $ 314,715 $ 340,829 $ 42,905 $ 51,194 Service cost 5,703 7,134 4,675 5,749 1,426 1,561 Interest cost 13,745 13,605 5,220 3,590 1,215 1,232 Plan participants' contributions — — 2,186 2,009 — — Benefits paid (17,680) (18,221) (9,756) (7,519) (3,831) (5,331) Actuarial gains (1) (126,985) (19,393) (72,977) (20,766) (9,596) (4,568) Amendments — — (2,291) 1,828 384 — Settlements and curtailments (33,228) (28,960) (8,849) (3,517) — (1,183) Currency translation and other — — (17,606) (7,488) — — Benefit obligation at end of year 319,901 478,346 215,317 314,715 32,503 42,905 Change in plan assets: Fair value of plan assets at beginning of year 573,100 606,896 219,677 212,748 — — Actual return on plan assets (125,011) 13,385 (48,147) 10,664 — — Company contributions — — 9,059 8,121 3,831 6,262 Plan participants' contributions — — 2,186 2,009 — — Benefits paid (17,680) (18,221) (9,756) (7,519) (3,831) (5,331) Settlements and curtailments (36,356) (28,960) (8,640) (2,287) — (931) Currency translation and other — — (11,519) (4,059) — — Fair value of plan assets at end of year 394,053 573,100 152,860 219,677 — — Funded (Unfunded) status $ 74,152 $ 94,754 $ (62,457) $ (95,038) $ (32,503) $ (42,905) Amounts recognized in the consolidated balance sheets consist of: Assets and Liabilities: Other assets and deferred charges $ 74,152 $ 94,754 $ 1,863 $ 1,575 $ — $ — Accrued compensation and employee benefits — — (1,774) (1,729) (7,243) (4,776) Other liabilities (deferred compensation) — — (62,546) (94,884) (25,260) (38,129) Total assets (liabilities) 74,152 94,754 (62,457) (95,038) (32,503) (42,905) Accumulated Other Comprehensive Loss (Earnings): Net actuarial losses (gains) 55,227 33,545 31,607 50,878 (28,304) (20,724) Prior service cost (credit) — 110 (3,006) (1,303) 1,874 2,980 Tax (benefit) expense (11,474) (6,686) (6,434) (11,836) 5,768 3,840 Total accumulated other comprehensive loss (earnings), net of tax 43,753 26,969 22,167 37,739 (20,662) (13,904) Net amount recognized at December 31, $ 117,905 $ 121,723 $ (40,290) $ (57,299) $ (53,165) $ (56,809) Accumulated benefit obligations $ 318,275 $ 471,871 $ 210,259 $ 302,929 $ 31,523 $ 41,110 (1) The actuarial gains were primarily due to discount rate fluctuations. The Company's net unfunded status at December 31, 2022 and 2021 includes net liabilities of $62,457 and $95,038, respectively, relating to the Company's significant international qualified plans, some in locations where it is not economically advantageous to pre-fund the plans due to local regulations. The majority of the international obligations relate to defined pension plans operated by the Company's businesses in Germany, France, the United Kingdom, and Italy. The accumulated benefit obligation for all defined benefit pension plans was $560,057 and $815,910 at December 31, 2022 and 2021, respectively. Non-U.S. pension plans with accumulated benefit obligations in excess of plan assets consist of the following at December 31, 2022 and 2021: 2022 2021 Accumulated benefit obligation $ 124,082 $ 193,710 Fair value of plan assets 64,112 106,519 Non-U.S. pension plans with projected benefit obligations in excess of plan assets consist of the following at December 31, 2022 and 2021: 2022 2021 Projected benefit obligation $ 200,671 $ 292,701 Fair value of plan assets 136,351 196,088 The Company has adjusted the prior year amounts for projected benefit obligations in excess of plan assets in the table above. Net Periodic Benefit Cost The operating expense component of net periodic benefit cost (service cost) is reported with similar compensation costs in the Company's consolidated statement of earnings. The non-operating components (all other components of net periodic benefit expense, including interest cost, amortization of prior service cost, curtailments and settlements, etc.) are reported outside of operating income in other income, net in the consolidated statement of earnings. Components of the net periodic benefit cost were as follows: Defined Benefit Plans Qualified Defined Benefits Non-Qualified Supplemental Benefits U.S. Plan Non-U.S. Plans 2022 2021 2020 2022 2021 2020 2022 2021 2020 Service cost $ 5,703 $ 7,134 $ 6,824 $ 4,675 $ 5,749 $ 5,345 $ 1,426 $ 1,561 $ 1,272 Interest cost 13,745 13,605 16,272 5,220 3,590 3,697 1,215 1,232 1,765 Expected return on plan assets (29,104) (28,980) (31,475) (7,191) (7,188) (6,837) — — — Amortization of: Prior service cost (credit) 110 212 227 (526) (453) (493) 1,490 1,531 1,695 Recognized actuarial loss (gain) 2,300 10,012 7,536 1,747 3,938 3,047 (2,016) (1,672) (1,857) Settlement and curtailment loss (gain) 6,276 2,031 — (393) 194 25 — (743) — Net periodic (benefit) expense $ (970) $ 4,014 $ (616) $ 3,532 $ 5,830 $ 4,784 $ 2,115 $ 1,909 $ 2,875 Assumptions The Company determines actuarial assumptions on an annual basis. The weighted average assumptions used in determining the benefit obligations were as follows: Qualified Defined Benefits Non-Qualified Supplemental Benefits U.S. Plan Non-U.S. Plans 2022 2021 2022 2021 2022 2021 Discount rate 5.55 % 2.95 % 3.57 % 1.18 % 5.50 % 2.90 % Average wage increase 4.00 % 4.00 % 1.70 % 1.53 % 4.50 % 4.50 % The weighted average assumptions used in determining the net periodic benefit cost were as follows: Qualified Defined Benefits Non- Qualified Supplemental Benefits U.S. Plan Non-U.S. Plans 2022 2021 2020 2022 2021 2020 2022 2021 2020 Discount rate 2.95 % 2.65 % 3.40 % 1.18 % 0.79 % 1.18 % 2.90 % 2.45 % 3.20 % Average wage increase 4.00 % 4.00 % 4.00 % 1.53 % 1.51 % 1.80 % 4.50 % 4.50 % 4.50 % Expected return on plan assets 5.60 % 5.60 % 6.30 % 3.47 % 3.40 % 3.69 % na na na The Company's discount rate assumption is determined by developing a yield curve based on high quality corporate bonds with maturities matching the plans' expected benefit payment streams. The plans' expected cash flows are then discounted by the resulting year-by-year spot rates. Plan Assets The primary financial objective of the plans is to secure participant retirement benefits. Accordingly, the key objective in the plans' financial management is to promote stability and, to the extent appropriate, growth in the funded status. Related and supporting financial objectives are established in conjunction with a review of current and projected plan financial requirements. As it relates to the funded defined benefit pension plans, the Company's funding policy is consistent with the funding requirements of the Employment Retirement Income Security Act ("ERISA") and applicable international laws. The Company is responsible for overseeing the management of the investments of the plans' assets and otherwise ensuring that the plans' investment programs are in compliance with ERISA, other relevant legislation and the related plan documents. Where relevant, the Company has retained professional investment managers to manage the plans' assets and implement the investment process. The investment managers, in implementing their investment processes, have the authority and responsibility to select appropriate investments in the asset classes specified by the terms of their applicable prospectus or investment manager agreements with the plans. The assets of the plans are invested to achieve an appropriate return for the plans consistent with a prudent level of risk. The plans' long-term investment objective is to generate investment returns that provide adequate assets to meet all benefit obligations in accordance with applicable regulations. The expected return on assets assumption used for net periodic benefit cost is developed through analysis of historical and forecasted market returns, statistical analysis, current market conditions and the past experience of plan asset investments. The Company's actual and target weighted average asset allocation for our U.S. Qualified Defined Benefits Plan was as follows: 2022 2021 Current Target Return-seeking investments 27 % 29 % 30 % Liability hedging investments 73 % 69 % 70 % Other — % 2 % — % Total 100 % 100 % 100 % Return-seeking investments include diversified foreign and domestic equities, U.S. high yield fixed income investments, and emerging market debt. Liability hedging investments primarily include a diversified portfolio of U.S. long duration fixed income assets. While the non-U.S. investment policies are different for each country, the long-term objectives are generally the same as for the U.S. pension assets. The fair values of both U.S. and non-U.S. pension plan assets by asset category within the fair value hierarchy (as defined in Note 13 — Financial Instruments) were as follows: U.S. Qualified Defined Benefits Plan 12/31/2022 12/31/2021 Level 1 Level 2 Total Fair Value Level 1 Level 2 Total Fair Value Corporate bonds $ — $ 201,203 $ 201,203 $ — $ 316,367 $ 316,367 Government securities — 56,978 56,978 — 73,115 73,115 Interest-bearing cash and short-term investments 2,900 — 2,900 3,227 — 3,227 Total investments at fair value 2,900 258,181 261,081 3,227 389,482 392,709 Investments measured at net asset value* Collective funds — — 106,273 — — 167,551 Short-term investment funds — — 26,699 — — 12,840 Total investments $ 2,900 $ 258,181 $ 394,053 $ 3,227 $ 389,482 $ 573,100 Non-U.S. Plans 12/31/2022 12/31/2021 Level 1 Level 2 Level 3 Total Fair Value Level 1 Level 2 Level 3 Total Fair Value Common stocks $ 46,618 $ — $ — $ 46,618 $ 58,054 $ — $ — $ 58,054 Fixed income investments — 25,168 — 25,168 — 27,034 — 27,034 Mutual funds 20,031 — — 20,031 30,675 — — 30,675 Cash and cash equivalents 909 — — 909 3,634 — — 3,634 Other — 996 16,294 17,290 — 2,877 20,252 23,129 Total investments at fair value 67,558 26,164 16,294 110,016 92,363 29,911 20,252 142,526 Investments measured at net asset value* Collective funds — — — 39,675 — — — 72,235 Other — — — 3,169 — — — 4,916 Total investments $ 67,558 $ 26,164 $ 16,294 $ 152,860 $ 92,363 $ 29,911 $ 20,252 $ 219,677 * In accordance with Fair Value Measurement Topic 820 (Subtopic 820-10), certain investments that are measured at fair value using the net asset value per share (or its equivalent) as a practical expedient were not classified in the fair value hierarchy. These are included to permit reconciliation of the fair value hierarchy to the aggregate pension plan assets. Common stocks represent investments in domestic and foreign equities, which are publicly traded on active exchanges and are valued based on quoted market prices. Fixed income investments include bonds and notes, which are valued based on quoted market prices, as well as investments in other government and municipal securities and corporate bonds, which are valued based on yields currently available on comparable securities of issuers with similar credit ratings. Mutual funds are categorized as either Level 1, 2 or Net Asset Value ("NAV") as a practical expedient depending on the nature of the observable inputs. Collective funds and short-term investment funds are valued using NAV as a practical expedient as of the last business day of the year. The NAV is based on the underlying value of the assets owned by the fund, minus its liabilities, and then divided by the number of shares outstanding. The methods described above may produce a fair value calculation that may not be indicative of net realizable value or reflective of future fair values. Furthermore, while the Company believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date. The availability of observable data is monitored by plan management to assess appropriate classification of financial instruments within the fair value hierarchy. Depending upon the availability of such inputs, specific securities may transfer between levels. In such instances, the transfer is reported at the end of the reporting period. The fair value measurement of plan assets using significant unobservable inputs (Level 3) changed during 2021 and 2022, due to the following: Level 3 Balance at December 31, 2020 $ 21,276 Actual return on plan assets: Relating to assets still held at December 31, 2021 48 Relating to assets sold during the period — Purchases 1,664 Sales and settlements (2,158) Foreign currency translation (578) Balance at December 31, 2021 20,252 Actual return on plan assets: Relating to assets still held at December 31, 2022 (382) Relating to assets sold during the period — Purchases 1,852 Sales and settlements (4,808) Foreign currency translation (620) Balance at December 31, 2022 $ 16,294 Future Estimates Benefit Payments Estimated future benefit payments to retirees, which reflect expected future service except to the extent frozen, are as follows: Qualified Defined Benefits Non-Qualified Supplemental Benefits U.S. Plan Non-U.S. Plans 2023 $ 25,946 $ 10,677 $ 7,440 2024 27,511 10,969 5,231 2025 26,121 10,800 2,312 2026 25,567 11,859 4,599 2027 25,307 14,156 1,800 2028 - 2032 122,304 68,857 14,348 Contributions |
Accumulated Other Comprehensive
Accumulated Other Comprehensive Earnings (Loss) | 12 Months Ended |
Dec. 31, 2022 | |
Equity [Abstract] | |
Accumulated Other Comprehensive Earnings (Loss) | 18. Accumulated Other Comprehensive Earnings (Loss) The components of accumulated other comprehensive earnings (loss) are as follows: December 31, 2022 December 31, 2021 Cumulative foreign currency translation adjustments $ (220,224) $ (107,130) Pension and other postretirement benefit plans (45,258) (50,448) Changes in fair value of cash flow hedges and other (741) 3,526 $ (266,223) $ (154,052) Amounts reclassified from accumulated other comprehensive earnings (loss) to earnings (loss) during the year ended December 31, 2022, 2021 and 2020 were as follows: Years Ended December 31, 2022 2021 2020 Foreign currency translation: Reclassification of foreign currency translation losses to earnings $ 5,915 $ — $ — Tax benefit — — — Net of tax $ 5,915 $ — $ — Pension and other postretirement benefit plans: Amortization of actuarial losses $ 2,965 $ 12,278 $ 8,583 Amortization of prior service costs and transition obligation 1,074 1,304 1,442 Settlement and curtailment 4,282 1,482 25 Total before tax 8,321 15,064 10,050 Tax benefit (1,842) (3,423) (2,184) Net of tax $ 6,479 $ 11,641 $ 7,866 Cash flow hedges: Net gains reclassified into earnings $ (4,797) $ (6,271) $ (817) Tax expense 1,065 1,400 185 Net of tax $ (3,732) $ (4,871) $ (632) The Company recognizes the amortization of net actuarial losses, prior service costs and transition obligation as well as settlements and curtailments, in other income, net in the consolidated statements of earnings. Cash flow hedges consist mainly of foreign currency forward contracts. The Company recognizes the realized gains and losses on its cash flow hedges in the same line item as the hedged transaction, such as revenue, cost of goods and services, or selling, general and administrative expenses in the consolidated statements of earnings. |
Segment Information
Segment Information | 12 Months Ended |
Dec. 31, 2022 | |
Segment Reporting [Abstract] | |
Segment Information | 19. Segment Information The Company categorizes its operating companies into five reportable segments: Engineered Products, Clean Energy & Fueling, Imaging & Identification, Pumps & Process Solutions, and Climate & Sustainability Technologies. The Company's businesses are structured around similar business models, go-to market strategies, manufacturing practices and product categories which increases management efficiency and better aligns Dover's operations with its strategic initiatives and capital allocation priorities, and provides greater transparency about performance. Operating segments are defined as the components of an enterprise for which separate financial information is available, that engage in business activities from which they may recognize revenues and incur expenses, and that are regularly evaluated by the entity's chief operating decision maker or decision-making group, which is composed of Dover's executive leadership team, in making resource allocation decisions and evaluating performance. The five reportable segments are as follows: • Engineered Products segment provides a wide range of equipment, components, software, solutions and services to the vehicle aftermarket, waste handling, industrial automation, aerospace and defense, industrial winch and hoist, and fluid dispensing end-markets. • Clean Energy & Fueling segment provides components, equipment, software, solutions and services enabling safe and reliable storage, transport and dispensing of traditional and clean fuels (including liquefied natural gas, hydrogen, and electric vehicle charging), cryogenic gases, and other hazardous substances along the supply chain, and safe and efficient operation of convenience retail, retail fueling and vehicle wash establishments, as well as facilities where cryogenic gases are produced, stored or consumed. • Imaging & Identification segment supplies precision marking and coding, product traceability, brand protection and digital textile printing equipment, as well as related consumables, software and services to the global packaged and consumer goods, pharmaceutical, industrial manufacturing, textile and other end-markets. • Pumps & Process Solutions segment manufactures specialty pumps and flow meters, highly engineered precision components for rotating and reciprocating machines, fluid connecting solutions and plastics and polymer processing equipment, serving single-use biopharmaceutical production, diversified industrial manufacturing, chemical production, plastics and polymer processing, midstream and downstream oil and gas and other end-markets. • Climate & Sustainability Technologies segment is a provider of innovative and energy-efficient equipment, components and parts for the commercial refrigeration, equipment and systems, heating and cooling and beverage can-making equipment markets. The Company's Chief Operating Decision Maker ("CODM") uses segment earnings to evaluate segment performance and allocate resources. Segment earnings is defined as earnings before purchase accounting expenses, restructuring and other costs, loss (gain) on dispositions, corporate expenses/other, interest expense, interest income and provision for income taxes. During the year ended December 31, 2022, the segment measure of profit and loss used by the CODM was changed to segment earnings from segment earnings (EBIT), defined as earnings before corporate expenses/other, interest expense, interest income and provision for income taxes. This change in segment measure allows the CODM to better assess operating results over time and is consistent with how the CODM evaluates our businesses. Accordingly, we have updated our segment earnings for the years ended 2021 and 2020 to conform to the new presentation. Segment financial information and a reconciliation of segment results to consolidated results follows: Years Ended December 31, 2022 2021 2020 Revenue: Engineered Products $ 2,043,632 $ 1,780,827 $ 1,531,277 Clean Energy & Fueling 1,878,507 1,648,153 1,476,282 Imaging & Identification 1,123,815 1,163,367 1,038,178 Pumps & Process Solutions 1,728,235 1,708,634 1,324,003 Climate & Sustainability Technologies 1,737,724 1,608,175 1,316,090 Intersegment eliminations (3,825) (2,075) (2,070) Total consolidated revenue $ 8,508,088 $ 7,907,081 $ 6,683,760 Net earnings: Segment earnings: Engineered Products $ 346,519 $ 277,852 $ 265,143 Clean Energy & Fueling 352,993 327,186 290,233 Imaging & Identification 268,084 266,932 224,033 Pumps & Process Solutions 533,018 575,593 348,733 Climate & Sustainability Technologies 254,484 185,517 126,093 Total segment earnings 1,755,098 1,633,080 1,254,235 Purchase accounting expenses (1) 181,103 141,980 138,515 Restructuring and other costs (2) 38,990 38,436 51,472 Loss (gain) on dispositions (3) 194 (206,338) (5,213) Corporate expense / other (4) 135,280 156,298 119,361 Interest expense 116,456 106,319 111,937 Interest income (4,430) (4,441) (3,571) Earnings before provision for income taxes 1,287,505 1,400,826 841,734 Provision for income taxes 222,129 277,008 158,283 Net earnings $ 1,065,376 $ 1,123,818 $ 683,451 Segment margins: Engineered Products 17.0 % 15.6 % 17.3 % Clean Energy & Fueling 18.8 % 19.9 % 19.7 % Imaging & Identification 23.9 % 22.9 % 21.6 % Pumps & Process Solutions 30.8 % 33.7 % 26.3 % Climate & Sustainability Technologies 14.6 % 11.5 % 9.6 % Total segments 20.6 % 20.7 % 18.8 % Net earnings 12.5 % 14.2 % 10.2 % Depreciation and amortization: Other depreciation and amortization (5) : Engineered Products $ 27,745 $ 27,036 $ 25,242 Clean Energy & Fueling 28,815 25,842 26,053 Imaging & Identification 14,185 14,189 13,795 Pumps & Process Solutions 40,839 39,272 38,667 Climate & Sustainability Technologies 26,204 26,987 24,582 Total other depreciation and amortization 137,788 133,326 128,339 Corporate depreciation and amortization 8,137 7,250 6,535 Depreciation and amortization included in purchase accounting expenses and restructuring and other 161,613 149,547 144,177 Consolidated total $ 307,538 $ 290,123 $ 279,051 (1) Purchase accounting expenses are primarily comprised of amortization of intangible assets and charges related to fair value step-ups for acquired inventory sold during the period. (2) Restructuring and other costs relate to actions taken for headcount reductions, facility consolidations and site closures, exit costs, and other asset charges. Restructuring and other costs consist of the following: Years Ended December 31, 2022 2021 2020 Restructuring $ 30,480 $ 26,705 $ 44,468 Other costs, net 8,510 11,731 7,004 Restructuring and other costs $ 38,990 $ 38,436 $ 51,472 (3) Loss (gain) on dispositions includes working capital adjustments related to dispositions. (4) Certain expenses are maintained at the corporate level and not allocated to the segments. These expenses include executive and functional compensation costs, non-service pension costs, non-operating insurance expenses, shared business services overhead costs, deal related expenses and various administrative expenses relating to the corporate headquarters. (5) Other depreciation and amortization relates to property, plant, and equipment and intangibles, and excludes amounts related to purchase accounting expenses and restructuring and other costs. Selected financial information by segment (continued): Capital expenditures: 2022 2021 2020 Engineered Products $ 39,765 $ 48,453 $ 23,515 Clean Energy & Fueling 33,489 25,167 26,903 Imaging & Identification 14,695 10,671 10,690 Pumps & Process Solutions 82,817 44,578 52,804 Climate & Sustainability Technologies 41,426 34,335 42,923 Corporate 8,770 8,261 8,857 Consolidated total $ 220,962 $ 171,465 $ 165,692 Total assets at December 31: 2022 2021 Engineered Products $ 1,771,689 $ 1,678,317 Clean Energy & Fueling 3,068,260 3,201,504 Imaging & Identification 1,821,649 1,871,039 Pumps & Process Solutions (6) 2,161,210 1,709,852 Climate & Sustainability Technologies 1,525,449 1,358,118 Corporate (7) 548,262 584,797 Total assets $ 10,896,519 $ 10,403,627 (6) Increase primarily driven by 2022 acquisitions. See Note 3 — Acquisitions for additional information. (7) Corporate assets are comprised primarily of cash and cash equivalents. Revenue Long-Lived Assets (8) Years Ended December 31, At December 31, 2022 2021 2020 2022 2021 United States $ 4,847,321 $ 4,305,957 $ 3,677,285 $ 629,140 $ 584,948 Europe 1,792,020 1,797,138 1,482,520 291,921 283,952 Asia 939,093 901,141 745,150 57,253 62,210 Other Americas 667,673 612,751 535,091 21,763 20,627 Other 261,981 290,094 243,714 4,748 5,573 Consolidated total $ 8,508,088 $ 7,907,081 $ 6,683,760 $ 1,004,825 $ 957,310 (8) Long-lived assets are comprised of net property, plant and equipment. The U.S. was the largest geographical market for the Engineered Products, Clean Energy & Fueling, Pumps & Process Solutions, and Climate & Sustainability Technologies segments, and Europe was the largest market for the Imaging & Identification segment. Revenue is attributed to regions based on the location of the Company's customer, which in some instances is an intermediary and not necessarily the end user. The Company's businesses serve thousands of customers, none of which individually accounted for more than 10% of consolidated revenue. |
Earnings per Share
Earnings per Share | 12 Months Ended |
Dec. 31, 2022 | |
Earnings Per Share [Abstract] | |
Earnings per Share | 20. Earnings per Share The following table sets forth a reconciliation of the information used in computing basic and diluted earnings per share: Years Ended December 31, 2022 2021 2020 Net earnings $ 1,065,376 $ 1,123,818 $ 683,451 Basic earnings per common share: Net earnings $ 7.47 $ 7.81 $ 4.74 Weighted average basic shares outstanding 142,681,000 143,923,000 144,050,000 Diluted earnings per common share: Net earnings $ 7.42 $ 7.74 $ 4.70 Weighted average diluted shares outstanding 143,595,000 145,273,000 145,393,000 The following table is a reconciliation of the share amounts used in computing earnings per share: Years Ended December 31, 2022 2021 2020 Weighted average shares outstanding - basic 142,681,000 143,923,000 144,050,000 Dilutive effect of assumed exercise of SARs and vesting of performance shares and RSUs 914,000 1,350,000 1,343,000 Weighted average shares outstanding - diluted 143,595,000 145,273,000 145,393,000 |
Stockholders' Equity
Stockholders' Equity | 12 Months Ended |
Dec. 31, 2022 | |
Equity [Abstract] | |
Stockholders' Equity | 21. Stockholders' Equity Share Repurchases In November 2020, the Company's Board of Directors approved a new standing share repurchase authorization, whereby the Company may repurchase up to 20 million shares beginning on January 1, 2021 through December 31, 2023. This share repurchase authorization replaced the February 2018 share repurchase authorization. The Company's prior February 2018 share repurchase authorization, whereby the Company was authorized to repurchase up to 20 million shares of its common stock, expired on December 31, 2020. Upon expiration, there were 7,380,879 shares remaining. On August 31, 2022, the Company entered into a $500,000 accelerated share repurchase agreement (the "ASR Agreement") with Bank of America N.A. ("Bank of America") to repurchase its shares in an accelerated share repurchase program (the "ASR Program"). The ASR Program is classified as equity, initially recorded at fair value with no subsequent remeasurement. The Company conducted the ASR Program under the November 2020 share repurchase authorization. The Company funded the ASR Program with net proceeds from commercial paper. Under the terms of the ASR Agreement, the Company paid Bank of America $500,000 on September 1, 2022 and on that date received initial deliveries of 3,201,025 shares, representing a substantial majority of the shares expected to be retired over the course of the ASR Agreement. In December 2022, Bank of America delivered 691,270 additional shares which completed the ASR Program. During 2022, the Company received a total of 3,892,295 shares upon completion of the ASR Agreement. The total number of shares ultimately repurchased under the ASR Agreement was based on the volume-weighted average share price of Dover's common stock during the calculation period of the ASR Program, less a discount, which was $128.46 over the term of the ASR Program. During the years ended December 31, 2022, 2021, and 2020, exclusive of the ASR Program, the Company repurchased 641,428, 182,951, and 979,165 shares of common stock at a total cost of $85,000, $21,637, and $106,279 or $132.52, $118.27, and $108.54 per share, respectively. As of December 31, 2022, 15,283,326 shares remain authorized for repurchase under the November 2020 share repurchase authorization. |
SCHEDULE_II VALUATION AND QUALI
SCHEDULE II VALUATION AND QUALIFYING ACCOUNTS | 12 Months Ended |
Dec. 31, 2022 | |
Schedule II Valuation and Qualifying Accounts [Abstract] | |
SCHEDULE II VALUATION AND QUALIFYING ACCOUNTS | SCHEDULE II VALUATION AND QUALIFYING ACCOUNTS Years Ended December 31, 2022, 2021 and 2020 (In thousands) Deferred Tax Valuation Allowance Balance at Beginning of Year Additions Reductions Balance at End of Year Year Ended December 31, 2022 $ 306,066 4,960 (39,823) $ 271,203 Year Ended December 31, 2021 $ 287,679 38,514 (20,127) $ 306,066 Year Ended December 31, 2020 $ 244,153 49,130 (5,604) $ 287,679 LIFO Reserve Balance at Beginning of Year Charged to Cost and Expense Reductions Balance at End of Year Year Ended December 31, 2022 $ 13,155 2,329 (1,333) $ 14,151 Year Ended December 31, 2021 $ 7,149 7,220 (1,214) $ 13,155 Year Ended December 31, 2020 $ 11,428 357 (4,636) $ 7,149 |
Description of Business and S_2
Description of Business and Summary of Significant Accounting Policies (Policies) | 12 Months Ended |
Dec. 31, 2022 | |
Accounting Policies [Abstract] | |
Principles of Consolidation | Principles of ConsolidationThe consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. Intercompany accounts and transactions have been eliminated in consolidation. The results of operations of acquired businesses are included from the dates of acquisitions. |
Use of Estimates | Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the Consolidated Financial Statements and accompanying disclosures. These estimates may be adjusted due to changes in future economic, industry, or customer financial conditions, as well as changes in technology or demand. Estimates are used for, but not limited to, allowances for doubtful accounts receivable, net realizable value of inventories, restructuring reserves, warranty reserves, pension and post-retirement plans, stock-based compensation, useful lives for depreciation and amortization of long-lived assets including finite-lived intangibles, future cash flows associated with impairment testing for goodwill, indefinite-lived intangible assets and other long-lived assets, deferred tax assets, unrecognized tax benefits and contingencies. Actual results may ultimately differ from these estimates, although management does not believe such differences would materially affect the consolidated financial statements in any individual year. Estimates and assumptions are periodically reviewed and the effects of changes in these estimates and assumptions are reflected in the Consolidated Financial Statements in the period that they are determined. |
Cash and Cash Equivalents | Cash and Cash Equivalents Cash and cash equivalents include cash on hand, demand deposits and short-term investments, which are highly liquid in nature and have original maturities at the time of purchase of three months or less. The carrying value of cash and cash equivalents approximates fair value. |
Accounts Receivable and Allowance for Credit Losses | Accounts Receivable and Allowance for Credit Losses |
Inventories | Inventories Inventories are stated at the lower of cost, determined on the first-in, first-out (FIFO) basis, or net realizable value. An immaterial portion of domestic inventories is stated at cost, determined on the last-in, first-out (LIFO) basis, which is less than net realizable value. |
Property, Plant and Equipment | Property, Plant and EquipmentProperty, plant and equipment includes the historical cost of land, buildings, machinery and equipment, purchased software, finance lease assets and significant improvements to existing plant and equipment or, in the case of acquisitions, the fair value of acquired assets. Expenditures for maintenance, repairs and minor renewals are expensed as incurred. When property or equipment is sold or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts and the gain or loss realized on disposition is reflected in earnings. The Company depreciates its assets on a straight-line basis over their estimated useful lives as follows: buildings and improvements 5 to 31.5 years; machinery and equipment 3 to 15 years; furniture and fixtures 3 to 7 years; vehicles 3 to 7 years; and software 3 to 10 years. |
Derivative Financial Instruments | Derivative Financial Instruments The Company uses derivative financial instruments to hedge its exposures to various risks, including foreign currency exchange rate risk. The Company does not enter into derivative financial instruments for speculative purposes and does not have a material portfolio of derivative financial instruments. Derivative financial instruments used for hedging purposes must be designated and effective as a hedge of the identified risk exposure at inception of the contract. The Company recognizes all derivatives as either assets or liabilities on the consolidated balance sheet and measures those instruments at fair value. For derivatives designated as hedges of the fair value of assets or liabilities, the changes in fair value of both the derivatives and of the hedged items are recorded in current earnings. For derivatives designated as cash flow hedges, the change in the fair value of the derivatives is recorded as a component of other comprehensive earnings and subsequently recognized in net earnings when the hedged items impact earnings. |
Goodwill and Other Intangible Assets | Goodwill and Other Intangible Assets Goodwill represents the excess of purchase price over the fair value of net assets acquired. Goodwill and certain other intangible assets deemed to have indefinite lives (primarily trademarks) are not amortized. For goodwill, impairment tests are required at least annually, or more frequently if events or circumstances indicate that it may be impaired, when some portion but not all of a reporting unit is disposed of or classified as assets held for sale, or when a change in the composition of reporting units occurs for other reasons, such as a change in segments. Based on its current organizational structure, the Company identified reporting units for which cash flows are determinable and to which goodwill was allocated. The Company performs its goodwill impairment test annually in the fourth quarter at the reporting unit level. A quantitative test is used to determine existence of goodwill impairment and the amount of the impairment loss at the reporting unit level. The quantitative test compares the fair value of a reporting unit with its carrying amount, including goodwill. The Company uses an income-based valuation method, determining the present value of estimated future cash flows, to estimate the fair value of a reporting unit. If the fair value of a reporting unit exceeds its carrying amount, goodwill of the reporting unit is not impaired. If the carrying amount of a reporting unit exceeds its fair value, an impairment loss shall be recognized in an amount equal to that excess, limited to the total amount of goodwill allocated to that reporting unit. Factors used in the impairment analysis require significant judgment, and actual results may differ from assumed and estimated amounts. The Company uses its own market assumptions including internal projections of future cash flows, discount rates and other assumptions considered reasonable in the analysis and reflective of market participant assumptions. These forecasts are based on historical performance and future estimated results. The discount rates utilized are based on a capital asset pricing model and published relevant industry rates, which take into consideration the risks and uncertainties inherent to the reporting units and in the internally developed forecasts. See Note 9 — Goodwill and Other Intangible Assets for further discussion of the Company's annual goodwill impairment test and results. No impairment of goodwill was required for the years ended December 31, 2022, 2021, or 2020. |
Other Intangible Assets | Other intangible assets with determinable lives primarily consist of customer intangibles, unpatented technologies, patents and trademarks. The other intangible assets are amortized over their estimated useful lives, ranging from 5 to 20 years. |
Long-Lived Assets | Long-lived assets (including definite-lived intangible assets) are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable, such as a significant sustained change in the business climate. If an indicator of impairment exists for any grouping of assets, an estimate of undiscounted future cash flows is prepared and compared to its carrying value. If an asset group is determined to be impaired, the loss is measured by the excess of the carrying amount of the asset group over its fair value, as determined by an estimate of discounted future cash flows. |
Leases | Leases The Company determines if an arrangement is a lease at inception of a contract. The Company has operating and finance leases for corporate offices, manufacturing plants, research and development facilities, shared services facilities, vehicle fleets and certain office and manufacturing equipment. Operating lease right-of-use ("ROU") assets are included in other assets and deferred charges and operating lease liabilities are included in other accrued expenses and other liabilities in the consolidated balance sheet. Finance lease ROU assets are included in property, plant and equipment, and the related lease liabilities are included in other accrued expenses and other liabilities in the consolidated balance sheet. Leases with an initial term of 12 months or less are not recorded in the balance sheet. The Company accounts for each separate lease component of a contract and its associated non-lease components as a single lease component, thus causing all fixed payments to be capitalized. Variable lease payment amounts that cannot be determined at the commencement of the lease, such as increases in lease payments based on changes in index rates or usage, are not included in the ROU assets or lease liabilities. These are expensed as incurred and recorded as variable lease expense. ROU assets represent the Company's right to use an underlying asset during the lease term and lease liabilities represent the Company's obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the commencement date based on the net present value of fixed lease payments over the lease term. The lease term includes options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. ROU assets also include any advance lease payments made and exclude lease incentives. As most of the Company's operating leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. Finance lease agreements include an interest rate that is used to determine the present value of future lease payments. Fixed operating lease expense and finance lease depreciation expense are recognized on a straight-line basis over the lease term. |
Restructuring Accruals | Restructuring Accruals The Company takes actions to reduce headcount, close facilities, or otherwise exit operations. Such restructuring activities at an operation are recorded when management has committed to an exit or reorganization plan and when termination benefits are probable and can be reasonably estimated based on circumstances at the time the restructuring plan is approved by management or when termination benefits are communicated. Exit costs may include contractual terminations and asset impairments as a result of an approved restructuring plan. The accrual of both severance and exit costs requires the use of estimates. Though the Company believes that its estimates accurately reflect the anticipated costs, actual results may be different from the original estimated amounts. |
Foreign Currency | Foreign Currency Assets and liabilities of non-U.S. subsidiaries, where the functional currency is not the U.S. dollar, have been translated at year-end exchange rates and profit and loss accounts have been translated using weighted-average monthly exchange rates. Foreign currency translation gains and losses are included in the consolidated statements of comprehensive earnings as a component of other comprehensive earnings (loss). Assets and liabilities of an entity that are denominated in currencies other than an entity's functional currency are re-measured into the functional currency using end of period exchange rates, where applicable to certain balances. Gains and losses related to these re-measurements are recorded within the consolidated statements of earnings as a component of other income, net. Gains and losses arising from intercompany foreign currency transactions that are of a long-term investment in nature are reported in the same manner as translation adjustments. |
Revenue Recognition | Revenue Recognition The majority of the Company's revenue is generated through the manufacture and sale of a broad range of specialized products and components, with revenue recognized upon transfer of control, title and risk of loss, which is generally upon shipment. Service revenue represents less than 5% of total revenue and is recognized as the services are performed. In limited cases, revenue arrangements with customers require delivery, installation, testing, certification, or other acceptance provisions to be satisfied before revenue is recognized. The Company includes shipping costs billed to customers in revenue and the related shipping costs in cost of goods and services. |
Share-Based Compensation | Stock-Based CompensationThe principal awards issued under the Company's stock-based compensation plans include non-qualified stock appreciation rights ("SARs"), restricted stock units ("RSUs") and performance share awards ("PSAs"). The cost for such awards is measured at the grant date based on the fair value of the award. At the time of grant, the Company estimates forfeitures, based on historical experience, in order to estimate the portion of the award that will ultimately vest. The value of the portion of the award that is expected to ultimately vest is recognized as expense on a straight-line basis, generally over the explicit service period of three years (except for retirement-eligible employees) and is included in selling, general and administrative expenses in the consolidated statements of earnings. Expense for awards granted to retirement-eligible employees is recorded over the period from the date of grant through the date the employee first becomes eligible to retire and is no longer required to provide service. |
Income Taxes | Income Taxes The provision for income taxes includes federal, state, local and non-U.S. taxes. Tax credits, primarily for research and experimentation, are recognized as a reduction of the provision for income taxes in the year in which they are available for tax purposes. Deferred taxes are provided using enacted rates on the future tax consequences of temporary differences. Temporary differences include the differences between the financial statement carrying amounts of assets and liabilities and their respective tax basis and the tax benefit of carryforwards. A valuation allowance is established for deferred tax assets for which it is more likely than not that some portion or all of the deferred tax benefit will not be realized. In assessing the need for a valuation allowance, management considers all available evidence, including the future reversal of existing taxable temporary differences, taxable income in carryback periods, prudent and feasible tax planning strategies and estimated future taxable income. The valuation allowance can be affected by changes to tax regulations, interpretations and rulings, changes to enacted statutory tax rates and changes to future taxable income estimates. Tax benefits are recognized from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position in consideration of applicable tax statutes and related interpretations and precedents. Tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than 50% likelihood of being realized on ultimate settlement. |
Research and Development Costs | Research and Development Costs Research and development costs, including qualifying engineering costs, are expensed when incurred and amounted to $163,300 in 2022, $157,826 in 2021 and $142,101 in 2020. These costs as a percent of revenue were 1.9% in 2022, 2.0% in 2021 and 2.1% in 2020. Research and development costs are reported within selling, general and administrative expenses in the consolidated statements of earnings. |
Advertising cost | Advertising Costs Advertising costs are expensed when incurred and amounted to $25,905 in 2022, $23,685 in 2021 and $21,375 in 2020. Advertising costs are reported within selling, general and administrative expenses in the consolidated statements of earnings. |
Risk, Retention, Insurance | Risk, Retention, Insurance The Company's insurance programs contain various deductibles that, based on the Company's experience, are typical and customary for a company of its size and risk profile. The Company does not consider any of the deductibles to represent a material risk to the Company. The Company generally maintains insurance policies with deductibles for claims and liabilities related primarily to workers' compensation, health and welfare claims, general liability, product and automobile liability, cybersecurity risks, property damage and business interruption resulting from certain events. The Company accrues for claim exposures that are probable of occurrence and can be reasonably estimated. |
Recent Accounting Pronouncements | Recent Accounting Pronouncements Recently Issued Accounting Standards The following accounting standards updates ("ASU"), issued by the Financial Accounting Standards Board ("FASB"), will, or are expected to, result in a change in practice and/or have a financial impact to the Company's Consolidated Financial Statements: In September 2022, the FASB issued ASU No. 2022-04 Liabilities-Supplier Finance Programs (Topic 405-50): Disclosure of Supplier Finance Program Obligations. The amendments in this update require a buyer in a supplier finance program to disclose information about the program's nature, activity during the period, changes from period to period, and potential magnitude. The guidance will become effective January 1, 2023 and early adoption is permitted. Management is currently evaluating the impact of adopting this ASU on the Company's Consolidated Financial Statements. Recently Adopted Accounting Standards In October 2021, the FASB issued ASU No. 2021-08 Business Combinations (Topic 805)-Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The amendments in this update require that an acquirer recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606, Revenue from Contracts with Customers, as if the acquirer had originated the contracts. Under current guidance, the acquirer generally recognizes such contract assets and contract liabilities at fair value on the acquisition date. The amendments in this update are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The amendments in this update should be applied prospectively to business combinations occurring on or after the effective date of the amendments. Early adoption of the amendments is permitted, including adoption in an interim period. The Company early adopted the guidance as of January 1, 2022, which did not have a material impact on the Company's Consolidated Financial Statements. In March 2020 and January 2021, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform on Financial Reporting and ASU No. 2021-01, Reference Rate Reform, Scope, respectively. In December 2022, the FASB issued ASU No. 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848 as an update to ASU No. 2020-04. These updates provide optional guidance for a limited time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform, including expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments in these updates are elective and are effective upon issuance for all entities. The Company adopted the guidance, which did not have a material impact on the Company's Consolidated Financial Statements. |
Revenue (Tables)
Revenue (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Revenue from Contract with Customer [Abstract] | |
Contract Assets and Contract Liabilities From Contracts With Customers | The following table provides information about contract assets and contract liabilities from contracts with customers: December 31, 2022 December 31, 2021 December 31, 2020 Contract assets $ 11,074 $ 11,440 $ 15,020 Contract liabilities - current 256,933 227,549 184,845 Contract liabilities - non-current 19,879 21,513 13,921 |
Acquisitions (Tables)
Acquisitions (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Business Combination and Asset Acquisition [Abstract] | |
Schedule of Purchase Price Allocation | The following presents the preliminary allocation of purchase price to the assets acquired and liabilities assumed under the Malema acquisition, based on their estimated fair values at acquisition date: Total Current assets, net of cash acquired $ 8,985 Property, plant and equipment 2,733 Goodwill 153,082 Intangible assets 84,000 Other assets and deferred charges 1,159 Current liabilities (4,487) Non-current liabilities (22,010) Net assets acquired $ 223,462 The following presents, for the two acquisitions other than Malema, the preliminary allocation of purchase price to the assets acquired and liabilities assumed, based on their estimated fair values at acquisition date: Total Current assets, net of cash acquired $ 23,369 Property, plant and equipment 4,325 Goodwill 47,431 Intangible assets 40,416 Other assets and deferred charges 20 Current liabilities (13,614) Non-current liabilities (12,554) Net assets acquired $ 89,393 The following presents the allocation of purchase price, net of cash acquired of $10,382, to the assets acquired and liabilities assumed under the RegO acquisition, based on their estimated fair values at acquisition date: Total Accounts receivable $ 33,900 Inventories 71,529 Other current assets 2,958 Property, plant and equipment 50,027 Goodwill 281,163 Intangible assets 234,000 Other assets and deferred charges 884 Current liabilities (20,150) Non-current liabilities (27,693) Net assets acquired $ 626,618 The following presents the allocation of purchase price to the assets acquired and liabilities assumed under the Acme Cryogenics acquisition, based on their estimated fair values at acquisition date: Total Current assets, net of cash acquired $ 25,932 Property, plant and equipment 8,640 Goodwill 167,291 Intangible assets 127,300 Other assets and deferred charges 5,057 Current liabilities (7,286) Non-current liabilities (34,628) Net assets acquired $ 292,306 The following presents, for the seven acquisitions other than RegO and Acme Cryogenics, the allocation of purchase price to the assets acquired and liabilities assumed, based on their estimated fair values at acquisition date: Total Current assets, net of cash acquired $ 12,751 Property, plant and equipment 8,272 Goodwill 135,932 Intangible assets 78,179 Other assets and deferred charges 4,485 Current liabilities (15,368) Non-current liabilities (17,389) Net assets acquired $ 206,862 The following presents the allocation of purchase price to the assets acquired and liabilities assumed, based on their estimated fair values at acquisition date: Total Current assets, net of cash acquired $ 44,159 Property, plant and equipment 8,424 Goodwill 205,805 Intangible assets 134,049 Other assets and deferred charges 12,986 Current liabilities (34,803) Non-current liabilities (34,834) Net assets acquired $ 335,786 |
Schedule of Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination | The amounts assigned to goodwill and major intangible asset classifications for all 2022 acquisitions were as follows: Amount allocated Useful life Goodwill - non-deductible $ 200,513 na Customer intangibles 90,657 10 - 15 Patents 16,000 10 Unpatented technology 10,355 8 Trademarks 7,404 15 $ 324,929 The amounts assigned to goodwill and major intangible asset classifications for all 2021 acquisitions were as follows: Amount allocated Useful life Goodwill - tax deductible $ 200,117 na Goodwill - non deductible 384,269 na Customer intangibles 310,819 12 - 15 Patents 49,056 7 - 12 Unpatented technology 44,180 7 - 12 Trademarks 35,424 15 - 16 $ 1,023,865 The amounts assigned to goodwill and major intangible asset classifications were as follows: Amount allocated Useful life Goodwill - tax deductible $ 33,183 na Goodwill - non deductible 172,622 na Customer intangibles 103,310 10 - 14 Unpatented technology 21,125 5 - 9 Trademarks 9,614 15 $ 339,854 |
Schedule of Pro forma results of operations | The following unaudited pro forma results of operations reflect the 2021 acquisitions of RegO and Acme Cryogenics as if they had occurred on January 1, 2020. The pro forma information is not necessarily indicative of the results that actually would have occurred, nor does it indicate future operating results of the combined companies. The pro forma earnings are adjusted to reflect the comparable impact of additional depreciation and amortization expense, net of tax, resulting from the fair value measurement of tangible and intangible assets; nonrecurring acquisition-related costs, net of tax, of $5,855; and inventory step-up charges, net of tax, of $15,082. These unaudited pro forma adjustments are based upon purchase price allocations. The actual revenues and earnings for RegO and Acme Cryogenics from the date of acquisition on December 28, 2021 and December 16, 2021, respectively, to December 31, 2021 were not material. Years Ended December 31, 2021 2020 Revenue: As reported $ 7,907,081 $ 6,683,760 Pro forma (unaudited) 8,163,185 6,920,929 Earnings: As reported $ 1,123,818 $ 683,451 Pro forma (unaudited) 1,145,106 669,458 |
Inventories, net (Tables)
Inventories, net (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Inventory, Net [Abstract] | |
Components of Inventory | The components of inventories, net were as follows: December 31, 2022 December 31, 2021 Raw materials $ 812,066 $ 671,195 Work in progress 230,865 271,659 Finished goods 458,881 377,800 Subtotal 1,501,812 1,320,654 Less reserves (135,204) (129,559) Total $ 1,366,608 $ 1,191,095 |
Property, Plant and Equipment (
Property, Plant and Equipment (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Property, Plant and Equipment [Abstract] | |
Components of property, plant and equipment, net | The components of property, plant and equipment, net were as follows: December 31, 2022 December 31, 2021 Land $ 62,495 $ 63,656 Buildings and improvements 620,500 582,314 Machinery, equipment and other 1,895,502 1,816,473 Property, plant and equipment, gross 2,578,497 2,462,443 Total accumulated depreciation (1,573,672) (1,505,133) Property, plant and equipment, net $ 1,004,825 $ 957,310 |
Leases (Tables)
Leases (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Leases [Abstract] | |
Components of Lease Cost, Supplemental Cash Flow, and Balance Sheet, and Lease Assumptions | The components of lease costs were as follows: Years Ended December 31, 2022 2021 2020 Operating Lease Costs: Fixed $ 53,428 $ 54,397 $ 52,875 Variable 7,512 6,281 5,973 Short-term 22,097 17,847 18,436 Total (1) $ 83,037 $ 78,525 $ 77,284 (1) Finance lease cost and sublease income were immaterial. Supplemental cash flow information related to leases was as follows: Years Ended December 31, 2022 2021 2020 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows for operating leases $ 54,268 $ 55,921 $ 53,903 Operating cash flows for finance leases 335 357 434 Financing cash flows for finance leases 2,917 3,073 2,523 Total $ 57,520 $ 59,351 $ 56,860 Right-of-use assets obtained in exchange for lease obligations: Operating leases $ 57,190 $ 47,666 $ 21,381 Financing leases 3,149 2,016 3,708 Total $ 60,339 $ 49,682 $ 25,089 Supplemental balance sheet information related to leases were as follows : December 31, 2022 December 31, 2021 Operating Leases Right-of-use assets: Other assets and deferred charges $ 197,058 $ 169,022 Lease liabilities: Other accrued expenses $ 42,649 $ 43,086 Other liabilities 165,741 134,448 Total operating lease liabilities $ 208,390 $ 177,534 Finance Leases Right-of-use assets: Property, plant and equipment, net (1) $ 7,846 $ 8,588 Lease liabilities: Other accrued expenses $ 2,554 $ 2,475 Other liabilities 6,189 6,767 Total finance lease liabilities $ 8,743 $ 9,242 (1) Finance lease right-of-use assets are recorded net of accumulated depreciation of $8,017 and $7,675 for the years ended December 31, 2022 and December 31, 2021, respectively. Average lease terms and discount rates were as follows: December 31, 2022 December 31, 2021 December 31, 2020 Weighted-average remaining lease term (years) Operating leases 7.8 5.8 5.9 Finance leases 3.6 4.2 4.8 Weighted-average discount rate Operating leases 3.5 % 2.7 % 2.9 % Finance leases 3.4 % 3.4 % 3.6 % |
Maturity of Operating Lease Liability | The aggregate future lease payments for operating and finance leases as of December 31, 2022 were as follows: Operating Finance 2023 $ 47,843 $ 2,860 2024 40,524 2,432 2025 32,759 1,963 2026 23,009 1,480 2027 19,447 816 Thereafter 81,937 1 Total lease payments 245,519 9,552 Less interest (37,129) (809) Present value of lease liabilities $ 208,390 $ 8,743 |
Maturity of Finance Lease Liability | The aggregate future lease payments for operating and finance leases as of December 31, 2022 were as follows: Operating Finance 2023 $ 47,843 $ 2,860 2024 40,524 2,432 2025 32,759 1,963 2026 23,009 1,480 2027 19,447 816 Thereafter 81,937 1 Total lease payments 245,519 9,552 Less interest (37,129) (809) Present value of lease liabilities $ 208,390 $ 8,743 |
Credit Losses (Tables)
Credit Losses (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Credit Loss [Abstract] | |
Roll-forward of the allowance for credit losses | The following table provides a roll-forward of the allowance for credit losses that is deducted from the amortized cost basis of accounts receivable to present the net amount expected to be collected. 2022 2021 2020 Beginning Balance, January 1, $ 40,126 $ 40,474 $ 29,381 Adoption of ASU No. 2016-13, cumulative-effect adjustment to retained earnings — — 2,706 Provision for expected credit losses, net of recoveries 5,552 5,053 11,171 Amounts written off charged against the allowance (4,462) (5,307) (3,863) Other, including dispositions and foreign currency translation (1,817) (94) 1,079 Ending balance, December 31 $ 39,399 $ 40,126 $ 40,474 |
Goodwill and Other Intangible_2
Goodwill and Other Intangible Assets (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Goodwill Rollforward by Segment | The changes in the carrying value of goodwill by reportable operating segments were as follows: Engineered Products Clean Energy & Fueling Imaging & Identification Pumps & Process Solutions Climate & Sustainability Technologies Total Goodwill $ 693,576 $ 940,973 $ 1,117,589 $ 846,250 $ 544,715 $ 4,143,103 Accumulated impairment loss (1) (10,591) — — (59,970) — (70,561) Balance at January 1, 2021 682,985 940,973 1,117,589 786,280 544,715 4,072,542 Acquisitions 50,180 496,461 20,458 15,018 — 582,117 Measurement period adjustments — 2,640 (1,926) — — 714 Disposition of business — — — — (34,662) (34,662) Foreign currency translation (9,882) (12,383) (29,919) (8,459) (1,246) (61,889) Balance at December 31, 2021 723,283 1,427,691 1,106,202 792,839 508,807 4,558,822 Acquisitions — — — 200,513 — 200,513 Measurement period adjustments (286) 2,432 (1,544) 968 — 1,570 Foreign currency translation (10,455) (38,705) (26,399) (14,785) (1,067) (91,411) Balance at December 31, 2022 $ 712,542 $ 1,391,418 $ 1,078,259 $ 979,535 $ 507,740 $ 4,669,494 (1) Accumulated impairment loss as of December 31, 2022 is not subject to foreign currency translation. |
Schedule of Intangible Assets | The Company's definite-lived and indefinite-lived intangible assets by major asset class were as follows: December 31, 2022 December 31, 2021 Gross Amount Accumulated Amortization Net Carrying Amount Gross Amount Accumulated Amortization Net Carrying Amount Amortized intangible assets: Customer intangibles $ 1,881,402 $ 996,947 $ 884,455 $ 1,829,492 $ 909,776 $ 919,716 Trademarks 265,466 132,791 132,675 263,367 116,633 146,734 Patents 219,199 146,337 72,862 205,910 140,327 65,583 Unpatented technologies 257,428 137,750 119,678 221,239 123,464 97,775 Distributor relationships 79,622 57,299 22,323 84,204 55,260 28,944 Drawings and manuals 26,062 26,062 — 27,792 27,303 489 Other 20,818 15,620 5,198 22,347 18,775 3,572 Total 2,749,997 1,512,806 1,237,191 2,654,351 1,391,538 1,262,813 Unamortized intangible assets: Trademarks 96,544 — 96,544 96,709 — 96,709 Total intangible assets, net $ 2,846,541 $ 1,512,806 $ 1,333,735 $ 2,751,060 $ 1,391,538 $ 1,359,522 |
Future Amortization Expense | Estimated future amortization expense related to intangible assets held at December 31, 2022 for the next five years is as follows: Estimated Amortization 2023 $ 154,124 2024 149,866 2025 145,857 2026 138,090 2027 135,785 |
Other Accrued Expenses and Ot_2
Other Accrued Expenses and Other Liabilities (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Accrued Liabilities and Other Liabilities [Abstract] | |
Major components of other accrued expenses | The following table details the major components of other accrued expenses: December 31, 2022 December 31, 2021 Accrued rebates and volume discounts $ 47,660 $ 52,909 Warranty 43,351 43,449 Operating lease liabilities 42,649 43,086 Taxes other than income (1) 33,782 49,992 Accrued interest 20,591 20,426 Accrued commissions (non-employee) 15,808 16,273 Restructuring and exit costs 14,510 13,797 Other (none of which are individually significant) 99,986 107,165 Total other accrued expenses $ 318,337 $ 347,097 (1) Taxes other than income includes a $15.3 million deferral of employment taxes related to the U.S. CARES Act as of December 31, 2021. |
Major components of other liabilities | The following table details the major components of other liabilities (non-current): December 31, 2022 December 31, 2021 Operating lease liabilities $ 165,741 $ 134,448 Defined benefit and other post-retirement benefit plans 92,630 138,992 Deferred compensation 82,479 88,681 Unrecognized tax benefits 34,361 79,757 Legal and environmental 30,139 31,304 Deferred revenue 19,879 21,513 Warranty 5,098 5,119 Other 44,576 32,728 Total other liabilities $ 474,903 $ 532,542 |
Carrying amount of product warranties | Warranty Estimated warranty program claims are provided for at the time of sale. Amounts provided for are based on historical costs and adjusted for new claims. The changes in the carrying amount of product warranties were as follows: Years Ended December 31, 2022 2021 2020 Beginning Balance, December 31 of the Prior Year $ 48,568 $ 51,088 $ 49,116 Provision for warranties 60,758 67,212 60,902 Settlements made (59,612) (65,498) (60,853) Other adjustments, including acquisitions and currency translation (1,265) (4,234) 1,923 Ending Balance, December 31 $ 48,449 $ 48,568 $ 51,088 |
Restructuring Activities (Table
Restructuring Activities (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Restructuring and Related Activities [Abstract] | |
Summary of Restructuring Programs | The Company initiated various restructuring programs and incurred severance and other restructuring costs by segment as follows: Years Ended December 31, 2022 2021 2020 Engineered Products $ 3,194 $ 9,507 $ 10,307 Clean Energy & Fueling 9,571 3,609 6,681 Imaging & Identification 4,702 4,589 5,946 Pumps & Process Solutions 4,685 1,911 13,374 Climate & Sustainability Technologies 6,007 5,068 4,015 Corporate 2,321 2,021 4,145 Total $ 30,480 $ 26,705 $ 44,468 These amounts are classified in the consolidated statements of earnings as follows: Cost of goods and services $ 6,855 $ 12,895 $ 18,895 Selling, general and administrative expenses 23,625 13,810 25,573 Total $ 30,480 $ 26,705 $ 44,468 |
Severance and Other Restructuring Accrual Activities | The following table details the Company's severance and other restructuring accrual activities: Severance Exit Total Balance at January 1, 2020 $ 13,751 $ 2,639 $ 16,390 Restructuring charges 25,716 18,752 44,468 Payments (29,768) (6,035) (35,803) Other, including foreign currency translation 848 (10,990) (1) (10,142) Balance at December 31, 2020 10,547 4,366 14,913 Restructuring charges 11,561 15,144 26,705 Payments (10,951) (6,171) (17,122) Other, including foreign currency translation (427) (10,272) (1) (10,699) Balance at December 31, 2021 10,730 3,067 13,797 Restructuring charges 15,388 15,092 (2) 30,480 Payments (13,975) (8,159) (22,134) Other, including foreign currency translation (136) (7,497) (2) (7,633) Balance at December 31, 2022 $ 12,007 $ 2,503 $ 14,510 (1) Other activity in exit reserves primarily represents the non-cash write-off of certain long-lived assets and inventory in connection with certain facility closures and product exits. (2) Other activity in exit reserves includes non-cash foreign currency translation losses recorded as restructuring charges due to the substantial liquidation of businesses in certain Latin America countries. |
Borrowings (Tables)
Borrowings (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Debt Disclosure [Abstract] | |
Schedule of short-term debt | Borrowings consist of the following: December 31, 2022 December 31, 2021 Short-term: Commercial paper $ 734,936 $ 105,000 Other 836 702 Short-term borrowings $ 735,772 $ 105,702 |
Borrowings | Carrying amount (1) Principal December 31, 2022 December 31, 2021 Long-term: 3.15% 10-year notes due November 15, 2025 $ 400,000 $ 398,063 $ 397,389 1.25% 10-year notes due November 9, 2026 (euro-denominated) € 600,000 631,522 674,217 0.750% 8-year notes due November 4, 2027 (euro denominated) € 500,000 525,654 561,293 6.65% 30-year debentures due June 1, 2028 $ 200,000 199,456 199,356 2.950% 10-year notes due November 4, 2029 $ 300,000 297,408 297,029 5.375% 30-year debentures due October 15, 2035 $ 300,000 296,808 296,559 6.60% 30-year notes due March 15, 2038 $ 250,000 248,279 248,166 5.375% 30-year notes due March 1, 2041 $ 350,000 344,982 344,705 Other 341 — Total long-term debt $ 2,942,513 $ 3,018,714 (1) Carrying amount is net of unamortized debt discount and deferred debt issuance costs. Total unamortized debt discounts were $12.7 million and $15.1 million as of December 31, 2022 and 2021, respectively. Total deferred debt issuance costs were $10.7 million and $12.5 million as of December 31, 2022 and 2021, respectively. |
Scheduled maturities | As of December 31, 2022, the future maturities of long-term debt were as follows: Future Maturities 2024 $ 118 2025 400,103 2026 635,915 2027 529,829 2028 and thereafter 1,400,000 Total $ 2,965,965 |
Financial Instruments (Tables)
Financial Instruments (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Fair value of derivative instruments and the balance sheet lines in which they are recorded | The following table sets forth the fair values of derivative instruments held by the Company as of December 31, 2022 and 2021 and the balance sheet lines in which they are recorded: Fair Value Asset (Liability) December 31, 2022 December 31, 2021 Balance Sheet Caption Foreign currency forward $ 944 $ 2,825 Prepaid and other current assets Foreign currency forward (2,760) (433) Other accrued expenses |
Amounts recognized in other comprehensive earnings | Amounts recognized in other comprehensive earnings (loss) for the gains (losses) on net investment hedges were as follows: 2022 2021 2020 Gain (loss) on euro-denominated debt $ 80,301 $ 94,003 $ (119,298) Tax (expense) benefit (17,824) (20,976) 26,957 Net gain (loss) on net investment hedges, net of tax $ 62,477 $ 73,027 $ (92,341) |
Assets and liabilities measured at fair value on a recurring basis | The Company's assets and liabilities measured at fair value on a recurring basis as of December 31, 2022 and 2021 were as follows: December 31, 2022 December 31, 2021 Level 2 Level 2 Assets: Foreign currency cash flow hedges $ 944 $ 2,825 Liabilities: Foreign currency cash flow hedges 2,760 433 |
Income Taxes (Tables)
Income Taxes (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Income Tax Disclosure [Abstract] | |
Schedule Of Earnings Before Provision For Income Taxes And Discontinued Operations | Income taxes have been based on the following components of earnings before provision for income taxes in the consolidated statements of earnings: Years Ended December 31, 2022 2021 2020 Domestic $ 731,796 $ 835,773 $ 464,145 Foreign 555,709 565,053 377,589 Total $ 1,287,505 $ 1,400,826 $ 841,734 |
Schedule of Components of Income Tax Expense (Benefit) | Income tax expense (benefit) for the years ended December 31, 2022, 2021 and 2020 is comprised of the following: Years Ended December 31, 2022 2021 2020 Current: U.S. federal $ 106,768 $ 150,990 $ 79,305 State and local 1,450 28,106 13,312 Foreign 140,696 154,147 97,106 Total current 248,914 333,243 189,723 Deferred: U.S. federal (4,760) (14,143) 2,777 State and local 303 3,165 (10,526) Foreign (22,328) (45,257) (23,691) Total deferred (26,785) (56,235) (31,440) Total expense $ 222,129 $ 277,008 $ 158,283 |
Schedule of Effective Income Tax Rate Reconciliation | Differences between the effective income tax rate and the U.S. federal income statutory tax rate are as follows: Years Ended December 31, 2022 2021 2020 U.S. federal income tax rate 21.0 % 21.0 % 21.0 % State and local taxes, net of federal income tax benefit 1.6 1.8 1.7 Foreign operations tax effect 0.1 (0.2) (0.8) Foreign-derived intangible income (1.3) (0.8) (1.1) Share awards (0.2) (0.8) (1.2) Dispositions — 0.3 — Audit resolutions (3.2) (1.4) (0.9) Other (0.7) (0.1) 0.1 Effective tax rate 17.3 % 19.8 % 18.8 % |
Schedule of Deferred Tax Assets and Liabilities | The tax effects of temporary differences that give rise to deferred tax assets and liabilities are as follows: December 31, 2022 December 31, 2021 Deferred Tax Assets: Accrued compensation, postretirement and other employee benefits $ 46,008 $ 61,388 Accrued expenses 20,608 30,143 Net operating loss and other carryforwards 317,186 334,483 Inventories 30,569 28,698 Allowance for credit losses 9,224 9,988 Accrued insurance 3,978 4,708 Long-term liabilities, warranty and environmental costs 2,851 3,043 Lease obligations 47,887 41,653 Capitalized research and development 26,548 — Total gross deferred tax assets 504,859 514,104 Valuation allowance (271,203) (306,066) Total deferred tax assets, net of valuation allowances $ 233,656 $ 208,038 Deferred Tax Liabilities: Intangible assets $ (417,809) $ (392,208) Property, plant and equipment (82,658) (77,918) Lease right-of-use assets (45,202) (40,181) Other liabilities (27,447) (28,786) Total gross deferred tax liabilities (573,116) (539,093) Net deferred tax liability $ (339,460) $ (331,055) Classified as follows in the Consolidated Balance Sheets: Other assets and deferred charges $ 35,690 $ 33,062 Deferred income taxes (375,150) (364,117) $ (339,460) $ (331,055) |
Schedule Of Unrecognized Tax Benefits | The following table is a reconciliation of the beginning and ending balances of the Company's unrecognized tax benefits: Total Unrecognized tax benefits at January 1, 2020 $ 83,214 Additions based on tax positions related to the current year 3,134 Additions for tax positions of prior years 5,490 Reductions for tax positions of prior years (3,599) Cash settlements (6,214) Lapse of statutes (9,687) Unrecognized tax benefits at December 31, 2020 (1) 72,338 Additions based on tax positions related to the current year 5,859 Additions for tax positions of prior years 3,784 Reductions for tax positions of prior years (13,008) Cash settlements (1,490) Lapse of statutes (2,831) Unrecognized tax benefits at December 31, 2021 (1) 64,652 Additions based on tax positions related to the current year 3,315 Additions for tax positions of prior years 3,421 Reductions for tax positions of prior years (39,439) Cash settlements (411) Lapse of statutes (3,352) Unrecognized tax benefits at December 31, 2022 (1) $ 28,186 (1) If recognized, the net amount of potential tax benefits as of December 31, 2022 that would impact the Company's effective tax rate is $23,496. During the years ended December 31, 2022, 2021 and 2020, the Company recorded income of $8,931, $2,654 and $78, respectively, as a component of provision for income taxes related to the accrued interest and penalties on net reductions to unrecognized tax benefits. The Company had accrued interest and penalties of $6,175 at December 31, 2022 and $15,107 at December 31, 2021, which are not included in the above table. |
Equity and Cash Incentive Pro_2
Equity and Cash Incentive Program (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Share-Based Payment Arrangement [Abstract] | |
Stock-based incentive plans compensation expense | Stock-based compensation costs are reported within selling, general and administrative expenses in the consolidated statements of earnings. The following table summarizes the Company's compensation expense relating to all stock-based incentive plans: Years Ended December 31, 2022 2021 2020 Pre-tax stock-based compensation expense $ 30,821 $ 31,111 $ 25,026 Tax benefit (2,993) (2,859) (2,731) Total stock-based compensation expense, net of tax $ 27,828 $ 28,252 $ 22,295 |
Fair Value Assumptions | The fair value of each SAR grant was estimated on the date of grant using a Black-Scholes option-pricing model with the following assumptions: 2022 2021 2020 Risk-free interest rate 1.86 % 0.59 % 1.44 % Dividend yield 1.25 % 1.62 % 1.65 % Expected life (years) 5.4 5.5 5.5 Volatility 29.46 % 30.49 % 22.76 % Grant price $160.21 $122.73 $119.86 Fair value per share at date of grant $42.07 $29.08 $22.54 2022 2021 2020 Risk-free interest rate 1.68 % 0.19 % 1.40 % Dividend yield 1.25 % 1.62 % 1.65 % Expected life (years) 2.9 2.9 2.9 Volatility 31.10 % 31.90 % 23.30 % Grant price $160.21 $122.73 $119.86 Fair value per share at date of grant $196.40 $148.29 $165.71 |
Summary of activity relating to SARs and stock options | A summary of activity relating to SARs granted under the 2021 Plan and the 2012 Plan for the year ended December 31, 2022 is as follows: SARs Number of Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term (Years) Outstanding at January 1, 2022 2,377,384 $ 89.49 Granted 335,285 160.21 Forfeited / expired (76,856) 135.59 Exercised (191,271) 76.15 Outstanding at December 31, 2022 2,444,542 98.70 6.0 Exercisable at December 31, 2022 1,443,544 $ 74.87 4.5 |
Awards outstanding, vested and exercisable | The following table summarizes information about outstanding SARs at December 31, 2022: SARs Outstanding SARs Exercisable Range of Exercise Prices Number of Shares Weighted Average Exercise Price Weighted Average Remaining Life in Years Aggregate Intrinsic Value Number of Shares Weighted Average Exercise Price Weighted Average Remaining Life in Years Aggregate Intrinsic Value $48.28 - $82.09 1,009,878 $ 67.86 3.8 $ 68,217 1,009,878 $ 67.86 3.8 $ 68,217 $84.94 - $119.86 771,613 $ 103.70 6.6 24,469 433,666 $ 91.20 6.1 19,172 $122.73 - $160.21 663,051 $ 139.87 8.6 4,515 — $ — 0 — 2,444,542 $ 97,201 1,443,544 $ 87,389 |
Other information for SARs and stock options | Other information regarding the exercise of SARs is listed below: 2022 2021 2020 Fair value of SARs that became exercisable $ 8,939 $ 10,199 $ 8,585 Aggregate intrinsic value of SARs exercised $ 11,992 $ 62,895 $ 55,031 |
Summary of activity for performance share awards | A summary of activity for PSAs for the year ended December 31, 2022 is as follows: Number of Shares Weighted Average Grant-Date Fair Value Unvested at January 1, 2022 96,129 $ 156.88 Granted 40,087 196.40 Forfeited (4,690) 167.93 Vested (45,719) 165.71 Unvested at December 31, 2022 85,807 $ 170.03 |
Summary of activity for restricted stock units | A summary of activity for RSUs for the year ended December 31, 2022 is as follows: Number of Shares Weighted Average Grant-Date Fair Value Unvested at January 1, 2022 202,682 $ 107.03 Granted 79,556 160.21 Forfeited (14,920) 136.85 Vested (119,642) 101.41 Unvested at December 31, 2022 147,676 $ 135.98 |
Shares granted to directors | The Company issued the following shares to its non-employee directors as partial compensation for serving as directors of the Company: Years ended December 31, 2022 2021 2020 Aggregate shares granted 10,730 7,917 9,854 Deferred stock units (7,247) (5,322) (6,278) Net shares issued 3,483 2,595 3,576 |
Employee Benefit Plans (Tables)
Employee Benefit Plans (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Retirement Benefits [Abstract] | |
Defined Benefit Plans Disclosures | The following tables summarize the change in benefit obligations, change in plan assets, and funded status associated with the Company's significant defined benefit plans and the amounts recognized in the consolidated balance sheets at December 31, 2022 and 2021: Qualified Defined Benefits Non-Qualified Supplemental Benefits U.S. Plan Non-U.S. Plans 2022 2021 2022 2021 2022 2021 Change in benefit obligation: Benefit obligation at beginning of year $ 478,346 $ 524,181 $ 314,715 $ 340,829 $ 42,905 $ 51,194 Service cost 5,703 7,134 4,675 5,749 1,426 1,561 Interest cost 13,745 13,605 5,220 3,590 1,215 1,232 Plan participants' contributions — — 2,186 2,009 — — Benefits paid (17,680) (18,221) (9,756) (7,519) (3,831) (5,331) Actuarial gains (1) (126,985) (19,393) (72,977) (20,766) (9,596) (4,568) Amendments — — (2,291) 1,828 384 — Settlements and curtailments (33,228) (28,960) (8,849) (3,517) — (1,183) Currency translation and other — — (17,606) (7,488) — — Benefit obligation at end of year 319,901 478,346 215,317 314,715 32,503 42,905 Change in plan assets: Fair value of plan assets at beginning of year 573,100 606,896 219,677 212,748 — — Actual return on plan assets (125,011) 13,385 (48,147) 10,664 — — Company contributions — — 9,059 8,121 3,831 6,262 Plan participants' contributions — — 2,186 2,009 — — Benefits paid (17,680) (18,221) (9,756) (7,519) (3,831) (5,331) Settlements and curtailments (36,356) (28,960) (8,640) (2,287) — (931) Currency translation and other — — (11,519) (4,059) — — Fair value of plan assets at end of year 394,053 573,100 152,860 219,677 — — Funded (Unfunded) status $ 74,152 $ 94,754 $ (62,457) $ (95,038) $ (32,503) $ (42,905) Amounts recognized in the consolidated balance sheets consist of: Assets and Liabilities: Other assets and deferred charges $ 74,152 $ 94,754 $ 1,863 $ 1,575 $ — $ — Accrued compensation and employee benefits — — (1,774) (1,729) (7,243) (4,776) Other liabilities (deferred compensation) — — (62,546) (94,884) (25,260) (38,129) Total assets (liabilities) 74,152 94,754 (62,457) (95,038) (32,503) (42,905) Accumulated Other Comprehensive Loss (Earnings): Net actuarial losses (gains) 55,227 33,545 31,607 50,878 (28,304) (20,724) Prior service cost (credit) — 110 (3,006) (1,303) 1,874 2,980 Tax (benefit) expense (11,474) (6,686) (6,434) (11,836) 5,768 3,840 Total accumulated other comprehensive loss (earnings), net of tax 43,753 26,969 22,167 37,739 (20,662) (13,904) Net amount recognized at December 31, $ 117,905 $ 121,723 $ (40,290) $ (57,299) $ (53,165) $ (56,809) Accumulated benefit obligations $ 318,275 $ 471,871 $ 210,259 $ 302,929 $ 31,523 $ 41,110 (1) The actuarial gains were primarily due to discount rate fluctuations. |
Projected Benefit Obligations and Accumulated Benefit Obligations in Excess of Plan Assets | Non-U.S. pension plans with accumulated benefit obligations in excess of plan assets consist of the following at December 31, 2022 and 2021: 2022 2021 Accumulated benefit obligation $ 124,082 $ 193,710 Fair value of plan assets 64,112 106,519 Non-U.S. pension plans with projected benefit obligations in excess of plan assets consist of the following at December 31, 2022 and 2021: 2022 2021 Projected benefit obligation $ 200,671 $ 292,701 Fair value of plan assets 136,351 196,088 |
Schedule of Net Periodic Benefit Costs | Components of the net periodic benefit cost were as follows: Defined Benefit Plans Qualified Defined Benefits Non-Qualified Supplemental Benefits U.S. Plan Non-U.S. Plans 2022 2021 2020 2022 2021 2020 2022 2021 2020 Service cost $ 5,703 $ 7,134 $ 6,824 $ 4,675 $ 5,749 $ 5,345 $ 1,426 $ 1,561 $ 1,272 Interest cost 13,745 13,605 16,272 5,220 3,590 3,697 1,215 1,232 1,765 Expected return on plan assets (29,104) (28,980) (31,475) (7,191) (7,188) (6,837) — — — Amortization of: Prior service cost (credit) 110 212 227 (526) (453) (493) 1,490 1,531 1,695 Recognized actuarial loss (gain) 2,300 10,012 7,536 1,747 3,938 3,047 (2,016) (1,672) (1,857) Settlement and curtailment loss (gain) 6,276 2,031 — (393) 194 25 — (743) — Net periodic (benefit) expense $ (970) $ 4,014 $ (616) $ 3,532 $ 5,830 $ 4,784 $ 2,115 $ 1,909 $ 2,875 |
Weighted-Average Assumptions Used in Benefit Obligations | The weighted average assumptions used in determining the benefit obligations were as follows: Qualified Defined Benefits Non-Qualified Supplemental Benefits U.S. Plan Non-U.S. Plans 2022 2021 2022 2021 2022 2021 Discount rate 5.55 % 2.95 % 3.57 % 1.18 % 5.50 % 2.90 % Average wage increase 4.00 % 4.00 % 1.70 % 1.53 % 4.50 % 4.50 % |
Weighted-Average Assumptions Used Calculating Net Periodic Cost | The weighted average assumptions used in determining the net periodic benefit cost were as follows: Qualified Defined Benefits Non- Qualified Supplemental Benefits U.S. Plan Non-U.S. Plans 2022 2021 2020 2022 2021 2020 2022 2021 2020 Discount rate 2.95 % 2.65 % 3.40 % 1.18 % 0.79 % 1.18 % 2.90 % 2.45 % 3.20 % Average wage increase 4.00 % 4.00 % 4.00 % 1.53 % 1.51 % 1.80 % 4.50 % 4.50 % 4.50 % Expected return on plan assets 5.60 % 5.60 % 6.30 % 3.47 % 3.40 % 3.69 % na na na |
Weighted-Average Asset Allocation Actual and Target | The Company's actual and target weighted average asset allocation for our U.S. Qualified Defined Benefits Plan was as follows: 2022 2021 Current Target Return-seeking investments 27 % 29 % 30 % Liability hedging investments 73 % 69 % 70 % Other — % 2 % — % Total 100 % 100 % 100 % |
Plan Assets by Asset Category | The fair values of both U.S. and non-U.S. pension plan assets by asset category within the fair value hierarchy (as defined in Note 13 — Financial Instruments) were as follows: U.S. Qualified Defined Benefits Plan 12/31/2022 12/31/2021 Level 1 Level 2 Total Fair Value Level 1 Level 2 Total Fair Value Corporate bonds $ — $ 201,203 $ 201,203 $ — $ 316,367 $ 316,367 Government securities — 56,978 56,978 — 73,115 73,115 Interest-bearing cash and short-term investments 2,900 — 2,900 3,227 — 3,227 Total investments at fair value 2,900 258,181 261,081 3,227 389,482 392,709 Investments measured at net asset value* Collective funds — — 106,273 — — 167,551 Short-term investment funds — — 26,699 — — 12,840 Total investments $ 2,900 $ 258,181 $ 394,053 $ 3,227 $ 389,482 $ 573,100 Non-U.S. Plans 12/31/2022 12/31/2021 Level 1 Level 2 Level 3 Total Fair Value Level 1 Level 2 Level 3 Total Fair Value Common stocks $ 46,618 $ — $ — $ 46,618 $ 58,054 $ — $ — $ 58,054 Fixed income investments — 25,168 — 25,168 — 27,034 — 27,034 Mutual funds 20,031 — — 20,031 30,675 — — 30,675 Cash and cash equivalents 909 — — 909 3,634 — — 3,634 Other — 996 16,294 17,290 — 2,877 20,252 23,129 Total investments at fair value 67,558 26,164 16,294 110,016 92,363 29,911 20,252 142,526 Investments measured at net asset value* Collective funds — — — 39,675 — — — 72,235 Other — — — 3,169 — — — 4,916 Total investments $ 67,558 $ 26,164 $ 16,294 $ 152,860 $ 92,363 $ 29,911 $ 20,252 $ 219,677 * In accordance with Fair Value Measurement Topic 820 (Subtopic 820-10), certain investments that are measured at fair value using the net asset value per share (or its equivalent) as a practical expedient were not classified in the fair value hierarchy. These are included to permit reconciliation of the fair value hierarchy to the aggregate pension plan assets. |
Measurement of Plan Assets use Significant Unobservable Inputs | The fair value measurement of plan assets using significant unobservable inputs (Level 3) changed during 2021 and 2022, due to the following: Level 3 Balance at December 31, 2020 $ 21,276 Actual return on plan assets: Relating to assets still held at December 31, 2021 48 Relating to assets sold during the period — Purchases 1,664 Sales and settlements (2,158) Foreign currency translation (578) Balance at December 31, 2021 20,252 Actual return on plan assets: Relating to assets still held at December 31, 2022 (382) Relating to assets sold during the period — Purchases 1,852 Sales and settlements (4,808) Foreign currency translation (620) Balance at December 31, 2022 $ 16,294 |
Expected Future Benefit Payments | Benefit Payments Estimated future benefit payments to retirees, which reflect expected future service except to the extent frozen, are as follows: Qualified Defined Benefits Non-Qualified Supplemental Benefits U.S. Plan Non-U.S. Plans 2023 $ 25,946 $ 10,677 $ 7,440 2024 27,511 10,969 5,231 2025 26,121 10,800 2,312 2026 25,567 11,859 4,599 2027 25,307 14,156 1,800 2028 - 2032 122,304 68,857 14,348 |
Accumulated Other Comprehensi_2
Accumulated Other Comprehensive Earnings (Loss) (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Equity [Abstract] | |
Components of Accumulated Other Comprehensive Income (Loss) | The components of accumulated other comprehensive earnings (loss) are as follows: December 31, 2022 December 31, 2021 Cumulative foreign currency translation adjustments $ (220,224) $ (107,130) Pension and other postretirement benefit plans (45,258) (50,448) Changes in fair value of cash flow hedges and other (741) 3,526 $ (266,223) $ (154,052) |
Amounts Reclassified from Accumulated Other Comprehensive Earnings (Loss) to Earnings (Loss) | Amounts reclassified from accumulated other comprehensive earnings (loss) to earnings (loss) during the year ended December 31, 2022, 2021 and 2020 were as follows: Years Ended December 31, 2022 2021 2020 Foreign currency translation: Reclassification of foreign currency translation losses to earnings $ 5,915 $ — $ — Tax benefit — — — Net of tax $ 5,915 $ — $ — Pension and other postretirement benefit plans: Amortization of actuarial losses $ 2,965 $ 12,278 $ 8,583 Amortization of prior service costs and transition obligation 1,074 1,304 1,442 Settlement and curtailment 4,282 1,482 25 Total before tax 8,321 15,064 10,050 Tax benefit (1,842) (3,423) (2,184) Net of tax $ 6,479 $ 11,641 $ 7,866 Cash flow hedges: Net gains reclassified into earnings $ (4,797) $ (6,271) $ (817) Tax expense 1,065 1,400 185 Net of tax $ (3,732) $ (4,871) $ (632) |
Segment Information (Tables)
Segment Information (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Segment Reporting [Abstract] | |
Segment Financial Information | Segment financial information and a reconciliation of segment results to consolidated results follows: Years Ended December 31, 2022 2021 2020 Revenue: Engineered Products $ 2,043,632 $ 1,780,827 $ 1,531,277 Clean Energy & Fueling 1,878,507 1,648,153 1,476,282 Imaging & Identification 1,123,815 1,163,367 1,038,178 Pumps & Process Solutions 1,728,235 1,708,634 1,324,003 Climate & Sustainability Technologies 1,737,724 1,608,175 1,316,090 Intersegment eliminations (3,825) (2,075) (2,070) Total consolidated revenue $ 8,508,088 $ 7,907,081 $ 6,683,760 Net earnings: Segment earnings: Engineered Products $ 346,519 $ 277,852 $ 265,143 Clean Energy & Fueling 352,993 327,186 290,233 Imaging & Identification 268,084 266,932 224,033 Pumps & Process Solutions 533,018 575,593 348,733 Climate & Sustainability Technologies 254,484 185,517 126,093 Total segment earnings 1,755,098 1,633,080 1,254,235 Purchase accounting expenses (1) 181,103 141,980 138,515 Restructuring and other costs (2) 38,990 38,436 51,472 Loss (gain) on dispositions (3) 194 (206,338) (5,213) Corporate expense / other (4) 135,280 156,298 119,361 Interest expense 116,456 106,319 111,937 Interest income (4,430) (4,441) (3,571) Earnings before provision for income taxes 1,287,505 1,400,826 841,734 Provision for income taxes 222,129 277,008 158,283 Net earnings $ 1,065,376 $ 1,123,818 $ 683,451 Segment margins: Engineered Products 17.0 % 15.6 % 17.3 % Clean Energy & Fueling 18.8 % 19.9 % 19.7 % Imaging & Identification 23.9 % 22.9 % 21.6 % Pumps & Process Solutions 30.8 % 33.7 % 26.3 % Climate & Sustainability Technologies 14.6 % 11.5 % 9.6 % Total segments 20.6 % 20.7 % 18.8 % Net earnings 12.5 % 14.2 % 10.2 % Depreciation and amortization: Other depreciation and amortization (5) : Engineered Products $ 27,745 $ 27,036 $ 25,242 Clean Energy & Fueling 28,815 25,842 26,053 Imaging & Identification 14,185 14,189 13,795 Pumps & Process Solutions 40,839 39,272 38,667 Climate & Sustainability Technologies 26,204 26,987 24,582 Total other depreciation and amortization 137,788 133,326 128,339 Corporate depreciation and amortization 8,137 7,250 6,535 Depreciation and amortization included in purchase accounting expenses and restructuring and other 161,613 149,547 144,177 Consolidated total $ 307,538 $ 290,123 $ 279,051 (1) Purchase accounting expenses are primarily comprised of amortization of intangible assets and charges related to fair value step-ups for acquired inventory sold during the period. (2) Restructuring and other costs relate to actions taken for headcount reductions, facility consolidations and site closures, exit costs, and other asset charges. Restructuring and other costs consist of the following: Years Ended December 31, 2022 2021 2020 Restructuring $ 30,480 $ 26,705 $ 44,468 Other costs, net 8,510 11,731 7,004 Restructuring and other costs $ 38,990 $ 38,436 $ 51,472 (3) Loss (gain) on dispositions includes working capital adjustments related to dispositions. (4) Certain expenses are maintained at the corporate level and not allocated to the segments. These expenses include executive and functional compensation costs, non-service pension costs, non-operating insurance expenses, shared business services overhead costs, deal related expenses and various administrative expenses relating to the corporate headquarters. (5) Other depreciation and amortization relates to property, plant, and equipment and intangibles, and excludes amounts related to purchase accounting expenses and restructuring and other costs. |
Reconciliation of Assets from Segment to Consolidated | Selected financial information by segment (continued): Capital expenditures: 2022 2021 2020 Engineered Products $ 39,765 $ 48,453 $ 23,515 Clean Energy & Fueling 33,489 25,167 26,903 Imaging & Identification 14,695 10,671 10,690 Pumps & Process Solutions 82,817 44,578 52,804 Climate & Sustainability Technologies 41,426 34,335 42,923 Corporate 8,770 8,261 8,857 Consolidated total $ 220,962 $ 171,465 $ 165,692 Total assets at December 31: 2022 2021 Engineered Products $ 1,771,689 $ 1,678,317 Clean Energy & Fueling 3,068,260 3,201,504 Imaging & Identification 1,821,649 1,871,039 Pumps & Process Solutions (6) 2,161,210 1,709,852 Climate & Sustainability Technologies 1,525,449 1,358,118 Corporate (7) 548,262 584,797 Total assets $ 10,896,519 $ 10,403,627 (6) Increase primarily driven by 2022 acquisitions. See Note 3 — Acquisitions for additional information. |
Revenue from External Customers and Long-Lived Assets, by Geographical Areas | Revenue Long-Lived Assets (8) Years Ended December 31, At December 31, 2022 2021 2020 2022 2021 United States $ 4,847,321 $ 4,305,957 $ 3,677,285 $ 629,140 $ 584,948 Europe 1,792,020 1,797,138 1,482,520 291,921 283,952 Asia 939,093 901,141 745,150 57,253 62,210 Other Americas 667,673 612,751 535,091 21,763 20,627 Other 261,981 290,094 243,714 4,748 5,573 Consolidated total $ 8,508,088 $ 7,907,081 $ 6,683,760 $ 1,004,825 $ 957,310 (8) Long-lived assets are comprised of net property, plant and equipment. |
Earnings per Share (Tables)
Earnings per Share (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Earnings Per Share [Abstract] | |
Reconciliation of information used in computing basic and diluted earnings per share | The following table sets forth a reconciliation of the information used in computing basic and diluted earnings per share: Years Ended December 31, 2022 2021 2020 Net earnings $ 1,065,376 $ 1,123,818 $ 683,451 Basic earnings per common share: Net earnings $ 7.47 $ 7.81 $ 4.74 Weighted average basic shares outstanding 142,681,000 143,923,000 144,050,000 Diluted earnings per common share: Net earnings $ 7.42 $ 7.74 $ 4.70 Weighted average diluted shares outstanding 143,595,000 145,273,000 145,393,000 |
Reconciliation of share amounts used in computing earnings per share | The following table is a reconciliation of the share amounts used in computing earnings per share: Years Ended December 31, 2022 2021 2020 Weighted average shares outstanding - basic 142,681,000 143,923,000 144,050,000 Dilutive effect of assumed exercise of SARs and vesting of performance shares and RSUs 914,000 1,350,000 1,343,000 Weighted average shares outstanding - diluted 143,595,000 145,273,000 145,393,000 |
Description of Business and S_3
Description of Business and Summary of Significant Accounting Policies (Details) | 12 Months Ended | ||
Dec. 31, 2022 USD ($) segment | Dec. 31, 2021 USD ($) | Dec. 31, 2020 USD ($) | |
Goodwill [Line Items] | |||
Number of reportable segments | segment | 5 | ||
Impairment loss on goodwill | $ 0 | $ 0 | $ 0 |
Impairment loss on indefinite-lived intangible assets | $ 0 | 0 | 0 |
Service requisite period | 3 years | ||
Research and development expense | $ 163,300,000 | $ 157,826,000 | $ 142,101,000 |
Research and development expense as a percent of revenue (in percent) | 0.019 | 0.02 | 0.021 |
Advertising expense | $ 25,905,000 | $ 23,685,000 | $ 21,375,000 |
Product Concentration Risk | Revenue Benchmark | Service Revenue | |||
Goodwill [Line Items] | |||
Concentration risk (in percent) | 5% | ||
Minimum | Buildings and improvements | |||
Goodwill [Line Items] | |||
Property, plant and equipment useful life | 5 years | ||
Minimum | Machinery and Equipment | |||
Goodwill [Line Items] | |||
Property, plant and equipment useful life | 3 years | ||
Minimum | Furniture and Fixtures | |||
Goodwill [Line Items] | |||
Property, plant and equipment useful life | 3 years | ||
Minimum | Vehicles | |||
Goodwill [Line Items] | |||
Property, plant and equipment useful life | 3 years | ||
Minimum | Software | |||
Goodwill [Line Items] | |||
Property, plant and equipment useful life | 3 years | ||
Maximum | Buildings and improvements | |||
Goodwill [Line Items] | |||
Property, plant and equipment useful life | 31 years 6 months | ||
Maximum | Machinery and Equipment | |||
Goodwill [Line Items] | |||
Property, plant and equipment useful life | 15 years | ||
Maximum | Furniture and Fixtures | |||
Goodwill [Line Items] | |||
Property, plant and equipment useful life | 7 years | ||
Maximum | Vehicles | |||
Goodwill [Line Items] | |||
Property, plant and equipment useful life | 7 years | ||
Maximum | Software | |||
Goodwill [Line Items] | |||
Property, plant and equipment useful life | 10 years | ||
Other intangibles | Minimum | |||
Goodwill [Line Items] | |||
Other intangible assets, useful life | 5 years | ||
Other intangibles | Maximum | |||
Goodwill [Line Items] | |||
Other intangible assets, useful life | 20 years |
Revenue - Narrative (Details)
Revenue - Narrative (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | ||
Future performance obligation | $ 296,698 | |
Revenue recognized during the period | $ 196,891 | $ 163,546 |
Recognized at a point in time | ||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | ||
Remaining performance obligation (in percent) | 95% | |
Recognized over time | ||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | ||
Remaining performance obligation (in percent) | 5% | |
Minimum | ||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | ||
General range of payment terms | 30 days | |
Maximum | ||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | ||
General range of payment terms | 90 days | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01 | ||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | ||
Remaining performance obligation (in percent) | 63.10% | |
Expected timing of performance obligation satisfaction | 12 months | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01 | ||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | ||
Expected timing of performance obligation satisfaction |
Revenue - Contract Balances (De
Revenue - Contract Balances (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 |
Revenue from Contract with Customer [Abstract] | |||
Contract assets | $ 11,074 | $ 11,440 | $ 15,020 |
Contract liabilities - current | 256,933 | 227,549 | 184,845 |
Contract liabilities - non-current | $ 19,879 | $ 21,513 | $ 13,921 |
Acquisitions - Narrative (Detai
Acquisitions - Narrative (Details) | 12 Months Ended | ||||||||||||||||||
Dec. 14, 2022 USD ($) | Jul. 01, 2022 USD ($) | May 02, 2022 USD ($) | Dec. 28, 2021 USD ($) | Dec. 16, 2021 USD ($) | Oct. 15, 2021 USD ($) | Sep. 15, 2021 USD ($) | Jul. 23, 2021 USD ($) | Jun. 24, 2021 USD ($) | Jun. 23, 2021 USD ($) | Apr. 19, 2021 USD ($) | Dec. 30, 2020 USD ($) | Aug. 20, 2020 USD ($) | Apr. 30, 2020 USD ($) | Feb. 18, 2020 USD ($) | Jan. 24, 2020 USD ($) | Dec. 31, 2022 USD ($) acquisition business | Dec. 31, 2021 USD ($) business | Dec. 31, 2020 USD ($) business acquisition | |
Business Acquisition [Line Items] | |||||||||||||||||||
Number of business acquisitions (in businesses) | business | 3 | 9 | |||||||||||||||||
Total consideration, net of cash acquired | $ 312,855,000 | $ 1,112,075,000 | $ 335,786,000 | ||||||||||||||||
Cash acquired | 18,475,000 | ||||||||||||||||||
Contingent consideration | 13,002,000 | ||||||||||||||||||
Number of business acquisitions with contingent consideration | acquisition | 1 | ||||||||||||||||||
Acquisitions | $ 200,513,000 | 582,117,000 | |||||||||||||||||
Intangible assets | 124,416,000 | ||||||||||||||||||
Goodwill recorded in acquisition | 4,669,494,000 | 4,558,822,000 | $ 4,072,542,000 | ||||||||||||||||
Consideration transferred | 1,125,786,000 | ||||||||||||||||||
Measurement period adjustments | 1,570,000 | 714,000 | |||||||||||||||||
Number of immaterial aquisitions | acquisition | 1 | ||||||||||||||||||
Acquisition-related Costs | |||||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||||
Revenue | 5,855,000 | ||||||||||||||||||
Fair Value Adjustment to Inventory | |||||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||||
Revenue | 15,082,000 | ||||||||||||||||||
Pumps & Process Solutions | |||||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||||
Acquisitions | 200,513,000 | 15,018,000 | |||||||||||||||||
Goodwill recorded in acquisition | 979,535,000 | 792,839,000 | $ 786,280,000 | ||||||||||||||||
Measurement period adjustments | $ 968,000 | $ 0 | |||||||||||||||||
Malema Engineering Corporation | |||||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||||
Total consideration, net of cash acquired | $ 223,462,000 | ||||||||||||||||||
Percentage acquired (in percent) | 99.70% | 0.30% | |||||||||||||||||
Contingent consideration, earnout financial performance target, each period | 12 months | ||||||||||||||||||
Contingent consideration, earnout financial performance target, maturity period | 2 years | ||||||||||||||||||
Contingent consideration payout maximum | $ 50,000,000 | ||||||||||||||||||
Fair value of contingent liability | 0 | ||||||||||||||||||
Acquisitions | 153,082,000 | ||||||||||||||||||
Intangible assets | 84,000,000 | ||||||||||||||||||
Goodwill recorded in acquisition | 153,082,000 | ||||||||||||||||||
Measurement period adjustments | 1,381,000 | ||||||||||||||||||
Malema Engineering Corporation | Customer intangibles | |||||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||||
Intangible assets | 64,000,000 | ||||||||||||||||||
Malema Engineering Corporation | Patents | |||||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||||
Intangible assets | 16,000,000 | ||||||||||||||||||
Malema Engineering Corporation | Trademarks | |||||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||||
Intangible assets | $ 4,000,000 | ||||||||||||||||||
Witte Pumps & Technology GmbH | |||||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||||
Total consideration, net of cash acquired | $ 81,293,000 | ||||||||||||||||||
Percentage acquired (in percent) | 100% | ||||||||||||||||||
Intangible assets | $ 34,791,000 | ||||||||||||||||||
Goodwill recorded in acquisition | $ 45,528,000 | ||||||||||||||||||
AMN DPI | |||||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||||
Total consideration, net of cash acquired | $ 8,100,000 | ||||||||||||||||||
Percentage acquired (in percent) | 100% | ||||||||||||||||||
Intangible assets | $ 5,625,000 | ||||||||||||||||||
Goodwill recorded in acquisition | $ 1,903,000 | ||||||||||||||||||
Series of individually immaterial acquistions | |||||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||||
Number of business acquisitions (in businesses) | business | 2 | 7 | 6 | ||||||||||||||||
Total consideration, net of cash acquired | $ 335,786,000 | ||||||||||||||||||
Goodwill - tax deductible | 33,183,000 | ||||||||||||||||||
Goodwill - non deductible | 172,622,000 | ||||||||||||||||||
Intangible assets | $ 40,416,000 | $ 78,179,000 | 134,049,000 | ||||||||||||||||
Goodwill recorded in acquisition | 47,431,000 | $ 135,932,000 | 205,805,000 | ||||||||||||||||
Series of individually immaterial acquistions | Pumps & Process Solutions | |||||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||||
Number of business acquisitions (in businesses) | business | 1 | ||||||||||||||||||
Series of individually immaterial acquistions | Customer intangibles | |||||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||||
Intangible assets | 103,310,000 | ||||||||||||||||||
Series of individually immaterial acquistions | Trademarks | |||||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||||
Intangible assets | 9,614,000 | ||||||||||||||||||
Series of individually immaterial acquistions | Unpatented technology | |||||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||||
Intangible assets | $ 21,125,000 | ||||||||||||||||||
RegO | |||||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||||
Total consideration, net of cash acquired | $ 626,618,000 | ||||||||||||||||||
Cash acquired | 10,382,000 | ||||||||||||||||||
Goodwill - tax deductible | 170,800,000 | ||||||||||||||||||
Goodwill - non deductible | $ 110,363,000 | ||||||||||||||||||
Percentage acquired (in percent) | 100% | ||||||||||||||||||
Intangible assets | $ 234,000,000 | ||||||||||||||||||
Accounts receivable | 33,900,000 | ||||||||||||||||||
Goodwill recorded in acquisition | 281,163,000 | ||||||||||||||||||
Fair value of trade receivables acquired | 34,606,000 | ||||||||||||||||||
Allowance for uncollectable accounts | (706,000) | ||||||||||||||||||
Measurement period adjustments | $ 4,187,000 | ||||||||||||||||||
RegO | Customer intangibles | |||||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||||
Intangible assets | 173,000,000 | ||||||||||||||||||
RegO | Patents | |||||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||||
Intangible assets | 40,000,000 | ||||||||||||||||||
RegO | Trademarks | |||||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||||
Intangible assets | $ 21,000,000 | ||||||||||||||||||
Acme Cryogenics | |||||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||||
Total consideration, net of cash acquired | $ 292,306,000 | ||||||||||||||||||
Goodwill - non deductible | $ 167,291,000 | ||||||||||||||||||
Percentage acquired (in percent) | 100% | ||||||||||||||||||
Intangible assets | $ 127,300,000 | ||||||||||||||||||
Accounts receivable | 14,644,000 | ||||||||||||||||||
Goodwill recorded in acquisition | 167,291,000 | ||||||||||||||||||
Allowance for uncollectable accounts | (268,000) | ||||||||||||||||||
Measurement period adjustments | (1,918,000) | ||||||||||||||||||
Gross trade receivables acquired | 14,912,000 | ||||||||||||||||||
Acme Cryogenics | Customer intangibles | |||||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||||
Intangible assets | 99,000,000 | ||||||||||||||||||
Acme Cryogenics | Trademarks | |||||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||||
Intangible assets | 6,500,000 | ||||||||||||||||||
Acme Cryogenics | Unpatented technology | |||||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||||
Intangible assets | $ 21,800,000 | ||||||||||||||||||
LIQAL | |||||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||||
Total consideration, net of cash acquired | $ 27,701,000 | ||||||||||||||||||
Percentage acquired (in percent) | 100% | ||||||||||||||||||
Acquisitions | $ 23,473,000 | ||||||||||||||||||
Intangible assets | $ 8,235,000 | ||||||||||||||||||
Espy | |||||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||||
Total consideration, net of cash acquired | $ 60,457,000 | ||||||||||||||||||
Percentage acquired (in percent) | 100% | ||||||||||||||||||
Acquisitions | $ 29,317,000 | ||||||||||||||||||
Intangible assets | $ 21,100,000 | ||||||||||||||||||
CDS Visual | |||||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||||
Total consideration, net of cash acquired | $ 29,147,000 | ||||||||||||||||||
Percentage acquired (in percent) | 100% | ||||||||||||||||||
Acquisitions | $ 20,863,000 | ||||||||||||||||||
Intangible assets | $ 9,930,000 | ||||||||||||||||||
Blue Bite | |||||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||||
Total consideration, net of cash acquired | $ 30,143,000 | ||||||||||||||||||
Percentage acquired (in percent) | 100% | ||||||||||||||||||
Acquisitions | $ 20,458,000 | ||||||||||||||||||
Intangible assets | $ 13,250,000 | ||||||||||||||||||
Quantex | |||||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||||
Total consideration, net of cash acquired | $ 23,747,000 | ||||||||||||||||||
Percentage acquired (in percent) | 100% | ||||||||||||||||||
Acquisitions | $ 14,327,000 | ||||||||||||||||||
Intangible assets | $ 11,034,000 | ||||||||||||||||||
AvaLAN | |||||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||||
Total consideration, net of cash acquired | $ 34,144,000 | ||||||||||||||||||
Percentage acquired (in percent) | 100% | ||||||||||||||||||
Acquisitions | $ 26,803,000 | ||||||||||||||||||
Intangible assets | $ 14,630,000 | ||||||||||||||||||
ICS | |||||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||||
Total consideration, net of cash acquired | $ 77,030,000 | ||||||||||||||||||
Percentage acquired (in percent) | 100% | ||||||||||||||||||
Solaris | |||||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||||
Total consideration, net of cash acquired | $ 18,680,000 | ||||||||||||||||||
Percentage acquired (in percent) | 100% | ||||||||||||||||||
Em-tec | |||||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||||
Total consideration, net of cash acquired | $ 30,396,000 | ||||||||||||||||||
Percentage acquired (in percent) | 100% | ||||||||||||||||||
Soft-Pak | |||||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||||
Total consideration, net of cash acquired | $ 45,500,000 | ||||||||||||||||||
Percentage acquired (in percent) | 100% | ||||||||||||||||||
Systech | |||||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||||
Total consideration, net of cash acquired | $ 161,830,000 | ||||||||||||||||||
Percentage acquired (in percent) | 100% |
Acquisitions - Purchase Price A
Acquisitions - Purchase Price Allocation (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Jul. 01, 2022 | Dec. 31, 2021 | Dec. 28, 2021 | Dec. 16, 2021 | Dec. 31, 2020 |
Business Acquisition [Line Items] | ||||||
Goodwill | $ 4,669,494 | $ 4,558,822 | $ 4,072,542 | |||
Intangible assets | 124,416 | |||||
Malema Engineering Corporation | ||||||
Business Acquisition [Line Items] | ||||||
Current assets, net of cash acquired | $ 8,985 | |||||
Property, plant and equipment | 2,733 | |||||
Goodwill | 153,082 | |||||
Intangible assets | 84,000 | |||||
Other assets and deferred charges | 1,159 | |||||
Current liabilities | (4,487) | |||||
Non-current liabilities | (22,010) | |||||
Net assets acquired | $ 223,462 | |||||
RegO | ||||||
Business Acquisition [Line Items] | ||||||
Accounts receivable | $ 33,900 | |||||
Inventories | 71,529 | |||||
Other current assets | 2,958 | |||||
Property, plant and equipment | 50,027 | |||||
Goodwill | 281,163 | |||||
Intangible assets | 234,000 | |||||
Other assets and deferred charges | 884 | |||||
Current liabilities | (20,150) | |||||
Non-current liabilities | (27,693) | |||||
Net assets acquired | $ 626,618 | |||||
Acme Cryogenics | ||||||
Business Acquisition [Line Items] | ||||||
Accounts receivable | $ 14,644 | |||||
Current assets, net of cash acquired | 25,932 | |||||
Property, plant and equipment | 8,640 | |||||
Goodwill | 167,291 | |||||
Intangible assets | 127,300 | |||||
Other assets and deferred charges | 5,057 | |||||
Current liabilities | (7,286) | |||||
Non-current liabilities | (34,628) | |||||
Net assets acquired | $ 292,306 | |||||
Series of individually immaterial acquistions | ||||||
Business Acquisition [Line Items] | ||||||
Current assets, net of cash acquired | 23,369 | 12,751 | 44,159 | |||
Property, plant and equipment | 4,325 | 8,272 | 8,424 | |||
Goodwill | 47,431 | 135,932 | 205,805 | |||
Intangible assets | 40,416 | 78,179 | 134,049 | |||
Other assets and deferred charges | 20 | 4,485 | 12,986 | |||
Current liabilities | (13,614) | (15,368) | (34,803) | |||
Non-current liabilities | (12,554) | (17,389) | (34,834) | |||
Net assets acquired | $ 89,393 | $ 206,862 | $ 335,786 |
Acquisitions - Goodwill and Int
Acquisitions - Goodwill and Intangible Assets (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Business Acquisition [Line Items] | |||
Intangible assets | $ 124,416 | ||
2022 Acquisitions | |||
Business Acquisition [Line Items] | |||
Goodwill - non deductible | 200,513 | ||
Goodwill and intangible assets | 324,929 | ||
2021 Acquisitions | |||
Business Acquisition [Line Items] | |||
Goodwill - tax deductible | $ 200,117 | ||
Goodwill - non deductible | 384,269 | ||
Goodwill and intangible assets | 1,023,865 | ||
Series of individually immaterial acquistions | |||
Business Acquisition [Line Items] | |||
Goodwill - tax deductible | $ 33,183 | ||
Goodwill - non deductible | 172,622 | ||
Intangible assets | 40,416 | 78,179 | 134,049 |
Goodwill and intangible assets | 339,854 | ||
Customer intangibles | 2022 Acquisitions | |||
Business Acquisition [Line Items] | |||
Intangible assets | $ 90,657 | ||
Customer intangibles | 2021 Acquisitions | |||
Business Acquisition [Line Items] | |||
Intangible assets | $ 310,819 | ||
Customer intangibles | Series of individually immaterial acquistions | |||
Business Acquisition [Line Items] | |||
Intangible assets | $ 103,310 | ||
Customer intangibles | Minimum | 2022 Acquisitions | |||
Business Acquisition [Line Items] | |||
Useful life (in years) | 10 years | ||
Customer intangibles | Minimum | 2021 Acquisitions | |||
Business Acquisition [Line Items] | |||
Useful life (in years) | 12 years | ||
Customer intangibles | Minimum | Series of individually immaterial acquistions | |||
Business Acquisition [Line Items] | |||
Useful life (in years) | 10 years | ||
Customer intangibles | Maximum | 2022 Acquisitions | |||
Business Acquisition [Line Items] | |||
Useful life (in years) | 15 years | ||
Customer intangibles | Maximum | 2021 Acquisitions | |||
Business Acquisition [Line Items] | |||
Useful life (in years) | 15 years | ||
Customer intangibles | Maximum | Series of individually immaterial acquistions | |||
Business Acquisition [Line Items] | |||
Useful life (in years) | 14 years | ||
Patents | 2022 Acquisitions | |||
Business Acquisition [Line Items] | |||
Intangible assets | $ 16,000 | ||
Useful life (in years) | 10 years | ||
Patents | 2021 Acquisitions | |||
Business Acquisition [Line Items] | |||
Intangible assets | $ 49,056 | ||
Patents | Minimum | 2021 Acquisitions | |||
Business Acquisition [Line Items] | |||
Useful life (in years) | 7 years | ||
Patents | Maximum | 2021 Acquisitions | |||
Business Acquisition [Line Items] | |||
Useful life (in years) | 12 years | ||
Unpatented technology | 2022 Acquisitions | |||
Business Acquisition [Line Items] | |||
Intangible assets | $ 10,355 | ||
Useful life (in years) | 8 years | ||
Unpatented technology | 2021 Acquisitions | |||
Business Acquisition [Line Items] | |||
Intangible assets | $ 44,180 | ||
Unpatented technology | Series of individually immaterial acquistions | |||
Business Acquisition [Line Items] | |||
Intangible assets | $ 21,125 | ||
Unpatented technology | Minimum | 2021 Acquisitions | |||
Business Acquisition [Line Items] | |||
Useful life (in years) | 7 years | ||
Unpatented technology | Minimum | Series of individually immaterial acquistions | |||
Business Acquisition [Line Items] | |||
Useful life (in years) | 5 years | ||
Unpatented technology | Maximum | 2021 Acquisitions | |||
Business Acquisition [Line Items] | |||
Useful life (in years) | 12 years | ||
Unpatented technology | Maximum | Series of individually immaterial acquistions | |||
Business Acquisition [Line Items] | |||
Useful life (in years) | 9 years | ||
Trademarks | 2022 Acquisitions | |||
Business Acquisition [Line Items] | |||
Intangible assets | $ 7,404 | ||
Useful life (in years) | 15 years | ||
Trademarks | 2021 Acquisitions | |||
Business Acquisition [Line Items] | |||
Intangible assets | $ 35,424 | ||
Trademarks | Series of individually immaterial acquistions | |||
Business Acquisition [Line Items] | |||
Intangible assets | $ 9,614 | ||
Useful life (in years) | 15 years | ||
Trademarks | Minimum | 2021 Acquisitions | |||
Business Acquisition [Line Items] | |||
Useful life (in years) | 15 years | ||
Trademarks | Maximum | 2021 Acquisitions | |||
Business Acquisition [Line Items] | |||
Useful life (in years) | 16 years |
Acquisitions - Pro Forma (Detai
Acquisitions - Pro Forma (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Earnings: | |||
Net earnings | $ 1,065,376 | $ 1,123,818 | $ 683,451 |
RegO and Acme | |||
Revenue: | |||
As reported | 7,907,081 | 6,683,760 | |
Pro forma (unaudited) | 8,163,185 | 6,920,929 | |
Earnings: | |||
Net earnings | 1,123,818 | 683,451 | |
Pro forma (unaudited) | $ 1,145,106 | $ 669,458 |
Dispositions (Details)
Dispositions (Details) $ in Thousands | 12 Months Ended | |||||
Dec. 01, 2021 USD ($) | Nov. 16, 2021 USD ($) | Mar. 06, 2020 USD ($) | Dec. 31, 2022 USD ($) disposition | Dec. 31, 2021 USD ($) | Dec. 31, 2020 USD ($) | |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||||||
Number of immaterial disposition | disposition | 1 | |||||
Proceeds from dispositions | $ 15,400 | |||||
Loss (gain) on dispositions | $ 194 | $ (206,338) | $ (5,213) | |||
Gain on disposition of assets | $ 0 | 206,338 | $ 5,213 | |||
Race Winning Brands | ||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||||||
Gain on sale of equity method investment | 24,723 | |||||
Unified Brands | ||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||||||
Proceeds from dispositions | $ 229,024 | |||||
Unified Brands | Climate & Sustainability Technologies | ||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||||||
Loss (gain) on dispositions | $ 181,615 | |||||
Race Winning Brands | ||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||||||
Proceeds from sale of equity method investment | $ 45,958 |
Inventories, net (Details)
Inventories, net (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Inventory, Net [Abstract] | ||
Raw materials | $ 812,066 | $ 671,195 |
Work in progress | 230,865 | 271,659 |
Finished goods | 458,881 | 377,800 |
Subtotal | 1,501,812 | 1,320,654 |
Less reserves | (135,204) | (129,559) |
Total | $ 1,366,608 | $ 1,191,095 |
Percentage of LIFO inventory | 4% | 4% |
Property, Plant and Equipment_2
Property, Plant and Equipment (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Property, Plant and Equipment [Line Items] | |||
Property, plant and equipment, gross | $ 2,578,497 | $ 2,462,443 | |
Total accumulated depreciation | (1,573,672) | (1,505,133) | |
Property, plant and equipment, net | 1,004,825 | 957,310 | |
Depreciation | 148,910 | 147,309 | $ 140,008 |
Land | |||
Property, Plant and Equipment [Line Items] | |||
Property, plant and equipment, gross | 62,495 | 63,656 | |
Buildings and improvements | |||
Property, Plant and Equipment [Line Items] | |||
Property, plant and equipment, gross | 620,500 | 582,314 | |
Machinery, equipment and other | |||
Property, Plant and Equipment [Line Items] | |||
Property, plant and equipment, gross | $ 1,895,502 | $ 1,816,473 |
Leases - Cost (Details)
Leases - Cost (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Operating Lease Costs: | |||
Fixed | $ 53,428 | $ 54,397 | $ 52,875 |
Variable | 7,512 | 6,281 | 5,973 |
Short-term | 22,097 | 17,847 | 18,436 |
Total | $ 83,037 | $ 78,525 | $ 77,284 |
Leases - Cash Flow (Details)
Leases - Cash Flow (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Cash paid for amounts included in the measurement of lease liabilities: | |||
Operating cash flows for operating leases | $ 54,268 | $ 55,921 | $ 53,903 |
Operating cash flows for finance leases | 335 | 357 | 434 |
Financing cash flows for finance leases | 2,917 | 3,073 | 2,523 |
Total | 57,520 | 59,351 | 56,860 |
Right-of-use assets obtained in exchange for lease obligations: | |||
Operating leases | 57,190 | 47,666 | 21,381 |
Financing leases | 3,149 | 2,016 | 3,708 |
Total | $ 60,339 | $ 49,682 | $ 25,089 |
Leases - Assets and Liabilities
Leases - Assets and Liabilities (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Right-of-use assets: | ||
Other assets and deferred charges | $ 197,058 | $ 169,022 |
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] | Other Assets, Noncurrent | Other Assets, Noncurrent |
Lease liabilities: | ||
Other accrued expenses | $ 42,649 | $ 43,086 |
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] | Other accrued expenses | Other accrued expenses |
Other liabilities | $ 165,741 | $ 134,448 |
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] | Other liabilities | Other liabilities |
Total operating lease liabilities | $ 208,390 | $ 177,534 |
Right-of-use assets: | ||
Property and equipment, net | $ 7,846 | $ 8,588 |
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] | Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization | Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization |
Lease liabilities: | ||
Other accrued expenses | $ 2,554 | $ 2,475 |
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] | Other accrued expenses | Other accrued expenses |
Other liabilities | $ 6,189 | $ 6,767 |
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] | Other liabilities | Other liabilities |
Total finance lease liabilities | $ 8,743 | $ 9,242 |
Accumulated depreciation | $ 8,017 | $ 7,675 |
Leases - Maturity Table (Detail
Leases - Maturity Table (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Operating | ||
2023 | $ 47,843 | |
2024 | 40,524 | |
2025 | 32,759 | |
2026 | 23,009 | |
2027 | 19,447 | |
Thereafter | 81,937 | |
Present value of lease liabilities | 245,519 | |
Less interest | (37,129) | |
Total operating lease liabilities | 208,390 | $ 177,534 |
Finance | ||
2023 | 2,860 | |
2024 | 2,432 | |
2025 | 1,963 | |
2026 | 1,480 | |
2027 | 816 | |
Thereafter | 1 | |
Total lease payments | 9,552 | |
Less interest | (809) | |
Present value of lease liabilities | $ 8,743 | $ 9,242 |
Leases - Assumptions (Details)
Leases - Assumptions (Details) | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 |
Weighted-average remaining lease term (years) | |||
Operating leases | 7 years 9 months 18 days | 5 years 9 months 18 days | 5 years 10 months 24 days |
Finance leases | 3 years 7 months 6 days | 4 years 2 months 12 days | 4 years 9 months 18 days |
Weighted-average discount rate | |||
Operating leases | 3.50% | 2.70% | 2.90% |
Finance leases | 3.40% | 3.40% | 3.60% |
Credit Losses (Details)
Credit Losses (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Accounts Receivable, Allowance for Credit Loss [Roll Forward] | |||
Beginning Balance, January 1, | $ 40,126 | $ 40,474 | $ 29,381 |
Adoption of ASU No. 2016-13, cumulative-effect adjustment to retained earnings | 0 | 0 | 2,706 |
Provision for expected credit losses, net of recoveries | 5,552 | 5,053 | 11,171 |
Amounts written off charged against the allowance | (4,462) | (5,307) | (3,863) |
Other, including dispositions and foreign currency translation | (1,817) | (94) | 1,079 |
Ending balance, December 31 | $ 39,399 | $ 40,126 | $ 40,474 |
Credit Losses - Narrative (Deta
Credit Losses - Narrative (Details) - USD ($) $ in Thousands | 12 Months Ended | ||||
Dec. 31, 2020 | Dec. 31, 2022 | Dec. 31, 2021 | Jan. 01, 2020 | Dec. 31, 2019 | |
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Adoption of ASU No. 2016-13- CECL | $ 4,286,366 | $ 4,189,528 | |||
Cumulative Effect, Period of Adoption, Adjustment | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Adoption of ASU No. 2016-13- CECL | $ (2,112) | ||||
Cumulative Effect, Period of Adoption, Adjustment | Retained Earnings | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Adoption of ASU No. 2016-13- CECL | $ (2,112) | ||||
Cumulative Effect, Period of Adoption, Adjustment | Accounting Standards Update 2016-13 | Retained Earnings | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Adoption of ASU No. 2016-13- CECL | $ (2,100) | ||||
Retained earnings effect, tax | $ 600 |
Goodwill and Other Intangible_3
Goodwill and Other Intangible Assets - Goodwill (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Goodwill [Roll Forward] | |||
Goodwill | $ 4,143,103 | ||
Accumulated impairment loss | (70,561) | ||
Beginning balance | $ 4,558,822 | $ 4,072,542 | |
Acquisitions | 200,513 | 582,117 | |
Disposition of business | 0 | (34,662) | |
Measurement period adjustments | 1,570 | 714 | |
Foreign currency translation | (91,411) | (61,889) | |
Ending balance | 4,669,494 | 4,558,822 | |
Engineered Products | |||
Goodwill [Roll Forward] | |||
Goodwill | 693,576 | ||
Accumulated impairment loss | (10,591) | ||
Beginning balance | 723,283 | 682,985 | |
Acquisitions | 0 | 50,180 | |
Disposition of business | 0 | ||
Measurement period adjustments | (286) | 0 | |
Foreign currency translation | (10,455) | (9,882) | |
Ending balance | 712,542 | 723,283 | |
Clean Energy & Fueling | |||
Goodwill [Roll Forward] | |||
Goodwill | 940,973 | ||
Accumulated impairment loss | 0 | ||
Beginning balance | 1,427,691 | 940,973 | |
Acquisitions | 0 | 496,461 | |
Disposition of business | 0 | ||
Measurement period adjustments | 2,432 | 2,640 | |
Foreign currency translation | (38,705) | (12,383) | |
Ending balance | 1,391,418 | 1,427,691 | |
Imaging & Identification | |||
Goodwill [Roll Forward] | |||
Goodwill | 1,117,589 | ||
Accumulated impairment loss | 0 | ||
Beginning balance | 1,106,202 | 1,117,589 | |
Acquisitions | 0 | 20,458 | |
Disposition of business | 0 | ||
Measurement period adjustments | (1,544) | (1,926) | |
Foreign currency translation | (26,399) | (29,919) | |
Ending balance | 1,078,259 | 1,106,202 | |
Pumps & Process Solutions | |||
Goodwill [Roll Forward] | |||
Goodwill | 846,250 | ||
Accumulated impairment loss | (59,970) | ||
Beginning balance | 792,839 | 786,280 | |
Acquisitions | 200,513 | 15,018 | |
Disposition of business | 0 | ||
Measurement period adjustments | 968 | 0 | |
Foreign currency translation | (14,785) | (8,459) | |
Ending balance | 979,535 | 792,839 | |
Climate & Sustainability Technologies | |||
Goodwill [Roll Forward] | |||
Goodwill | 544,715 | ||
Accumulated impairment loss | $ 0 | ||
Beginning balance | 508,807 | 544,715 | |
Acquisitions | 0 | 0 | |
Disposition of business | (34,662) | ||
Measurement period adjustments | 0 | 0 | |
Foreign currency translation | (1,067) | (1,246) | |
Ending balance | $ 507,740 | $ 508,807 |
Goodwill and Other Intangible_4
Goodwill and Other Intangible Assets - Narrative (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Goodwill [Line Items] | |||
Acquisitions | $ 200,513 | $ 582,117 | |
Disposition of business | $ 0 | (34,662) | |
Fair value discount rate, percent | 9.50% | ||
Intangible assets | $ 124,416 | ||
Amortization expense | 158,628 | $ 142,814 | $ 139,043 |
Electric Refuse Collection Vehicles | |||
Goodwill [Line Items] | |||
Purchase price | 29,750 | ||
Contingent consideration | $ 20,000 |
Goodwill and Other Intangible_5
Goodwill and Other Intangible Assets - Intangibles and Amortization Expense (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Finite-Lived Intangible Assets [Line Items] | ||
Gross Amount | $ 2,749,997 | $ 2,654,351 |
Accumulated Amortization | 1,512,806 | 1,391,538 |
Net Carrying Amount | 1,237,191 | 1,262,813 |
Unamortized intangible assets: | 96,544 | 96,709 |
Total, Gross Carrying Amount | 2,846,541 | 2,751,060 |
Total, Net Carrying Amount | 1,333,735 | 1,359,522 |
Customer intangibles | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Amount | 1,881,402 | 1,829,492 |
Accumulated Amortization | 996,947 | 909,776 |
Net Carrying Amount | 884,455 | 919,716 |
Trademarks | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Amount | 265,466 | 263,367 |
Accumulated Amortization | 132,791 | 116,633 |
Net Carrying Amount | 132,675 | 146,734 |
Patents | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Amount | 219,199 | 205,910 |
Accumulated Amortization | 146,337 | 140,327 |
Net Carrying Amount | 72,862 | 65,583 |
Unpatented technology | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Amount | 257,428 | 221,239 |
Accumulated Amortization | 137,750 | 123,464 |
Net Carrying Amount | 119,678 | 97,775 |
Distributor relationships | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Amount | 79,622 | 84,204 |
Accumulated Amortization | 57,299 | 55,260 |
Net Carrying Amount | 22,323 | 28,944 |
Drawings and manuals | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Amount | 26,062 | 27,792 |
Accumulated Amortization | 26,062 | 27,303 |
Net Carrying Amount | 0 | 489 |
Other intangibles | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Amount | 20,818 | 22,347 |
Accumulated Amortization | 15,620 | 18,775 |
Net Carrying Amount | 5,198 | 3,572 |
Trademarks | ||
Finite-Lived Intangible Assets [Line Items] | ||
Accumulated Amortization | 0 | 0 |
Unamortized intangible assets: | $ 96,544 | $ 96,709 |
Goodwill and Other Intangible_6
Goodwill and Other Intangible Assets - Future Amortization (Details) $ in Thousands | Dec. 31, 2022 USD ($) |
Goodwill and Intangible Assets Disclosure [Abstract] | |
2023 | $ 154,124 |
2024 | 149,866 |
2025 | 145,857 |
2026 | 138,090 |
2027 | $ 135,785 |
Other Accrued Expenses and Ot_3
Other Accrued Expenses and Other Liabilities - Accrued Expenses (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Accrued Liabilities and Other Liabilities [Abstract] | ||
Accrued rebates and volume discounts | $ 47,660 | $ 52,909 |
Warranty | 43,351 | 43,449 |
Operating lease liabilities | 42,649 | 43,086 |
Taxes other than income | 33,782 | 49,992 |
Accrued interest | 20,591 | 20,426 |
Accrued commissions (non-employee) | 15,808 | 16,273 |
Restructuring and exit costs | 14,510 | 13,797 |
Other (none of which are individually significant) | 99,986 | 107,165 |
Total other accrued expenses | $ 318,337 | 347,097 |
Deferral of employment taxes related to U.S. CARES Act | $ 15,300 |
Other Accrued Expenses and Ot_4
Other Accrued Expenses and Other Liabilities - Other Liabilities (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 |
Accrued Liabilities and Other Liabilities [Abstract] | |||
Operating lease liabilities | $ 165,741 | $ 134,448 | |
Defined benefit and other post-retirement benefit plans | 92,630 | 138,992 | |
Deferred compensation | 82,479 | 88,681 | |
Unrecognized tax benefits | 34,361 | 79,757 | |
Legal and environmental | 30,139 | 31,304 | |
Deferred revenue | 19,879 | 21,513 | $ 13,921 |
Warranty | 5,098 | 5,119 | |
Other | 44,576 | 32,728 | |
Other liabilities | $ 474,903 | $ 532,542 |
Other Accrued Expenses and Ot_5
Other Accrued Expenses and Other Liabilities - Warranty Program (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward] | |||
Beginning Balance | $ 48,568 | $ 51,088 | $ 49,116 |
Provision for warranties | 60,758 | 67,212 | 60,902 |
Settlements made | (59,612) | (65,498) | (60,853) |
Other adjustments, including acquisitions and currency translation | (1,265) | (4,234) | 1,923 |
Ending Balance | $ 48,449 | $ 48,568 | $ 51,088 |
Restructuring Activities (Detai
Restructuring Activities (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Restructuring Cost and Reserve [Line Items] | |||
Restructuring | $ 30,480 | $ 26,705 | $ 44,468 |
Cost of goods and services | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring | 6,855 | 12,895 | 18,895 |
Selling, general and administrative expenses | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring | 23,625 | 13,810 | 25,573 |
Corporate | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring | 2,321 | 2,021 | 4,145 |
Engineered Products | Total segments | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring | 3,194 | 9,507 | 10,307 |
Clean Energy & Fueling | Total segments | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring | 9,571 | 3,609 | 6,681 |
Imaging & Identification | Total segments | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring | 4,702 | 4,589 | 5,946 |
Pumps & Process Solutions | Total segments | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring | 4,685 | 1,911 | 13,374 |
Climate & Sustainability Technologies | Total segments | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring | $ 6,007 | $ 5,068 | $ 4,015 |
Restructuring Activities (Det_2
Restructuring Activities (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Restructuring Reserve [Roll Forward] | |||
Beginning balance | $ 13,797 | $ 14,913 | $ 16,390 |
Payments | (22,134) | (17,122) | (35,803) |
Restructuring | 30,480 | 26,705 | 44,468 |
Other, including foreign currency translation | (7,633) | (10,699) | (10,142) |
Ending balance | 14,510 | 13,797 | 14,913 |
Severance | |||
Restructuring Reserve [Roll Forward] | |||
Beginning balance | 10,730 | 10,547 | 13,751 |
Payments | (13,975) | (10,951) | (29,768) |
Restructuring | 15,388 | 11,561 | 25,716 |
Other, including foreign currency translation | (136) | (427) | 848 |
Ending balance | 12,007 | 10,730 | 10,547 |
Exit | |||
Restructuring Reserve [Roll Forward] | |||
Beginning balance | 3,067 | 4,366 | 2,639 |
Payments | (8,159) | (6,171) | (6,035) |
Restructuring | 15,092 | 15,144 | 18,752 |
Other, including foreign currency translation | (7,497) | (10,272) | (10,990) |
Ending balance | $ 2,503 | $ 3,067 | $ 4,366 |
Borrowings - Short Term (Detail
Borrowings - Short Term (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Debt Disclosure [Abstract] | ||
Short-term Debt | $ 836 | $ 702 |
Commercial paper | 734,936 | 105,000 |
Short-term borrowings | $ 735,772 | $ 105,702 |
Borrowings - Narrative (Details
Borrowings - Narrative (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Line of Credit Facility [Line Items] | ||
Letters of credit outstanding | $ 180,300,000 | |
Interest coverage ratio | 1,530% | |
Commercial Paper | ||
Line of Credit Facility [Line Items] | ||
Increase in borrowings | $ 629,936,000 | |
Weighted average interest rate | 2.29% | 0.38% |
Revolving Credit Facility | Credit Agreement | ||
Line of Credit Facility [Line Items] | ||
Maximum borrowing capacity | $ 1,000,000,000 | |
Term | 5 years | |
Interest coverage ratio required | 300% | |
Outstanding borrowings | $ 0 |
Borrowings - Summary (Details)
Borrowings - Summary (Details) € in Thousands, $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 USD ($) | Dec. 31, 2022 EUR (€) | Dec. 31, 2021 USD ($) | |
Debt Instrument [Line Items] | |||
Total long-term debt | $ 2,942,513 | $ 3,018,714 | |
Unamortized discount | 12,700 | 15,100 | |
Deferred debt issuance cost | 10,700 | 12,500 | |
3.15% 10-year notes due November 15, 2025 | |||
Debt Instrument [Line Items] | |||
Principal | 400,000 | ||
Total long-term debt | $ 398,063 | 397,389 | |
Debt instrument, stated interest rate | 3.15% | 3.15% | |
Term | 10 years | ||
1.25% 10-year notes due November 9, 2026 (euro-denominated) | |||
Debt Instrument [Line Items] | |||
Principal | € | € 600,000 | ||
Total long-term debt | $ 631,522 | 674,217 | |
Debt instrument, stated interest rate | 1.25% | 1.25% | |
Term | 10 years | ||
0.750% 8-year notes due November 4, 2027 (euro denominated) | |||
Debt Instrument [Line Items] | |||
Principal | € | € 500,000 | ||
Total long-term debt | $ 525,654 | 561,293 | |
Debt instrument, stated interest rate | 0.75% | 0.75% | |
Term | 8 years | ||
6.65% 30-year debentures due June 1, 2028 | |||
Debt Instrument [Line Items] | |||
Principal | $ 200,000 | ||
Total long-term debt | $ 199,456 | 199,356 | |
Debt instrument, stated interest rate | 6.65% | 6.65% | |
Term | 30 years | ||
2.950% 10-year notes due November 4, 2029 | |||
Debt Instrument [Line Items] | |||
Principal | 300,000 | ||
Total long-term debt | $ 297,408 | 297,029 | |
Debt instrument, stated interest rate | 2.95% | 2.95% | |
Term | 10 years | ||
5.375% 30-year debentures due October 15, 2035 | |||
Debt Instrument [Line Items] | |||
Principal | $ 300,000 | ||
Total long-term debt | $ 296,808 | 296,559 | |
Debt instrument, stated interest rate | 5.375% | 5.375% | |
Term | 30 years | ||
6.60% 30-year notes due March 15, 2038 | |||
Debt Instrument [Line Items] | |||
Principal | $ 250,000 | ||
Total long-term debt | $ 248,279 | 248,166 | |
Debt instrument, stated interest rate | 6.60% | 6.60% | |
Term | 30 years | ||
5.375% 30-year notes due March 1, 2041 | |||
Debt Instrument [Line Items] | |||
Principal | $ 350,000 | ||
Total long-term debt | $ 344,982 | 344,705 | |
Debt instrument, stated interest rate | 5.375% | 5.375% | |
Term | 30 years | ||
Other | |||
Debt Instrument [Line Items] | |||
Total long-term debt | $ 341 | $ 0 |
Borrowings - Maturity (Details)
Borrowings - Maturity (Details) $ in Thousands | Dec. 31, 2022 USD ($) |
Debt Disclosure [Abstract] | |
2024 | $ 118 |
2025 | 400,103 |
2026 | 635,915 |
2027 | 529,829 |
2028 and thereafter | 1,400,000 |
Total | $ 2,965,965 |
Financial Instruments - Narrati
Financial Instruments - Narrative (Details) € in Thousands, $ in Thousands | Dec. 31, 2022 USD ($) | Dec. 31, 2022 EUR (€) | Dec. 31, 2021 USD ($) |
Estimate of Fair Value Measurement | |||
Derivatives, Fair Value [Line Items] | |||
Fair value of long-term debt | $ 2,786,862 | $ 3,440,501 | |
Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Notional amount | 184,565 | 180,929 | |
Not Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Notional amount | $ 102,509 | $ 108,736 | |
1.25% 10-year notes due November 9, 2026 (euro-denominated) | |||
Derivatives, Fair Value [Line Items] | |||
Principal | € | € 600,000 | ||
0.750% 8-year notes due November 4, 2027 (euro denominated) | |||
Derivatives, Fair Value [Line Items] | |||
Principal | € | € 500,000 |
Financial Instruments - Balance
Financial Instruments - Balance Sheet Location (Details) - Foreign currency forward - Designated as Hedging Instrument - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Prepaid and other current assets | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Fair Value Asset | $ 944 | $ 2,825 |
Other accrued expenses | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Fair Value Liability | $ (2,760) | $ (433) |
Financial Instruments - Gain_Lo
Financial Instruments - Gain/Loss (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||
Gain (loss) on euro-denominated debt | $ 80,301 | $ 94,003 | $ (119,298) |
Tax (expense) benefit | (17,824) | (20,976) | 26,957 |
Net gain (loss) on net investment hedges, net of tax | $ 62,477 | $ 73,027 | $ (92,341) |
Financial Instruments - Fair Va
Financial Instruments - Fair Value (Details) - Level 2 - Fair Value, Measurements, Recurring - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Assets: | ||
Foreign currency cash flow hedges | $ 944 | $ 2,825 |
Liabilities: | ||
Foreign currency cash flow hedges | $ 2,760 | $ 433 |
Income Taxes - Earnings (Detail
Income Taxes - Earnings (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Earnings before provision for income taxes and discontinued operations [Abstract] | |||
Domestic | $ 731,796 | $ 835,773 | $ 464,145 |
Foreign | 555,709 | 565,053 | 377,589 |
Earnings before provision for income taxes | $ 1,287,505 | $ 1,400,826 | $ 841,734 |
Income Taxes - Tax Expense (Det
Income Taxes - Tax Expense (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Current: | |||
U.S. federal | $ 106,768 | $ 150,990 | $ 79,305 |
State and local | 1,450 | 28,106 | 13,312 |
Foreign | 140,696 | 154,147 | 97,106 |
Total current | 248,914 | 333,243 | 189,723 |
Deferred: | |||
U.S. federal | (4,760) | (14,143) | 2,777 |
State and local | 303 | 3,165 | (10,526) |
Foreign | (22,328) | (45,257) | (23,691) |
Total deferred | (26,785) | (56,235) | (31,440) |
Total expense | $ 222,129 | $ 277,008 | $ 158,283 |
Income Taxes - Rate Reconciliat
Income Taxes - Rate Reconciliation (Details) | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Effective Income Tax Rate, Continuing Operations, Tax Rate Reconciliation [Abstract] | |||
U.S. federal income tax rate | 21% | 21% | 21% |
State and local taxes, net of federal income tax benefit | 1.60% | 1.80% | 1.70% |
Foreign operations tax effect | 0.10% | (0.20%) | (0.80%) |
Foreign-derived intangible income | (1.30%) | (0.80%) | (1.10%) |
Share awards | (0.20%) | (0.80%) | (1.20%) |
Dispositions | 0% | 0.30% | 0% |
Audit resolutions | (3.20%) | (1.40%) | (0.90%) |
Other | (0.70%) | (0.10%) | 0.10% |
Effective tax rate | 17.30% | 19.80% | 18.80% |
Income Taxes - Deferred Tax Ass
Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Deferred Tax Assets: | ||
Accrued compensation, postretirement and other employee benefits | $ 46,008 | $ 61,388 |
Accrued expenses | 20,608 | 30,143 |
Net operating loss and other carryforwards | 317,186 | 334,483 |
Inventories | 30,569 | 28,698 |
Allowance for credit losses | 9,224 | 9,988 |
Accrued insurance | 3,978 | 4,708 |
Long-term liabilities, warranty and environmental costs | 2,851 | 3,043 |
Lease obligations | 47,887 | 41,653 |
Capitalized research and development | 26,548 | 0 |
Total gross deferred tax assets | 504,859 | 514,104 |
Valuation allowance | (271,203) | (306,066) |
Total deferred tax assets, net of valuation allowances | 233,656 | 208,038 |
Deferred Tax Liabilities: | ||
Intangible assets | (417,809) | (392,208) |
Property, plant and equipment | (82,658) | (77,918) |
Lease right-of-use assets | (45,202) | (40,181) |
Other liabilities | (27,447) | (28,786) |
Total gross deferred tax liabilities | (573,116) | (539,093) |
Net deferred tax liability | (339,460) | (331,055) |
Classified as follows in the Consolidated Balance Sheets: | ||
Other assets and deferred charges | 35,690 | 33,062 |
Deferred income taxes | $ (375,150) | $ (364,117) |
Income Taxes - Narrative (Detai
Income Taxes - Narrative (Details) $ in Thousands | Dec. 31, 2022 USD ($) |
Operating Loss Carryforwards [Line Items] | |
Non-U.S. operating loss carryforwards | $ 263,260 |
Deferred tax assets related to U.S. federal and state tax loss and tax credit carryforward | 53,617 |
Minimum | |
Operating Loss Carryforwards [Line Items] | |
Possible change in unrecognized tax benefits balance | 0 |
Maximum | |
Operating Loss Carryforwards [Line Items] | |
Possible change in unrecognized tax benefits balance | 5,113 |
Foreign Tax Authority | |
Operating Loss Carryforwards [Line Items] | |
Operating loss carryforwards subject to expiration | 59,366 |
Operating loss carryforward not subject to expiration | 203,894 |
Domestic Tax Authority | |
Operating Loss Carryforwards [Line Items] | |
Operating loss carryforwards subject to expiration | 46,186 |
Operating loss carryforward not subject to expiration | $ 7,431 |
Income Taxes - Unrecognized Tax
Income Taxes - Unrecognized Tax Benefits (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] | |||
Beginning balance | $ 64,652 | $ 72,338 | $ 83,214 |
Additions based on tax positions related to the current year | 3,315 | 5,859 | 3,134 |
Additions for tax positions of prior years | 3,421 | 3,784 | 5,490 |
Reductions for tax positions of prior years | (39,439) | (13,008) | (3,599) |
Cash settlements | (411) | (1,490) | (6,214) |
Lapse of statutes | (3,352) | (2,831) | (9,687) |
Ending balance | 28,186 | 64,652 | 72,338 |
Unrecognized potential tax benefits that would impact effective tax rate | 23,496 | ||
Potential interest and penalty expense (income) | 8,931 | 2,654 | $ 78 |
Accrued interest and penalties | $ 6,175 | $ 15,107 |
Equity and Cash Incentive Pro_3
Equity and Cash Incentive Program - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands | 12 Months Ended | ||||
May 03, 2012 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | May 07, 2021 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Shares available for grant | 13,188,197 | ||||
Plan expiration period | 10 years | ||||
Service requisite period | 3 years | ||||
Award term | 10 years | ||||
2021 Plan - Rollover from 2012 Plan | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Shares available for grant | 4,888,197 | ||||
2021 Plan - New Issuance | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Shares available for grant | 8,300,000 | ||||
Stock Appreciation Rights (SARs) | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Granted (in shares) | 335,285 | 413,173 | 390,780 | ||
Unrecognized compensation expense | $ 9,855 | ||||
Unrecognized compensation expense period of recognition | 1 year 9 months 18 days | ||||
Fair value per share at date of grant (in dollars per share) | $ 42.07 | $ 29.08 | $ 22.54 | ||
Performance Shares | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Service requisite period | 3 years | ||||
Granted (in shares) | 40,087 | 50,371 | 49,056 | ||
Vesting period | 3 years | ||||
Unrecognized compensation expense | $ 7,702 | ||||
Unrecognized compensation expense period of recognition | 1 year 8 months 12 days | ||||
Fair value per share at date of grant (in dollars per share) | $ 196.40 | $ 148.29 | $ 165.71 | ||
Restricted Stock Units (RSUs) | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Granted (in shares) | 79,556 | 87,177 | 83,512 | ||
Vesting period | 3 years | ||||
Unrecognized compensation expense | $ 9,762 | ||||
Unrecognized compensation expense period of recognition | 1 year 4 months 24 days | ||||
Fair value per share at date of grant (in dollars per share) | $ 160.21 | $ 122.73 | $ 119.86 |
Equity and Cash Incentive Pro_4
Equity and Cash Incentive Program - Expense (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Share-Based Payment Arrangement [Abstract] | |||
Pre-tax stock-based compensation expense | $ 30,821 | $ 31,111 | $ 25,026 |
Tax benefit | (2,993) | (2,859) | (2,731) |
Total stock-based compensation expense, net of tax | $ 27,828 | $ 28,252 | $ 22,295 |
Equity and Cash Incentive Pro_5
Equity and Cash Incentive Program - Fair Value Assumptions (Details) - $ / shares | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Stock Appreciation Rights (SARs) | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Risk-free interest rate | 1.86% | 0.59% | 1.44% |
Dividend yield | 1.25% | 1.62% | 1.65% |
Expected life (years) | 5 years 4 months 24 days | 5 years 6 months | 5 years 6 months |
Volatility | 29.46% | 30.49% | 22.76% |
Grant price (in dollars per share) | $ 160.21 | $ 122.73 | $ 119.86 |
Fair value per share at date of grant (in dollars per share) | $ 42.07 | $ 29.08 | $ 22.54 |
Performance Shares | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Risk-free interest rate | 1.68% | 0.19% | 1.40% |
Dividend yield | 1.25% | 1.62% | 1.65% |
Expected life (years) | 2 years 10 months 24 days | 2 years 10 months 24 days | 2 years 10 months 24 days |
Volatility | 31.10% | 31.90% | 23.30% |
Grant price (in dollars per share) | $ 160.21 | $ 122.73 | $ 119.86 |
Fair value per share at date of grant (in dollars per share) | $ 196.40 | $ 148.29 | $ 165.71 |
Equity and Cash Incentive Pro_6
Equity and Cash Incentive Program - SARs Activity (Details) - Stock Appreciation Rights (SARs) - $ / shares | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Number of Shares | |||
Outstanding, beginning balance (in shares) | 2,377,384 | ||
Granted (in shares) | 335,285 | 413,173 | 390,780 |
Forfeited/expired (in shares) | (76,856) | ||
Exercised (in shares) | (191,271) | ||
Outstanding, ending balance (in shares) | 2,444,542 | 2,377,384 | |
Exercisable (in shares) | 1,443,544 | ||
Weighted Average Exercise Price | |||
Beginning balance (in dollars per share) | $ 89.49 | ||
Granted (in dollars per share) | 160.21 | $ 122.73 | $ 119.86 |
Forfeited/Expired (in dollars per share) | 135.59 | ||
Exercised (in dollars per share) | 76.15 | ||
Ending balance (in dollars per share) | 98.70 | $ 89.49 | |
Weighted Average Exercise Price, Exercisable (in dollars per share) | $ 74.87 | ||
Weighted Average Remaining Contractual Term (Years) | |||
Outstanding | 6 years | ||
Exercisable | 4 years 6 months |
Equity and Cash Incentive Pro_7
Equity and Cash Incentive Program - Outstanding and Exercisable Awards (Details) - Stock Appreciation Rights (SARs) $ / shares in Units, $ in Thousands | 12 Months Ended |
Dec. 31, 2022 USD ($) $ / shares shares | |
Exercise Price Range [Line Items] | |
Outstanding, Number of Shares | shares | 2,444,542 |
Outstanding, Aggregate Intrinsic Value | $ | $ 97,201 |
Exercisable, Number of Shares | shares | 1,443,544 |
Exercisable, Aggregate Intrinsic Value | $ | $ 87,389 |
Exercise Price Range 1 | |
Exercise Price Range [Line Items] | |
Range of Exercise, lower range limit (in dollars per share) | $ 48.28 |
Range of Exercise, upper range limit (in dollars per share) | $ 82.09 |
Outstanding, Number of Shares | shares | 1,009,878 |
Outstanding, Weighted Average Exercise Price (in dollars per share) | $ 67.86 |
Outstanding, Weighted Average Remaining Life in Years | 3 years 9 months 18 days |
Outstanding, Aggregate Intrinsic Value | $ | $ 68,217 |
Exercisable, Number of Shares | shares | 1,009,878 |
Exercisable, Weighted Average Exercise Price (in dollars per share) | $ 67.86 |
Exercisable , Weighted Average Remaining Life in Years | 3 years 9 months 18 days |
Exercisable, Aggregate Intrinsic Value | $ | $ 68,217 |
Exercise Price Range 2 | |
Exercise Price Range [Line Items] | |
Range of Exercise, lower range limit (in dollars per share) | $ 84.94 |
Range of Exercise, upper range limit (in dollars per share) | $ 119.86 |
Outstanding, Number of Shares | shares | 771,613 |
Outstanding, Weighted Average Exercise Price (in dollars per share) | $ 103.70 |
Outstanding, Weighted Average Remaining Life in Years | 6 years 7 months 6 days |
Outstanding, Aggregate Intrinsic Value | $ | $ 24,469 |
Exercisable, Number of Shares | shares | 433,666 |
Exercisable, Weighted Average Exercise Price (in dollars per share) | $ 91.20 |
Exercisable , Weighted Average Remaining Life in Years | 6 years 1 month 6 days |
Exercisable, Aggregate Intrinsic Value | $ | $ 19,172 |
Exercise Price Range 3 | |
Exercise Price Range [Line Items] | |
Range of Exercise, lower range limit (in dollars per share) | $ 122.73 |
Range of Exercise, upper range limit (in dollars per share) | $ 160.21 |
Outstanding, Number of Shares | shares | 663,051 |
Outstanding, Weighted Average Exercise Price (in dollars per share) | $ 139.87 |
Outstanding, Weighted Average Remaining Life in Years | 8 years 7 months 6 days |
Outstanding, Aggregate Intrinsic Value | $ | $ 4,515 |
Exercisable, Number of Shares | shares | 0 |
Exercisable, Weighted Average Exercise Price (in dollars per share) | $ 0 |
Exercisable , Weighted Average Remaining Life in Years | 0 years |
Exercisable, Aggregate Intrinsic Value | $ | $ 0 |
Equity and Cash Incentive Pro_8
Equity and Cash Incentive Program - Other Information (Details) - Stock Appreciation Rights (SARs) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Fair value of SARs that became exercisable | $ 8,939 | $ 10,199 | $ 8,585 |
Aggregate intrinsic value of SARs exercised | $ 11,992 | $ 62,895 | $ 55,031 |
Equity and Cash Incentive Pro_9
Equity and Cash Incentive Program - Performance Shares and RSU Activity (Details) - $ / shares | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Performance Shares | |||
Number of Shares | |||
Unvested, beginning balance (in shares) | 96,129 | ||
Granted (in shares) | 40,087 | 50,371 | 49,056 |
Forfeited (in shares) | (4,690) | ||
Vested (in shares) | (45,719) | ||
Unvested, ending balance (in shares) | 85,807 | 96,129 | |
Weighted Average Grant-Date Fair Value | |||
Unvested, beginning balance (in dollars per share) | $ 156.88 | ||
Granted (in dollars per share) | 196.40 | $ 148.29 | $ 165.71 |
Forfeited (in dollars per share) | 167.93 | ||
Vested (in dollars per share) | 165.71 | ||
Unvested, ending balance (in dollars per share) | $ 170.03 | $ 156.88 | |
Restricted Stock Units (RSUs) | |||
Number of Shares | |||
Unvested, beginning balance (in shares) | 202,682 | ||
Granted (in shares) | 79,556 | 87,177 | 83,512 |
Forfeited (in shares) | (14,920) | ||
Vested (in shares) | (119,642) | ||
Unvested, ending balance (in shares) | 147,676 | 202,682 | |
Weighted Average Grant-Date Fair Value | |||
Unvested, beginning balance (in dollars per share) | $ 107.03 | ||
Granted (in dollars per share) | 160.21 | $ 122.73 | $ 119.86 |
Forfeited (in dollars per share) | 136.85 | ||
Vested (in dollars per share) | 101.41 | ||
Unvested, ending balance (in dollars per share) | $ 135.98 | $ 107.03 |
Equity and Cash Incentive Pr_10
Equity and Cash Incentive Program - Shares Issued to Non-Employee Directors (Details) - shares | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Share-Based Payment Arrangement [Abstract] | |||
Aggregate shares granted | 10,730 | 7,917 | 9,854 |
Deferred stock units | (7,247) | (5,322) | (6,278) |
Net shares issued | 3,483 | 2,595 | 3,576 |
Employee Benefit Plans - Narrat
Employee Benefit Plans - Narrative (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Defined Benefit Plan Disclosure [Line Items] | |||
Defined contribution plan expense | $ 57,543 | $ 59,719 | $ 52,629 |
Accumulated benefit obligations | 560,057 | 815,910 | |
United States | Qualified Defined Benefits | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Estimated future employer contributions in next fiscal year | 0 | ||
United States | Qualified Defined Benefits | Qualified Defined Benefits | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total assets (liabilities) | 74,152 | 94,754 | |
Accumulated benefit obligations | 318,275 | 471,871 | |
United States | Non-Qualified Supplemental Benefits | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Estimated future employer contributions in next fiscal year | 7,400 | ||
Foreign Plan | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Estimated future employer contributions in next fiscal year | 7,100 | ||
Foreign Plan | Qualified Defined Benefits | Qualified Defined Benefits | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total assets (liabilities) | (62,457) | (95,038) | |
Accumulated benefit obligations | $ 210,259 | $ 302,929 |
Employee Benefit Plans - Obliga
Employee Benefit Plans - Obligations and Funded Status (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Change in plan assets: | |||
Benefits paid | $ (18,221) | ||
Amounts recognized in the consolidated balance sheets consist of: | |||
Other liabilities (deferred compensation) | $ (92,630) | (138,992) | |
Accumulated Other Comprehensive Loss (Earnings): | |||
Accumulated benefit obligations | 560,057 | 815,910 | |
Qualified Defined Benefits | Qualified Defined Benefits | United States | |||
Change in benefit obligation: | |||
Benefit obligation at beginning of year | 478,346 | 524,181 | |
Service cost | 5,703 | 7,134 | $ 6,824 |
Interest cost | 13,745 | 13,605 | 16,272 |
Plan participants' contributions | 0 | 0 | |
Benefits paid | (17,680) | (18,221) | |
Actuarial gains | (126,985) | (19,393) | |
Amendments | 0 | 0 | |
Settlements and curtailments | (33,228) | (28,960) | |
Currency translation and other | 0 | 0 | |
Benefit obligation at end of year | 319,901 | 478,346 | 524,181 |
Change in plan assets: | |||
Fair value of plan assets at beginning of year | 573,100 | 606,896 | |
Actual return on plan assets | (125,011) | 13,385 | |
Company contributions | 0 | 0 | |
Plan participants' contributions | 0 | 0 | |
Benefits paid | (17,680) | ||
Settlements and curtailments | (36,356) | (28,960) | |
Currency translation and other | 0 | 0 | |
Fair value of plan assets at end of year | 394,053 | 573,100 | 606,896 |
Funded (Unfunded) status | 74,152 | 94,754 | |
Amounts recognized in the consolidated balance sheets consist of: | |||
Other assets and deferred charges | 74,152 | 94,754 | |
Accrued compensation and employee benefits | 0 | 0 | |
Other liabilities (deferred compensation) | 0 | 0 | |
Total assets (liabilities) | 74,152 | 94,754 | |
Accumulated Other Comprehensive Loss (Earnings): | |||
Net actuarial losses (gains) | 55,227 | 33,545 | |
Prior service cost (credit) | 0 | 110 | |
Tax (benefit) expense | (11,474) | (6,686) | |
Total accumulated other comprehensive loss (earnings), net of tax | 43,753 | 26,969 | |
Net amount recognized at December 31, | 117,905 | 121,723 | |
Accumulated benefit obligations | 318,275 | 471,871 | |
Qualified Defined Benefits | Qualified Defined Benefits | Foreign Plan | |||
Change in benefit obligation: | |||
Benefit obligation at beginning of year | 314,715 | 340,829 | |
Service cost | 4,675 | 5,749 | 5,345 |
Interest cost | 5,220 | 3,590 | 3,697 |
Plan participants' contributions | 2,186 | 2,009 | |
Benefits paid | (9,756) | (7,519) | |
Actuarial gains | (72,977) | (20,766) | |
Amendments | (2,291) | 1,828 | |
Settlements and curtailments | (8,849) | (3,517) | |
Currency translation and other | (17,606) | (7,488) | |
Benefit obligation at end of year | 215,317 | 314,715 | 340,829 |
Change in plan assets: | |||
Fair value of plan assets at beginning of year | 219,677 | 212,748 | |
Actual return on plan assets | (48,147) | 10,664 | |
Company contributions | 9,059 | 8,121 | |
Plan participants' contributions | 2,186 | 2,009 | |
Benefits paid | (9,756) | (7,519) | |
Settlements and curtailments | (8,640) | (2,287) | |
Currency translation and other | (11,519) | (4,059) | |
Fair value of plan assets at end of year | 152,860 | 219,677 | 212,748 |
Funded (Unfunded) status | (62,457) | (95,038) | |
Amounts recognized in the consolidated balance sheets consist of: | |||
Other assets and deferred charges | 1,863 | 1,575 | |
Accrued compensation and employee benefits | (1,774) | (1,729) | |
Other liabilities (deferred compensation) | (62,546) | (94,884) | |
Total assets (liabilities) | (62,457) | (95,038) | |
Accumulated Other Comprehensive Loss (Earnings): | |||
Net actuarial losses (gains) | 31,607 | 50,878 | |
Prior service cost (credit) | (3,006) | (1,303) | |
Tax (benefit) expense | (6,434) | (11,836) | |
Total accumulated other comprehensive loss (earnings), net of tax | 22,167 | 37,739 | |
Net amount recognized at December 31, | (40,290) | (57,299) | |
Accumulated benefit obligations | 210,259 | 302,929 | |
Non-Qualified Supplemental Benefits | Non-Qualified Supplemental Benefits | |||
Change in benefit obligation: | |||
Benefit obligation at beginning of year | 42,905 | 51,194 | |
Service cost | 1,426 | 1,561 | 1,272 |
Interest cost | 1,215 | 1,232 | 1,765 |
Plan participants' contributions | 0 | 0 | |
Benefits paid | (3,831) | (5,331) | |
Actuarial gains | (9,596) | (4,568) | |
Amendments | 384 | 0 | |
Settlements and curtailments | 0 | (1,183) | |
Currency translation and other | 0 | 0 | |
Benefit obligation at end of year | 32,503 | 42,905 | 51,194 |
Change in plan assets: | |||
Fair value of plan assets at beginning of year | 0 | 0 | |
Actual return on plan assets | 0 | 0 | |
Company contributions | 3,831 | 6,262 | |
Plan participants' contributions | 0 | 0 | |
Benefits paid | (3,831) | (5,331) | |
Settlements and curtailments | 0 | (931) | |
Currency translation and other | 0 | 0 | |
Fair value of plan assets at end of year | 0 | 0 | $ 0 |
Funded (Unfunded) status | (32,503) | (42,905) | |
Amounts recognized in the consolidated balance sheets consist of: | |||
Other assets and deferred charges | 0 | 0 | |
Accrued compensation and employee benefits | (7,243) | (4,776) | |
Other liabilities (deferred compensation) | (25,260) | (38,129) | |
Total assets (liabilities) | (32,503) | (42,905) | |
Accumulated Other Comprehensive Loss (Earnings): | |||
Net actuarial losses (gains) | (28,304) | (20,724) | |
Prior service cost (credit) | 1,874 | 2,980 | |
Tax (benefit) expense | 5,768 | 3,840 | |
Total accumulated other comprehensive loss (earnings), net of tax | (20,662) | (13,904) | |
Net amount recognized at December 31, | (53,165) | (56,809) | |
Accumulated benefit obligations | $ 31,523 | $ 41,110 |
Employee Benefit Plans - Accumu
Employee Benefit Plans - Accumulated Benefit Obligations (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Pension Plans with Accumulated Benefit Obligations in Excess of Plan Assets [Abstract] | ||
Accumulated benefit obligation | $ 124,082 | $ 193,710 |
Fair value of plan assets | 64,112 | 106,519 |
Defined Benefit Plan, Pension Plan with Project Benefit Obligation in Excess of Plan Assets [Abstract] | ||
Projected benefit obligation | 200,671 | 292,701 |
Fair value of plan assets | $ 136,351 | $ 196,088 |
Employee Benefit Plans - Net Pe
Employee Benefit Plans - Net Periodic Benefit Cost (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Net periodic benefit cost [Abstract] | |||
Settlement and curtailment impact | $ (3,688) | $ (1,167) | $ (18) |
Employee benefit plan expense | 3,096 | 11,897 | 7,205 |
Non-Qualified Supplemental Benefits | Non-Qualified Supplemental Benefits | |||
Net periodic benefit cost [Abstract] | |||
Service cost | 1,426 | 1,561 | 1,272 |
Interest cost | 1,215 | 1,232 | 1,765 |
Expected return on plan assets | 0 | 0 | 0 |
Prior service cost (credit) | 1,490 | 1,531 | 1,695 |
Recognized actuarial loss (gain) | (2,016) | (1,672) | (1,857) |
Settlement and curtailment impact | 0 | (743) | 0 |
Employee benefit plan expense | 2,115 | 1,909 | 2,875 |
United States | Qualified Defined Benefits | Qualified Defined Benefits | |||
Net periodic benefit cost [Abstract] | |||
Service cost | 5,703 | 7,134 | 6,824 |
Interest cost | 13,745 | 13,605 | 16,272 |
Expected return on plan assets | (29,104) | (28,980) | (31,475) |
Prior service cost (credit) | 110 | 212 | 227 |
Recognized actuarial loss (gain) | 2,300 | 10,012 | 7,536 |
Settlement and curtailment impact | 6,276 | 2,031 | 0 |
Employee benefit plan expense | (970) | 4,014 | (616) |
Foreign Plan | Qualified Defined Benefits | Qualified Defined Benefits | |||
Net periodic benefit cost [Abstract] | |||
Service cost | 4,675 | 5,749 | 5,345 |
Interest cost | 5,220 | 3,590 | 3,697 |
Expected return on plan assets | (7,191) | (7,188) | (6,837) |
Prior service cost (credit) | (526) | (453) | (493) |
Recognized actuarial loss (gain) | 1,747 | 3,938 | 3,047 |
Settlement and curtailment impact | (393) | 194 | 25 |
Employee benefit plan expense | $ 3,532 | $ 5,830 | $ 4,784 |
Employee Benefit Plans - Assump
Employee Benefit Plans - Assumptions (Details) | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Non-Qualified Supplemental Benefits | Non-Qualified Supplemental Benefits | |||
Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract] | |||
Discount rate | 5.50% | 2.90% | |
Average wage increase | 4.50% | 4.50% | |
Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract] | |||
Discount rate | 2.90% | 2.45% | 3.20% |
Average wage increase | 4.50% | 4.50% | 4.50% |
United States | Qualified Defined Benefits | Qualified Defined Benefits | |||
Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract] | |||
Discount rate | 5.55% | 2.95% | |
Average wage increase | 4% | 4% | |
Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract] | |||
Discount rate | 2.95% | 2.65% | 3.40% |
Average wage increase | 4% | 4% | 4% |
Expected return on plan assets | 5.60% | 5.60% | 6.30% |
Foreign Plan | Qualified Defined Benefits | Qualified Defined Benefits | |||
Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract] | |||
Discount rate | 3.57% | 1.18% | |
Average wage increase | 1.70% | 1.53% | |
Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract] | |||
Discount rate | 1.18% | 0.79% | 1.18% |
Average wage increase | 1.53% | 1.51% | 1.80% |
Expected return on plan assets | 3.47% | 3.40% | 3.69% |
Employee Benefit Plans - Actual
Employee Benefit Plans - Actual and Target Allocations of Plan Assets (Details) | Dec. 31, 2022 | Dec. 31, 2021 |
Defined Benefit Plan, Plan Assets, Allocations [Abstract] | ||
Actual plan asset allocations | 100% | 100% |
Target plan asset allocations | 100% | |
Return-seeking investments | ||
Defined Benefit Plan, Plan Assets, Allocations [Abstract] | ||
Actual plan asset allocations | 27% | 29% |
Target plan asset allocations | 30% | |
Liability hedging investments | ||
Defined Benefit Plan, Plan Assets, Allocations [Abstract] | ||
Actual plan asset allocations | 73% | 69% |
Target plan asset allocations | 70% | |
Other | ||
Defined Benefit Plan, Plan Assets, Allocations [Abstract] | ||
Actual plan asset allocations | 0% | 2% |
Target plan asset allocations | 0% |
Employee Benefit Plans - Fair V
Employee Benefit Plans - Fair Value of Plan Assets (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 |
Level 3 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | $ 16,294 | $ 20,252 | $ 21,276 |
United States | Qualified Defined Benefits | Qualified Defined Benefits | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 394,053 | 573,100 | 606,896 |
Total investments at fair value | 261,081 | 392,709 | |
United States | Qualified Defined Benefits | Qualified Defined Benefits | Level 1 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 2,900 | 3,227 | |
Total investments at fair value | 2,900 | 3,227 | |
United States | Qualified Defined Benefits | Qualified Defined Benefits | Level 2 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 258,181 | 389,482 | |
Total investments at fair value | 258,181 | 389,482 | |
United States | Qualified Defined Benefits | Qualified Defined Benefits | Corporate bonds | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 201,203 | 316,367 | |
United States | Qualified Defined Benefits | Qualified Defined Benefits | Corporate bonds | Level 1 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 0 | 0 | |
United States | Qualified Defined Benefits | Qualified Defined Benefits | Corporate bonds | Level 2 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 201,203 | 316,367 | |
United States | Qualified Defined Benefits | Qualified Defined Benefits | Government securities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 56,978 | 73,115 | |
United States | Qualified Defined Benefits | Qualified Defined Benefits | Government securities | Level 1 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 0 | 0 | |
United States | Qualified Defined Benefits | Qualified Defined Benefits | Government securities | Level 2 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 56,978 | 73,115 | |
United States | Qualified Defined Benefits | Qualified Defined Benefits | Interest-bearing cash and short-term investments | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 2,900 | 3,227 | |
United States | Qualified Defined Benefits | Qualified Defined Benefits | Interest-bearing cash and short-term investments | Level 1 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 2,900 | 3,227 | |
United States | Qualified Defined Benefits | Qualified Defined Benefits | Interest-bearing cash and short-term investments | Level 2 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 0 | 0 | |
United States | Qualified Defined Benefits | Qualified Defined Benefits | Collective funds | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 106,273 | 167,551 | |
United States | Qualified Defined Benefits | Qualified Defined Benefits | Collective funds | Level 1 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 0 | 0 | |
United States | Qualified Defined Benefits | Qualified Defined Benefits | Collective funds | Level 2 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 0 | 0 | |
United States | Qualified Defined Benefits | Qualified Defined Benefits | Short-term investment funds | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 26,699 | 12,840 | |
United States | Qualified Defined Benefits | Qualified Defined Benefits | Short-term investment funds | Level 1 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 0 | 0 | |
United States | Qualified Defined Benefits | Qualified Defined Benefits | Short-term investment funds | Level 2 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 0 | 0 | |
Foreign Plan | Qualified Defined Benefits | Qualified Defined Benefits | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 152,860 | 219,677 | $ 212,748 |
Total investments at fair value | 110,016 | 142,526 | |
Foreign Plan | Qualified Defined Benefits | Qualified Defined Benefits | Level 1 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 67,558 | 92,363 | |
Total investments at fair value | 67,558 | 92,363 | |
Foreign Plan | Qualified Defined Benefits | Qualified Defined Benefits | Level 2 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 26,164 | 29,911 | |
Total investments at fair value | 26,164 | 29,911 | |
Foreign Plan | Qualified Defined Benefits | Qualified Defined Benefits | Level 3 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 16,294 | 20,252 | |
Total investments at fair value | 16,294 | 20,252 | |
Foreign Plan | Qualified Defined Benefits | Qualified Defined Benefits | Collective funds | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 39,675 | 72,235 | |
Foreign Plan | Qualified Defined Benefits | Qualified Defined Benefits | Collective funds | Level 1 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 0 | 0 | |
Foreign Plan | Qualified Defined Benefits | Qualified Defined Benefits | Collective funds | Level 2 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 0 | 0 | |
Foreign Plan | Qualified Defined Benefits | Qualified Defined Benefits | Collective funds | Level 3 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 0 | 0 | |
Foreign Plan | Qualified Defined Benefits | Qualified Defined Benefits | Cash and cash equivalents | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 909 | 3,634 | |
Foreign Plan | Qualified Defined Benefits | Qualified Defined Benefits | Cash and cash equivalents | Level 1 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 909 | 3,634 | |
Foreign Plan | Qualified Defined Benefits | Qualified Defined Benefits | Cash and cash equivalents | Level 2 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 0 | 0 | |
Foreign Plan | Qualified Defined Benefits | Qualified Defined Benefits | Cash and cash equivalents | Level 3 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 0 | 0 | |
Foreign Plan | Qualified Defined Benefits | Qualified Defined Benefits | Common stocks | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 46,618 | 58,054 | |
Foreign Plan | Qualified Defined Benefits | Qualified Defined Benefits | Common stocks | Level 1 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 46,618 | 58,054 | |
Foreign Plan | Qualified Defined Benefits | Qualified Defined Benefits | Common stocks | Level 2 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 0 | 0 | |
Foreign Plan | Qualified Defined Benefits | Qualified Defined Benefits | Common stocks | Level 3 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 0 | 0 | |
Foreign Plan | Qualified Defined Benefits | Qualified Defined Benefits | Fixed income investments | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 25,168 | 27,034 | |
Foreign Plan | Qualified Defined Benefits | Qualified Defined Benefits | Fixed income investments | Level 1 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 0 | 0 | |
Foreign Plan | Qualified Defined Benefits | Qualified Defined Benefits | Fixed income investments | Level 2 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 25,168 | 27,034 | |
Foreign Plan | Qualified Defined Benefits | Qualified Defined Benefits | Fixed income investments | Level 3 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 0 | 0 | |
Foreign Plan | Qualified Defined Benefits | Qualified Defined Benefits | Mutual funds | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 20,031 | 30,675 | |
Foreign Plan | Qualified Defined Benefits | Qualified Defined Benefits | Mutual funds | Level 1 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 20,031 | 30,675 | |
Foreign Plan | Qualified Defined Benefits | Qualified Defined Benefits | Mutual funds | Level 2 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 0 | 0 | |
Foreign Plan | Qualified Defined Benefits | Qualified Defined Benefits | Mutual funds | Level 3 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 0 | 0 | |
Foreign Plan | Qualified Defined Benefits | Qualified Defined Benefits | Other | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 17,290 | 23,129 | |
Foreign Plan | Qualified Defined Benefits | Qualified Defined Benefits | Other | Level 1 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 0 | 0 | |
Foreign Plan | Qualified Defined Benefits | Qualified Defined Benefits | Other | Level 2 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 996 | 2,877 | |
Foreign Plan | Qualified Defined Benefits | Qualified Defined Benefits | Other | Level 3 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 16,294 | 20,252 | |
Foreign Plan | Qualified Defined Benefits | Qualified Defined Benefits | Other | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 3,169 | 4,916 | |
Foreign Plan | Qualified Defined Benefits | Qualified Defined Benefits | Other | Level 1 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 0 | 0 | |
Foreign Plan | Qualified Defined Benefits | Qualified Defined Benefits | Other | Level 2 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | 0 | 0 | |
Foreign Plan | Qualified Defined Benefits | Qualified Defined Benefits | Other | Level 3 | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Total investments | $ 0 | $ 0 |
Employee Benefit Plans - Plan A
Employee Benefit Plans - Plan Asset Rollforward (Details) - Level 3 - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Defined Benefit Plan, Change in Fair Value of Plan Assets, Level 3 Reconciliation [Roll Forward] | ||
Fair value of plan assets at beginning of year | $ 20,252 | $ 21,276 |
Relating to assets still held at December 31, 2021 | (382) | 48 |
Relating to assets sold during the period | 0 | 0 |
Purchases | 1,852 | 1,664 |
Sales and settlements | (4,808) | (2,158) |
Foreign currency translation | (620) | (578) |
Fair value of plan assets at end of year | $ 16,294 | $ 20,252 |
Employee Benefit Plans - Benefi
Employee Benefit Plans - Benefit Payments and Contributions (Details) $ in Thousands | Dec. 31, 2022 USD ($) |
Non-Qualified Supplemental Benefits | Non-Qualified Supplemental Benefits | |
Expected Future Benefit Payments by Fiscal Year [Abstract] | |
2023 | $ 7,440 |
2024 | 5,231 |
2025 | 2,312 |
2026 | 4,599 |
2027 | 1,800 |
2028 - 2032 | 14,348 |
United States | Qualified Defined Benefits | Qualified Defined Benefits | |
Expected Future Benefit Payments by Fiscal Year [Abstract] | |
2023 | 25,946 |
2024 | 27,511 |
2025 | 26,121 |
2026 | 25,567 |
2027 | 25,307 |
2028 - 2032 | 122,304 |
Foreign Plan | Qualified Defined Benefits | Qualified Defined Benefits | |
Expected Future Benefit Payments by Fiscal Year [Abstract] | |
2023 | 10,677 |
2024 | 10,969 |
2025 | 10,800 |
2026 | 11,859 |
2027 | 14,156 |
2028 - 2032 | $ 68,857 |
Accumulated Other Comprehensi_3
Accumulated Other Comprehensive Earnings (Loss) - Summary (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ||
Adoption of ASU No. 2016-13- CECL | $ 4,286,366 | $ 4,189,528 |
Cumulative foreign currency translation adjustments | ||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ||
Adoption of ASU No. 2016-13- CECL | (220,224) | (107,130) |
Pension and other postretirement benefit plans | ||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ||
Adoption of ASU No. 2016-13- CECL | (45,258) | (50,448) |
Cash flow hedges: | ||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ||
Adoption of ASU No. 2016-13- CECL | (741) | 3,526 |
Accumulated Other Comprehensive Earnings (Loss) | ||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ||
Adoption of ASU No. 2016-13- CECL | $ (266,223) | $ (154,052) |
Accumulated Other Comprehensi_4
Accumulated Other Comprehensive Earnings (Loss) - Reclassifications (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||
Selling, general and administrative expenses | $ 1,684,226 | $ 1,688,278 | $ 1,541,032 |
Tax benefit | 222,129 | 277,008 | 158,283 |
Net of tax | (1,065,376) | (1,123,818) | (683,451) |
Other income, net | (20,201) | (14,858) | (11,900) |
Earnings before provision for income taxes | (1,287,505) | (1,400,826) | (841,734) |
Reclassification out of Accumulated Other Comprehensive Income | Cumulative foreign currency translation adjustments | |||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||
Selling, general and administrative expenses | 5,915 | 0 | 0 |
Tax benefit | 0 | 0 | 0 |
Net of tax | 5,915 | 0 | 0 |
Reclassification out of Accumulated Other Comprehensive Income | Pension and other postretirement benefit plans | |||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||
Tax benefit | (1,842) | (3,423) | (2,184) |
Net of tax | 6,479 | 11,641 | 7,866 |
Earnings before provision for income taxes | 8,321 | 15,064 | 10,050 |
Reclassification out of Accumulated Other Comprehensive Income | Amortization of actuarial losses | |||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||
Other income, net | 2,965 | 12,278 | 8,583 |
Reclassification out of Accumulated Other Comprehensive Income | Amortization of prior service costs and transition obligation | |||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||
Other income, net | 1,074 | 1,304 | 1,442 |
Reclassification out of Accumulated Other Comprehensive Income | Settlement and curtailment | |||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||
Other income, net | 4,282 | 1,482 | 25 |
Reclassification out of Accumulated Other Comprehensive Income | Cash flow hedges: | |||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||
Tax benefit | 1,065 | 1,400 | 185 |
Net of tax | (3,732) | (4,871) | (632) |
Earnings before provision for income taxes | $ (4,797) | $ (6,271) | $ (817) |
Segment Information- Reporting
Segment Information- Reporting Information by Segment (Details) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 USD ($) segment | Dec. 31, 2021 USD ($) | Dec. 31, 2020 USD ($) | |
Segment Reporting [Abstract] | |||
Number of reportable segments | segment | 5 | ||
Reconciliation from Segment Totals to Consolidated [Abstract] | |||
Revenue | $ 8,508,088 | $ 7,907,081 | $ 6,683,760 |
Earnings before provision for income taxes | 1,287,505 | 1,400,826 | 841,734 |
Purchase accounting expenses | 181,103 | 141,980 | 138,515 |
Restructuring and other costs | 38,990 | 38,436 | 51,472 |
Loss (gain) on dispositions | 194 | (206,338) | (5,213) |
Interest expense | 116,456 | 106,319 | 111,937 |
Interest income | 4,430 | 4,441 | 3,571 |
Provision for income taxes | 222,129 | 277,008 | 158,283 |
Net earnings | $ 1,065,376 | $ 1,123,818 | $ 683,451 |
Segment margins: | |||
Net earnings (in percent) | 12.50% | 14.20% | 10.20% |
Depreciation and amortization | $ 307,538 | $ 290,123 | $ 279,051 |
Restructuring | 30,480 | 26,705 | 44,468 |
Other costs, net | 8,510 | 11,731 | 7,004 |
Restructuring and other costs | 38,990 | 38,436 | 51,472 |
Total segments | |||
Reconciliation from Segment Totals to Consolidated [Abstract] | |||
Earnings before provision for income taxes | $ 1,755,098 | $ 1,633,080 | $ 1,254,235 |
Segment margins: | |||
Total Segments (in percent) | 20.60% | 20.70% | 18.80% |
Other depreciation and amortization | $ 137,788 | $ 133,326 | $ 128,339 |
Intersegment eliminations | |||
Reconciliation from Segment Totals to Consolidated [Abstract] | |||
Revenue | (3,825) | (2,075) | (2,070) |
Corporate | |||
Reconciliation from Segment Totals to Consolidated [Abstract] | |||
Other Nonoperating Expense | 135,280 | 156,298 | 119,361 |
Segment margins: | |||
Other depreciation and amortization | 8,137 | 7,250 | 6,535 |
Depreciation and amortization included in purchase accounting expenses and restructuring and other | 161,613 | 149,547 | 144,177 |
Restructuring | 2,321 | 2,021 | 4,145 |
Engineered Products | Total segments | |||
Reconciliation from Segment Totals to Consolidated [Abstract] | |||
Revenue | 2,043,632 | 1,780,827 | 1,531,277 |
Earnings before provision for income taxes | $ 346,519 | $ 277,852 | $ 265,143 |
Segment margins: | |||
Total Segments (in percent) | 17% | 15.60% | 17.30% |
Other depreciation and amortization | $ 27,745 | $ 27,036 | $ 25,242 |
Restructuring | 3,194 | 9,507 | 10,307 |
Clean Energy & Fueling | Total segments | |||
Reconciliation from Segment Totals to Consolidated [Abstract] | |||
Revenue | 1,878,507 | 1,648,153 | 1,476,282 |
Earnings before provision for income taxes | $ 352,993 | $ 327,186 | $ 290,233 |
Segment margins: | |||
Total Segments (in percent) | 18.80% | 19.90% | 19.70% |
Other depreciation and amortization | $ 28,815 | $ 25,842 | $ 26,053 |
Restructuring | 9,571 | 3,609 | 6,681 |
Imaging & Identification | Total segments | |||
Reconciliation from Segment Totals to Consolidated [Abstract] | |||
Revenue | 1,123,815 | 1,163,367 | 1,038,178 |
Earnings before provision for income taxes | $ 268,084 | $ 266,932 | $ 224,033 |
Segment margins: | |||
Total Segments (in percent) | 23.90% | 22.90% | 21.60% |
Other depreciation and amortization | $ 14,185 | $ 14,189 | $ 13,795 |
Restructuring | 4,702 | 4,589 | 5,946 |
Pumps & Process Solutions | Total segments | |||
Reconciliation from Segment Totals to Consolidated [Abstract] | |||
Revenue | 1,728,235 | 1,708,634 | 1,324,003 |
Earnings before provision for income taxes | $ 533,018 | $ 575,593 | $ 348,733 |
Segment margins: | |||
Total Segments (in percent) | 30.80% | 33.70% | 26.30% |
Other depreciation and amortization | $ 40,839 | $ 39,272 | $ 38,667 |
Restructuring | 4,685 | 1,911 | 13,374 |
Climate & Sustainability Technologies | Total segments | |||
Reconciliation from Segment Totals to Consolidated [Abstract] | |||
Revenue | 1,737,724 | 1,608,175 | 1,316,090 |
Earnings before provision for income taxes | $ 254,484 | $ 185,517 | $ 126,093 |
Segment margins: | |||
Total Segments (in percent) | 14.60% | 11.50% | 9.60% |
Other depreciation and amortization | $ 26,204 | $ 26,987 | $ 24,582 |
Restructuring | $ 6,007 | $ 5,068 | $ 4,015 |
Segment Information - Reconcili
Segment Information - Reconciliation (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Capital expenditures: | |||
Capital expenditures: | $ 220,962 | $ 171,465 | $ 165,692 |
Total assets | 10,896,519 | 10,403,627 | |
Corporate | |||
Capital expenditures: | |||
Capital expenditures: | 8,770 | 8,261 | 8,857 |
Total assets | 548,262 | 584,797 | |
Engineered Products | Total segments | |||
Capital expenditures: | |||
Capital expenditures: | 39,765 | 48,453 | 23,515 |
Total assets | 1,771,689 | 1,678,317 | |
Clean Energy & Fueling | Total segments | |||
Capital expenditures: | |||
Capital expenditures: | 33,489 | 25,167 | 26,903 |
Total assets | 3,068,260 | 3,201,504 | |
Imaging & Identification | Total segments | |||
Capital expenditures: | |||
Capital expenditures: | 14,695 | 10,671 | 10,690 |
Total assets | 1,821,649 | 1,871,039 | |
Pumps & Process Solutions | Total segments | |||
Capital expenditures: | |||
Capital expenditures: | 82,817 | 44,578 | 52,804 |
Total assets | 2,161,210 | 1,709,852 | |
Climate & Sustainability Technologies | Total segments | |||
Capital expenditures: | |||
Capital expenditures: | 41,426 | 34,335 | $ 42,923 |
Total assets | $ 1,525,449 | $ 1,358,118 |
Segment Information - Revenue a
Segment Information - Revenue and Long-Lived Assets by Geography (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Revenue | $ 8,508,088 | $ 7,907,081 | $ 6,683,760 |
Long-lived assets | 1,004,825 | 957,310 | |
United States | |||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Revenue | 4,847,321 | 4,305,957 | 3,677,285 |
Long-lived assets | 629,140 | 584,948 | |
Europe | |||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Revenue | 1,792,020 | 1,797,138 | 1,482,520 |
Long-lived assets | 291,921 | 283,952 | |
Asia | |||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Revenue | 939,093 | 901,141 | 745,150 |
Long-lived assets | 57,253 | 62,210 | |
Other Americas | |||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Revenue | 667,673 | 612,751 | 535,091 |
Long-lived assets | 21,763 | 20,627 | |
Other | |||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Revenue | 261,981 | 290,094 | $ 243,714 |
Long-lived assets | $ 4,748 | $ 5,573 |
Earnings per Share - Reconcilia
Earnings per Share - Reconciliation of the information (Details) - USD ($) $ / shares in Units, $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Earnings Per Share [Abstract] | |||
Net earnings | $ 1,065,376 | $ 1,123,818 | $ 683,451 |
Basic earnings per common share: | |||
Net earnings (in dollars per basic share) | $ 7.47 | $ 7.81 | $ 4.74 |
Weighted average basic shares outstanding (in shares) | 142,681,000 | 143,923,000 | 144,050,000 |
Diluted earnings per common share: | |||
Net earnings (in dollars per diluted share) | $ 7.42 | $ 7.74 | $ 4.70 |
Weighted average diluted shares outstanding (in shares) | 143,595,000 | 145,273,000 | 145,393,000 |
Earnings per Share - Reconcil_2
Earnings per Share - Reconciliation (Details) - shares | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Earnings Per Share [Abstract] | |||
Weighted average shares outstanding - basic | 142,681,000 | 143,923,000 | 144,050,000 |
Dilutive effect of assumed exercise of SARs and vesting of performance shares and RSUs | 914,000 | 1,350,000 | 1,343,000 |
Weighted average shares outstanding - diluted | 143,595,000 | 145,273,000 | 145,393,000 |
Earnings per Share - Narrative
Earnings per Share - Narrative (Details) - shares | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Earnings Per Share [Abstract] | |||
Weighted average number of anti-dilutive potential common shares excluded from reconciliation calculations (in shares) | 21,173 | 1,072 | 30,378 |
Stockholders' Equity (Details)
Stockholders' Equity (Details) - USD ($) $ / shares in Units, $ in Thousands | 1 Months Ended | 12 Months Ended | ||||||
Sep. 01, 2022 | Dec. 31, 2022 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | Aug. 31, 2022 | Nov. 30, 2020 | Feb. 28, 2018 | |
Schedule of share repurchases [Line Items] | ||||||||
Payments for repurchase of common stock (in dollars) | $ 585,000 | $ 21,637 | $ 106,279 | |||||
February 2018 Authorization | ||||||||
Schedule of share repurchases [Line Items] | ||||||||
Number of shares authorized to be repurchased | 20,000,000 | |||||||
Remaining number of shares authorized to be repurchased | 7,380,879 | |||||||
November 2020 Authorization | ||||||||
Schedule of share repurchases [Line Items] | ||||||||
Number of shares authorized to be repurchased | 20,000,000 | |||||||
Remaining number of shares authorized to be repurchased | 15,283,326 | 15,283,326 | ||||||
Shares repurchased | 641,428 | 182,951 | 979,165 | |||||
Average price per share for repurchased shares (in dollars per share) | $ 132.52 | $ 118.27 | $ 108.54 | |||||
Payments for repurchase of common stock (in dollars) | $ 85,000 | $ 21,637 | $ 106,279 | |||||
August 2022 ASR Agreement | ||||||||
Schedule of share repurchases [Line Items] | ||||||||
Payment for ASR agreement | $ 500,000 | $ 500,000 | ||||||
Shares repurchased | 3,201,025 | 691,270 | 3,892,295 | |||||
Average price per share for repurchased shares (in dollars per share) | $ 128.46 |
SCHEDULE_II VALUATION AND QUA_2
SCHEDULE II VALUATION AND QUALIFYING ACCOUNTS (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Deferred Tax Valuation Allowance | |||
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward] | |||
Balance at Beginning of Year | $ 306,066 | $ 287,679 | $ 244,153 |
Additions | 4,960 | 38,514 | 49,130 |
Reductions | (39,823) | (20,127) | (5,604) |
Balance at End of Year | 271,203 | 306,066 | 287,679 |
LIFO Reserve | |||
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward] | |||
Balance at Beginning of Year | 13,155 | 7,149 | 11,428 |
Charged to Cost and Expense | 2,329 | 7,220 | 357 |
Reductions | (1,333) | (1,214) | (4,636) |
Balance at End of Year | $ 14,151 | $ 13,155 | $ 7,149 |